<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Platelet‐rich therapies for musculoskeletal soft tissue injuries - Moraes, VY - 2014 | Cochrane Library</title> <meta content="Platelet‐rich therapies for musculoskeletal soft tissue injuries - Moraes, VY - 2014 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010071.pub3/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Platelet‐rich therapies for musculoskeletal soft tissue injuries - Moraes, VY - 2014 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010071.pub3/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD010071.pub3" name="dc.identifier" scheme="DOI"/> <meta content="Platelet‐rich therapies for musculoskeletal soft tissue injuries" name="citation_title"/> <meta content="Vinícius Y Moraes" name="citation_author"/> <meta content="Universidade Federal de São Paulo" name="citation_author_institution"/> <meta content="vymoraes@gmail.com" name="citation_author_email"/> <meta content="Mário Lenza" name="citation_author"/> <meta content="Hospital Israelita Albert Einstein" name="citation_author_institution"/> <meta content="Marcel Jun Tamaoki" name="citation_author"/> <meta content="Universidade Federal de São Paulo" name="citation_author_institution"/> <meta content="Flávio Faloppa" name="citation_author"/> <meta content="Universidade Federal de São Paulo" name="citation_author_institution"/> <meta content="João Carlos Belloti" name="citation_author"/> <meta content="Universidade Federal de São Paulo" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="4" name="citation_issue"/> <meta content="10.1002/14651858.CD010071.pub3" name="citation_doi"/> <meta content="2014" name="citation_date"/> <meta content="2014/04/29" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010071.pub3/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010071.pub3/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010071.pub3/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="*Platelet‐Rich Plasma; Achilles Tendon [injuries]; Anterior Cruciate Ligament Reconstruction; Blood Transfusion, Autologous; Platelet Transfusion [*methods]; Randomized Controlled Trials as Topic; Rotator Cuff Injuries; Shoulder Impingement Syndrome [therapy]; Soft Tissue Injuries [*therapy]; Tendinopathy [therapy]; Tennis Elbow [therapy]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010071.pub3&amp;doi=10.1002/14651858.CD010071.pub3&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010071.pub3&amp;doi=10.1002/14651858.CD010071.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010071.pub3&amp;doi=10.1002/14651858.CD010071.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010071.pub3&amp;doi=10.1002/14651858.CD010071.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010071.pub3&amp;doi=10.1002/14651858.CD010071.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010071.pub3&amp;doi=10.1002/14651858.CD010071.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010071.pub3&amp;doi=10.1002/14651858.CD010071.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010071.pub3&amp;doi=10.1002/14651858.CD010071.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010071.pub3&amp;doi=10.1002/14651858.CD010071.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010071.pub3&amp;doi=10.1002/14651858.CD010071.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010071.pub3&amp;doi=10.1002/14651858.CD010071.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010071.pub3&amp;doi=10.1002/14651858.CD010071.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010071.pub3&amp;doi=10.1002/14651858.CD010071.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010071.pub3&amp;doi=10.1002/14651858.CD010071.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010071.pub3&amp;doi=10.1002/14651858.CD010071.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010071.pub3&amp;doi=10.1002/14651858.CD010071.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010071.pub3&amp;doi=10.1002/14651858.CD010071.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010071.pub3&amp;doi=10.1002/14651858.CD010071.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010071.pub3&amp;doi=10.1002/14651858.CD010071.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010071.pub3&amp;doi=10.1002/14651858.CD010071.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010071.pub3&amp;doi=10.1002/14651858.CD010071.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010071.pub3&amp;doi=10.1002/14651858.CD010071.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010071.pub3&amp;doi=10.1002/14651858.CD010071.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773519000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773548000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="IYhCEbRn";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD010071\x2epub3\x26doi\x3d10\x2e1002\x2f14651858\x2eCD010071\x2epub3\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010071\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010071\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","de","hr","fr","fa"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD010071.pub3",title:"Platelet\\u2010rich therapies for musculoskeletal soft tissue injuries",firstPublishedDate:"Apr 29, 2014 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Bone, Joint and Muscle Trauma Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734739000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=IYhCEbRn&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010071.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD010071.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD010071.pub3/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD010071.pub3/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010071.pub3%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD010071.PUB3" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Laienverständliche Zusammenfassung&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]},{&quot;param&quot;: &quot;comments&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Comments&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD010071.pub3/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD010071.PUB3" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD010071.pub3/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD010071.pub3/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>11547 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD010071.pub3" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010071.pub3/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010071.pub3/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010071.pub3/full#CD010071-abs-0004"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010071.pub3/full#CD010071-sec-0115"> Authors' conclusions </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010071.pub3/full#CD010071-sec-0022"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010071.pub3/full#CD010071-sec-0027"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010071.pub3/full#CD010071-sec-0028"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010071.pub3/full#CD010071-sec-0052"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010071.pub3/full#CD010071-sec-0109"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010071.pub3/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010071.pub3/appendices#CD010071-sec-0120"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010071.pub3/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010071.pub3/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/table_n/CD010071StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/table_n/CD010071StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010071.pub3/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010071.pub3/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010071.pub3/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD010071.pub3/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD010071.pub3/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD010071.pub3/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2014 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Platelet‐rich therapies for musculoskeletal soft tissue injuries</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010071.pub3/information#CD010071-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Vinícius Y Moraes</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010071.pub3/information#CD010071-cr-0003">Mário Lenza</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010071.pub3/information#CD010071-cr-0004">Marcel Jun Tamaoki</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010071.pub3/information#CD010071-cr-0005">Flávio Faloppa</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010071.pub3/information#CD010071-cr-0006">João Carlos Belloti</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/information/en#CD010071-sec-0133">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 29 April 2014 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD010071.pub3">https://doi.org/10.1002/14651858.CD010071.pub3</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD010071-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010071-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD010071-abs-0003">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD010071-abs-0009">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD010071-abs-0002">Français</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD010071-abs-0001" lang="en"> <section id="CD010071-sec-0001"> <h3 class="title" id="CD010071-sec-0001">Background</h3> <p>Platelet‐rich therapies are being used increasingly in the treatment of musculoskeletal soft tissue injuries such as ligament, muscle and tendon tears and tendinopathies. These therapies can be used as the principal treatment or as an augmentation procedure (application after surgical repair or reconstruction). Platelet‐rich therapies are produced by centrifuging a quantity of the patient’s own blood and extracting the active, platelet‐rich, fraction. The platelet‐rich fraction is applied to the injured tissue; for example, by injection. Platelets have the ability to produce several growth factors, so these therapies should enhance tissue healing. There is a need to assess whether this translates into clinical benefit. </p> </section> <section id="CD010071-sec-0002"> <h3 class="title" id="CD010071-sec-0002">Objectives</h3> <p>To assess the effects (benefits and harms) of platelet‐rich therapies for treating musculoskeletal soft tissue injuries. </p> </section> <section id="CD010071-sec-0003"> <h3 class="title" id="CD010071-sec-0003">Search methods</h3> <p>We searched the Cochrane Bone, Joint and Muscle Trauma Group Specialised Register (25 March 2013), the Cochrane Central Register of Controlled Trials (CENTRAL 2013 Issue 2), MEDLINE (1946 to March 2013), EMBASE (1980 to 2013 Week 12) and LILACS (1982 to March 2012). We also searched trial registers (to Week 2 2013) and conference abstracts (2005 to March 2012). No language or publication restrictions were applied. </p> </section> <section id="CD010071-sec-0004"> <h3 class="title" id="CD010071-sec-0004">Selection criteria</h3> <p>We included randomised and quasi‐randomised controlled trials that compared platelet‐rich therapy with either placebo, autologous whole blood, dry needling or no platelet‐rich therapy for people with acute or chronic musculoskeletal soft tissue injuries. Primary outcomes were functional status, pain and adverse effects. </p> </section> <section id="CD010071-sec-0005"> <h3 class="title" id="CD010071-sec-0005">Data collection and analysis</h3> <p>Two review authors independently extracted data and assessed each study's risk of bias. Disagreement was resolved by discussion or by arbitration by a third author. We contacted trial authors for clarification of methods or missing data. Treatment effects were assessed using risk ratios for dichotomous data and mean differences (MD) or standardised mean differences (SMD) for continuous data, together with 95% confidence intervals. Where appropriate, data were pooled using the fixed‐effect model for RR and MD, and the random‐effects model for SMD. The quality of the evidence for each outcome was assessed using GRADE criteria. </p> </section> <section id="CD010071-sec-0006"> <h3 class="title" id="CD010071-sec-0006">Main results</h3> <p>We included data from 19 small single centre trials (17 randomised and two quasi‐randomised; 1088 participants) that compared platelet‐rich therapy with placebo, autologous whole blood, dry needling or no platelet‐rich therapy. These trials covered eight clinical conditions: rotator cuff tears (arthroscopic repair) (six trials); shoulder impingement syndrome surgery (one trial); elbow epicondylitis (three trials); anterior cruciate ligament (ACL) reconstruction (four trials), ACL reconstruction (donor graft site application) (two trials), patellar tendinopathy (one trial), Achilles tendinopathy (one trial) and acute Achilles rupture surgical repair (one trial). We also grouped trials into 'tendinopathies' where platelet‐rich therapy (PRT) injections were the main treatment (five trials), and surgical augmentation procedures where PRT was applied during surgery (14 trials). Trial participants were mainly male, except in trials including rotator cuff tears, and elbow and Achilles tendinopathies. </p> <p>Three trials were judged as being at low risk of bias; the other 16 were at high or unclear risk of bias relating to selection, detection, attrition or selective reporting, or combinations of these. The methods of preparing platelet‐rich plasma (PRP) varied and lacked standardisation and quantification of the PRP applied to the patient. </p> <p>We were able to pool data for our primary outcomes (function, pain, adverse events) for a maximum of 11 trials and 45% of participants. The evidence for all primary outcomes was judged as being of very low quality. </p> <p>Data assessing function in the short term (up to three months) were pooled from four trials that assessed PRT in three clinical conditions and used four different measures. These showed no significant difference between PRT and control (SMD 0.26; 95% confidence interval (CI) ‐0.19 to 0.71; P value 0.26; I² = 51%; 162 participants; positive values favour PRT). Medium‐term function data (at six months) were pooled from five trials that assessed PRT in five clinical conditions and used five different measures. These also showed no difference between groups (SMD ‐0.09, 95% CI ‐0.56 to 0.39; P value 0.72; I² = 50%; 151 participants). Long‐term function data (at one year) were pooled from 10 trials that assessed PRT in five clinical conditions and used six different measures. These also showed no difference between groups (SMD 0.25, 95% CI ‐0.07 to 0.57; P value 0.12; I² = 66%; 484 participants). Although the 95% confidence intervals indicate the possibility of a poorer outcome in the PRT group up to a moderate difference in favour of PRT at short‐ and long‐term follow‐up, these do not translate into clinically relevant differences. </p> <p>Data pooled from four trials that assessed PRT in three clinical conditions showed a small reduction in short‐term pain in favour of PRT on a 10‐point scale (MD ‐0.95, 95% CI ‐1.41 to ‐0.48; I² = 0%; 175 participants). The clinical significance of this result is marginal. </p> <p>Four trials reported adverse events; another seven trials reported an absence of adverse events. There was no difference between treatment groups in the numbers of participants with adverse effects (7/241 versus 5/245; RR 1.31, 95% CI 0.48 to 3.59; I² = 0%; 486 participants). </p> <p>In terms of individual conditions, we pooled heterogeneous data for long‐term function from six trials of PRT application during rotator cuff tear surgery. This showed no statistically or clinically significant differences between the two groups (324 participants). </p> <p>The available evidence is insufficient to indicate whether the effects of PRT will differ importantly in individual clinical conditions. </p> </section> <section id="CD010071-sec-0007"> <h3 class="title" id="CD010071-sec-0007">Authors' conclusions</h3> <p>Overall, and for the individual clinical conditions, there is currently insufficient evidence to support the use of PRT for treating musculoskeletal soft tissue injuries. Researchers contemplating RCTs should consider the coverage of currently ongoing trials when assessing the need for future RCTs on specific conditions. There is need for standardisation of PRP preparation methods. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD010071-abs-0004" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010071-abs-0004">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD010071-abs-0005">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD010071-abs-0008">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD010071-abs-0010">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD010071-abs-0007">Français</a> </li> <li class="section-language"> <a class="" href="full/hr#CD010071-abs-0006">Hrvatski</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD010071-abs-0004" lang="en"> <h3>Platelet‐rich therapies for musculoskeletal soft tissue injuries</h3> <p><b>What is the medical problem?</b> </p> <p>Muscle, ligament and tendon injuries frequently occur during activities such as sports, and may be due to tissue degeneration. These injuries are more frequent in particular parts of the body, such as the tendons located in the shoulder, elbow, knee and ankle. </p> <p><b>What treatments are available?</b> </p> <p>Several treatment options are available. These include conservative methods, such as physical therapy, and surgery, for example to repair torn tendons. Another, increasingly popular, therapy is platelet‐rich therapy. </p> <p><b>What is platelet‐rich therapy?</b> </p> <p>Platelets form part of blood. They produce growth factors that assist in repair and regeneration of tissue. It is possible that if a high concentration of platelets is applied to an injury, healing may progress faster. Platelet‐rich therapy involves the production of a platelet‐rich (concentrated) fraction of the patient's own blood. This is then applied, such as by an injection, to the site of injury. </p> <p><b>Does it work?</b> </p> <p>This review set out to examine the evidence to see if platelet‐rich therapy (PRT) works in practice. </p> <p>We searched medical databases (until March 2013) and registers of new studies (until March 2012) and found 19 studies that compared PRT with a control condition (such as no PRT). These involved a total of 1088 participants. Most participants were men, except in trials involving shoulder (rotator cuff) injuries, and elbow and Achilles tendinopathies (sometimes called tendinitis), where similar numbers of women were included. </p> <p>The 19 trials covered eight types of injury, some of which were being treated surgically: rotator cuff tears (surgical repair) (six trials); shoulder impingement syndrome (surgery to release trapped tissues in the shoulder) (one trial); tennis elbow (three trials); knee ligament reconstruction using a section of tendon from the patient (four trials); the donor site of the tendon used for knee ligament reconstruction (two trials); patellar tendinopathy (jumper's knee) (one trial); Achilles tendinopathy (tendinitis) (one trial); and acute rupture of the Achilles tendon (surgical repair) (one trial). </p> <p>The quality of the evidence is very low, partly because most trials used flawed methods that mean their results may not be reliable. The trials also used different ways of preparing and applying the platelet‐rich plasma. We were only able to pool data for our primary outcomes (function, pain, adverse events) for a maximum of 11 studies and 45% of participants. </p> <p>When we pooled the limited data that was available for all these conditions, we found very weak (very low quality) evidence for a slight benefit of PRT in pain in the short term (up to three months). However, pooled data do not show that PRT makes a difference in function in the short, medium or long term. There was weak evidence that suggested that adverse events (harms) occurred at comparable, low rates in people treated with PRT and people not treated with PRT. </p> <p>In terms of individual conditions, we were able to pool results from six studies and found no differences in long‐term function between those who received PRT during rotator cuff surgery and those who did not. </p> <p>In conclusion, the available evidence is insufficient to to support the use of PRT for treating musculoskeletal soft tissue injuries or show whether the effects of PRT vary according to the type of injury. Any future research in this area should bear in mind the several studies currently going on and should consider the need for standardisation of the PRP preparation. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD010071-sec-0115" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD010071-sec-0115"></div> <h3 class="title" id="CD010071-sec-0116">Implications for practice</h3> <section id="CD010071-sec-0116"> <p>The available evidence base for assessing the effects of platelet‐rich therapies (PRT) for treating musculoskeletal soft tissue injuries comprises a diverse collection of small trials that applied PRT in various ways for treating tendinopathies or as an augmentation procedure for surgically treated soft tissue injuries. There is very low quality evidence from a subset of these trials for a marginal short‐term benefit in pain from PRT; however, other very low quality evidence indicates that the use of PRT does not appear to have a clinically relevant effect on short‐term or long‐term function. Very low quality evidence showed no difference in adverse effects between the PRT and the various control interventions. Overall, and for the individual conditions, there is currently insufficient evidence to support the use of PRT for treating these injuries. </p> </section> <h3 class="title" id="CD010071-sec-0117">Implications for research</h3> <section id="CD010071-sec-0117"> <p>This is an active research field, as shown by the large number of ongoing studies that are likely to be included in future updates. The findings of this review and assessment of the coverage of current ongoing trials should be considered for assessing the need and viability of future RCTs on specific conditions. An important preliminary to further PRT clinical research would be the development of a standardised methodology for PRP preparation. This may need some additional input from basic scientific research. Consensus methodology for PRP preparation is a key way to increase confidence in the generalisability of study findings. </p> <p>As well as condition‐specific RCTs, more general RCTs that include a wider range of participants, with flexible inclusion criteria, should be considered. For these, a priori subgroup analysis of different clinical populations should be established. Methodological safeguards, such as allocation concealment, independent, possibly blinded, assessment and efforts to avoid participant loss to follow‐up are key. Short‐term (less than three months) and long‐term assessment (one year of longer) of pain and functional outcome data should be collected. A dedicated evaluation of adverse effects is also required. </p> </section> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD010071-sec-0022" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD010071-sec-0022"></div> <section id="CD010071-sec-0023"> <h3 class="title" id="CD010071-sec-0023">Description of the condition</h3> <p>Musculoskeletal soft tissues include tendons, ligaments, cartilage and muscles. Treatment of musculoskeletal soft‐tissue injuries ranges from 'wait‐and‐see' approaches through to surgery. Studies report diverse rates of effectiveness of therapy and sometimes poor outcomes (<a href="./references#CD010071-bbs2-0067" title="SchepullT , KvistJ , NorrmanH , TrinksM , BerlinG , AspenbergP . Autologous platelets have no effect on the healing of human achilles tendon ruptures. American Journal of Sports Medicine2011;39(1):38‐47. ">Schepull 2011</a>). </p> <p>Musculoskeletal soft tissue injuries are very common, particularly in sports–active adults (<a href="./references#CD010071-bbs2-0042" title="ClaytonRA ,  Court‐BrownCM . The epidemiology of musculoskeletal tendinous and ligamentous injuries. Injury2008;39(12):1338‐44. ">Clayton 2008</a>; <a href="./references#CD010071-bbs2-0052" title="HootmanJM , MaceraCA , AinsworthBE , AddyCL , MartinM , BlairSN . Epidemiology of musculoskeletal injuries among sedentary and physically active adults. Medicine and Science in Sports and Exercise2002;34(5):838‐44. ">Hootman 2002</a>). A survey conducted in 1986 of a cohort of physically active adults found that a quarter of these had sustained a musculoskeletal injury during the past year (<a href="./references#CD010071-bbs2-0052" title="HootmanJM , MaceraCA , AinsworthBE , AddyCL , MartinM , BlairSN . Epidemiology of musculoskeletal injuries among sedentary and physically active adults. Medicine and Science in Sports and Exercise2002;34(5):838‐44. ">Hootman 2002</a>). Both <a href="./references#CD010071-bbs2-0042" title="ClaytonRA ,  Court‐BrownCM . The epidemiology of musculoskeletal tendinous and ligamentous injuries. Injury2008;39(12):1338‐44. ">Clayton 2008</a> and <a href="./references#CD010071-bbs2-0052" title="HootmanJM , MaceraCA , AinsworthBE , AddyCL , MartinM , BlairSN . Epidemiology of musculoskeletal injuries among sedentary and physically active adults. Medicine and Science in Sports and Exercise2002;34(5):838‐44. ">Hootman 2002</a> reported that the largest category was soft tissue injuries of the knee. However, many more people with more minor soft tissue injuries will remain undiagnosed and unreported because they do not seek medical attention. </p> <p>Musculoskeletal soft tissue injuries can be either acute or chronic. Acute injuries mainly involve tearing of anatomical structure(s) and haematoma formation after a traumatic event. These trigger the recovery process ‐ cellular proliferation, regeneration, repair and remodeling processes (<a href="./references#CD010071-bbs2-0058" title="LeeK , WilsonJJ , RabagoDP , BaerGS , JacobsonJA , BorreroCG . Musculoskeletal applications of platelet‐rich plasma: fad or future?. American Journal of Roentgenology2011;196(3):628‐36. ">Lee 2011</a>). Chronic injuries, which are sometimes referred to as overuse or cumulative trauma injuries, are common with increasing age and sports participation but there is still a lack of knowledge about their aetiology and pathogenesis (<a href="./references#CD010071-bbs2-0060" title="MaffulliN , WongJ , AlmekindersLC . Types and epidemiology of tendinopathy. Clinical Journal of Sports Medicine2003;22(4):675‐92. ">Maffulli 2003</a>). The underlying processes of chronic injuries are degenerative, and these are mainly characterised by neovascularisation and absence of inflammation (<a href="./references#CD010071-bbs2-0050" title="FosterTE , PuskasBL , MandelbaumBL , GerhardtMB , RodeoSA . Platelet‐rich plasma: from basic science to clinical applications. American Journal of Sports Medicine2009;37(11):2259‐72. ">Foster 2009</a>; <a href="./references#CD010071-bbs2-0054" title="KhanKM ,  CookJL ,  BonarF ,  HarcourtP ,  AstromM . Histopathology of common tendinopathies. Update and implications for clinical management. Sports Medicine1999;27(6):393‐408. ">Khan 1999</a>). </p> <p>The clinical features of musculoskeletal soft‐tissue injuries include local pain and impaired performance. Physical examination may show swelling and bruising in the site of injury. Initial 'first aid' treatment of acute injuries is summed up by the acronym RICE, which stands for rest, ice, compression and elevation. Otherwise, standard treatments include pain killers, including oral non‐steroidal anti‐inflammatory drugs (NSAIDs), bracing and physiotherapy (<a href="./references#CD010071-bbs2-0062" title="PaoloniJA , OrchardJW . The use of therapeutic medications for soft‐tissue injuries in sports medicine. Medical Journal of Australia2005;183(7):384‐8. ">Paoloni 2005</a>). Overall, tendon, ligament and muscle injuries are more commonly treated by a combination of treatment methods such as bracing followed by physiotherapy (<a href="./references#CD010071-bbs2-0062" title="PaoloniJA , OrchardJW . The use of therapeutic medications for soft‐tissue injuries in sports medicine. Medical Journal of Australia2005;183(7):384‐8. ">Paoloni 2005</a>). When surgery is recommended, platelet‐rich therapies can act as adjuvant or complementary treatments. In these cases, surgical repair or reconstruction is the main intervention. </p> </section> <section id="CD010071-sec-0024"> <h3 class="title" id="CD010071-sec-0024">Description of the intervention</h3> <p>Platelet‐rich plasma is derived from centrifuging whole blood extracted from the patient, resulting in a platelet‐rich fraction in which the platelet concentration is higher than that of whole blood (<a href="./references#CD010071-bbs2-0050" title="FosterTE , PuskasBL , MandelbaumBL , GerhardtMB , RodeoSA . Platelet‐rich plasma: from basic science to clinical applications. American Journal of Sports Medicine2009;37(11):2259‐72. ">Foster 2009</a>; <a href="./references#CD010071-bbs2-0058" title="LeeK , WilsonJJ , RabagoDP , BaerGS , JacobsonJA , BorreroCG . Musculoskeletal applications of platelet‐rich plasma: fad or future?. American Journal of Roentgenology2011;196(3):628‐36. ">Lee 2011</a>). Its anticipated role is to act as a biological enhancer for tissue healing (<a href="./references#CD010071-bbs2-0047" title="Dohan EhrenfestDM , RasmussonL , AlbrektssonT . Classification of platelet concentrates: from pure platelet‐rich plasma (P‐PRP) to leucocyte‐ and platelet‐rich fibrin (L‐PRF). Trends in Biotechnology2009;27(3):158‐67. ">Dohan 2009</a>; <a href="./references#CD010071-bbs2-0050" title="FosterTE , PuskasBL , MandelbaumBL , GerhardtMB , RodeoSA . Platelet‐rich plasma: from basic science to clinical applications. American Journal of Sports Medicine2009;37(11):2259‐72. ">Foster 2009</a>). <a href="./references#CD010071-bbs2-0047" title="Dohan EhrenfestDM , RasmussonL , AlbrektssonT . Classification of platelet concentrates: from pure platelet‐rich plasma (P‐PRP) to leucocyte‐ and platelet‐rich fibrin (L‐PRF). Trends in Biotechnology2009;27(3):158‐67. ">Dohan 2009</a> proposed a comprehensive classification for platelet concentrates based on their biological properties and potential clinical uses of each concentrate: 1) pure platelet rich plasma (P‐PRP); 2) leucocyte and platelet rich plasma (L‐PRP); 3) pure platelet rich fibrin (P‐PRF); and 4) leucocyte and platelet rich fibrin (L‐PRF). <a href="./references#CD010071-bbs2-0047" title="Dohan EhrenfestDM , RasmussonL , AlbrektssonT . Classification of platelet concentrates: from pure platelet‐rich plasma (P‐PRP) to leucocyte‐ and platelet‐rich fibrin (L‐PRF). Trends in Biotechnology2009;27(3):158‐67. ">Dohan 2009</a> also stated the indications for each platelet‐derived product, based on their biological properties (<a href="./references#CD010071-bbs2-0047" title="Dohan EhrenfestDM , RasmussonL , AlbrektssonT . Classification of platelet concentrates: from pure platelet‐rich plasma (P‐PRP) to leucocyte‐ and platelet‐rich fibrin (L‐PRF). Trends in Biotechnology2009;27(3):158‐67. ">Dohan 2009</a>). </p> <p>Platelet‐rich therapies can be used as a sole or main treatment when the injury is being treated by conservative interventions, or as an additional therapy alongside other conservative interventions or when surgery is performed. Platelet‐rich plasma for conservatively treated injuries is applied after the identification of the area of injury based on physical examination and sometimes imaging (such as ultrasound), and area of maximum tenderness. Some clinicians use dynamic musculoskeletal ultrasound to identify the area for injection with platelet‐rich plasma (<a href="./references#CD010071-bbs2-0050" title="FosterTE , PuskasBL , MandelbaumBL , GerhardtMB , RodeoSA . Platelet‐rich plasma: from basic science to clinical applications. American Journal of Sports Medicine2009;37(11):2259‐72. ">Foster 2009</a>; <a href="./references#CD010071-bbs2-0058" title="LeeK , WilsonJJ , RabagoDP , BaerGS , JacobsonJA , BorreroCG . Musculoskeletal applications of platelet‐rich plasma: fad or future?. American Journal of Roentgenology2011;196(3):628‐36. ">Lee 2011</a>). The site for applying platelet‐rich therapy can be indirectly visualised during arthroscopic surgery. </p> <p>This review compared platelet‐rich therapy with no platelet‐rich therapy, or a placebo or 'whole blood' control. Injections, for example such as of saline, can be considered as possible placebo control interventions (<a href="./references#CD010071-bbs2-0044" title="DeVosRJ , WeirA , VanSchieHT , Bierma‐ZeinstraSM , VerhaarJA , WeinansH , et al. Platelet‐rich plasma injection for chronic Achilles tendinopathy. JAMA2010;303(2):144‐9. ">De Vos 2010a</a>). Dry needling could be considered a 'whole blood' control (<a href="./references#CD010071-bbs2-0056" title="KiterE , CelikbasE , AkkayaS , DemirkanF , KiliçBA . Comparison of injection modalities in the treatment of plantar heel pain: a randomized controlled trial. Journal of the American Podiatric Medical Association2006;96(4):293‐6. ">Kiter 2006</a>). </p> </section> <section id="CD010071-sec-0025"> <h3 class="title" id="CD010071-sec-0025">How the intervention might work</h3> <p>A high concentration of platelets and growth factors are produced from whole blood by the preparation process (<a href="./references#CD010071-bbs2-0047" title="Dohan EhrenfestDM , RasmussonL , AlbrektssonT . Classification of platelet concentrates: from pure platelet‐rich plasma (P‐PRP) to leucocyte‐ and platelet‐rich fibrin (L‐PRF). Trends in Biotechnology2009;27(3):158‐67. ">Dohan 2009</a>). Growth factors such as transforming growth factor–β (TGF‐β), platelet‐derived growth factor (PDGF), insulin‐like growth factor (IGF‐I, IGF‐II), fibroblast growth factor (FGF), epidermal growth factor, vascular endothelial growth factor (VEGF) and endothelial cell growth factor are responsible for enhancing tissue recovery (<a href="./references#CD010071-bbs2-0050" title="FosterTE , PuskasBL , MandelbaumBL , GerhardtMB , RodeoSA . Platelet‐rich plasma: from basic science to clinical applications. American Journal of Sports Medicine2009;37(11):2259‐72. ">Foster 2009</a>; <a href="./references#CD010071-bbs2-0058" title="LeeK , WilsonJJ , RabagoDP , BaerGS , JacobsonJA , BorreroCG . Musculoskeletal applications of platelet‐rich plasma: fad or future?. American Journal of Roentgenology2011;196(3):628‐36. ">Lee 2011</a>). The intervention works by delivering these growth factors to the injury site, where they are assumed to enhance tissue regeneration and improve angiogenesis (formation of blood vessels) (<a href="./references#CD010071-bbs2-0047" title="Dohan EhrenfestDM , RasmussonL , AlbrektssonT . Classification of platelet concentrates: from pure platelet‐rich plasma (P‐PRP) to leucocyte‐ and platelet‐rich fibrin (L‐PRF). Trends in Biotechnology2009;27(3):158‐67. ">Dohan 2009</a>). Thus it is assumed that the autologous preparation (from the patient's own blood) could help to 'empower' the biocellular environment for promoting and accelerating the healing process. </p> <p>The reported incidence of patients with side effects of platelet‐rich therapy is low, with an average of 2% to 5% (<a href="./references#CD010071-bbs2-0049" title="FilardoG , KonE , Della VillaS , VincentelliF , FornasariPM , MarcacciM . Use of platelet‐rich plasma for the treatment of refractory jumper's knee. International Orthopaedics2010;34(6):909‐15. ">Filardo 2010</a>). The vast majority of reported side effects relate to local tenderness and pain, which tend to last less than two days (<a href="./references#CD010071-bbs2-0049" title="FilardoG , KonE , Della VillaS , VincentelliF , FornasariPM , MarcacciM . Use of platelet‐rich plasma for the treatment of refractory jumper's knee. International Orthopaedics2010;34(6):909‐15. ">Filardo 2010</a>; <a href="./references#CD010071-bbs2-0063" title="PeerboomsJC , SluimerJ , BruijnDJ , GosensT . Positive effect of an autologous platelet concentrate in lateral epicondylitis in a double‐blind randomized controlled trial: platelet‐rich plasma versus corticosteroid injection with a 1‐year follow‐up. American Journal of Sports Medicine2010;38(2):255‐62. ">Peerbooms 2010</a>). </p> </section> <section id="CD010071-sec-0026"> <h3 class="title" id="CD010071-sec-0026">Why it is important to do this review</h3> <p>Platelet‐rich therapies are becoming widely used, mostly within sports medicine where early return to function is a major concern. The supposition that these therapies could enhance tissue recovery, allowing early return to activities and sports, has led to the promotion of their use for a myriad of conditions (<a href="./references#CD010071-bbs2-0058" title="LeeK , WilsonJJ , RabagoDP , BaerGS , JacobsonJA , BorreroCG . Musculoskeletal applications of platelet‐rich plasma: fad or future?. American Journal of Roentgenology2011;196(3):628‐36. ">Lee 2011</a>), but without clear proof of their clinical effectiveness (<a href="./references#CD010071-bbs2-0047" title="Dohan EhrenfestDM , RasmussonL , AlbrektssonT . Classification of platelet concentrates: from pure platelet‐rich plasma (P‐PRP) to leucocyte‐ and platelet‐rich fibrin (L‐PRF). Trends in Biotechnology2009;27(3):158‐67. ">Dohan 2009</a>; <a href="./references#CD010071-bbs2-0067" title="SchepullT , KvistJ , NorrmanH , TrinksM , BerlinG , AspenbergP . Autologous platelets have no effect on the healing of human achilles tendon ruptures. American Journal of Sports Medicine2011;39(1):38‐47. ">Schepull 2011</a>). These therapies also have some media‐induced appeal (<a href="./references#CD010071-bbs2-0050" title="FosterTE , PuskasBL , MandelbaumBL , GerhardtMB , RodeoSA . Platelet‐rich plasma: from basic science to clinical applications. American Journal of Sports Medicine2009;37(11):2259‐72. ">Foster 2009</a>), and commercial interest from manufacturers supplying the blood preparation kits. </p> <p>This has led to a growing number of clinical studies testing the properties and effectiveness of platelet‐rich therapies for musculoskeletal injuries (<a href="./references#CD010071-bbs2-0049" title="FilardoG , KonE , Della VillaS , VincentelliF , FornasariPM , MarcacciM . Use of platelet‐rich plasma for the treatment of refractory jumper's knee. International Orthopaedics2010;34(6):909‐15. ">Filardo 2010</a>; <a href="./references#CD010071-bbs2-0063" title="PeerboomsJC , SluimerJ , BruijnDJ , GosensT . Positive effect of an autologous platelet concentrate in lateral epicondylitis in a double‐blind randomized controlled trial: platelet‐rich plasma versus corticosteroid injection with a 1‐year follow‐up. American Journal of Sports Medicine2010;38(2):255‐62. ">Peerbooms 2010</a>; <a href="./references#CD010071-bbs2-0067" title="SchepullT , KvistJ , NorrmanH , TrinksM , BerlinG , AspenbergP . Autologous platelets have no effect on the healing of human achilles tendon ruptures. American Journal of Sports Medicine2011;39(1):38‐47. ">Schepull 2011</a>). However, published systematic reviews, e.g. <a href="./references#CD010071-bbs2-0045" title="DeVosRJ , vanVeldhovenPL , MoenMH , WeirA , TolJL , MaffulliN . Autologous growth factor injections in chronic tendinopathy: a systematic review. British Medial Bulletin2010;95(1):63‐77. ">De Vos 2010b</a>, <a href="./references#CD010071-bbs2-0058" title="LeeK , WilsonJJ , RabagoDP , BaerGS , JacobsonJA , BorreroCG . Musculoskeletal applications of platelet‐rich plasma: fad or future?. American Journal of Roentgenology2011;196(3):628‐36. ">Lee 2011</a> and <a href="./references#CD010071-bbs2-0070" title="TaylorDW , PetreraM , HendryM , TheodoropoulosJS . A systematic review of the use of platelet‐rich plasma in sports medicine as a new treatment for tendon and ligament injuries. Clinical Journal of Sport Medicine2011;21(4):344‐52. ">Taylor 2011</a>, have included studies other than randomised trials, or studies testing other treatments in combination with platelet‐rich therapies; together these act to decrease both the internal and external validity of these reviews. None of these reviews has provided clear evidence regarding effectiveness and safety of platelet‐rich therapies. By restricting our focus to randomised or quasi‐randomised controlled trials comparing platelet‐rich therapy with either a no intervention, or placebo intervention, control, as well as updating the search for trials, this review aimed to provide a reliable summary of the best evidence to inform decisions on the use of platelet‐rich therapies for treating musculoskeletal soft‐tissue injuries. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD010071-sec-0027" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD010071-sec-0027"></div> <p>To assess the effects (benefits and harms) of platelet‐rich therapies for treating musculoskeletal soft tissue injuries. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD010071-sec-0028" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD010071-sec-0028"></div> <section id="CD010071-sec-0029"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD010071-sec-0030"> <h4 class="title">Types of studies</h4> <p>We included randomised controlled trials and quasi‐randomised controlled trials (where the allocation is not strictly random, for example, by date of birth, hospital record number, alternation) comparing platelet‐rich therapy with no platelet‐rich therapy or a placebo for musculoskeletal soft tissue injuries in adults. </p> </section> <section id="CD010071-sec-0031"> <h4 class="title">Types of participants</h4> <p>People with musculoskeletal soft tissue injuries being treated either conservatively or surgically (for example, repair and reconstruction). Injuries include: </p> <p> <ol id="CD010071-list-0001"> <li> <p>traumatic injuries, for example, Achilles tendon rupture, anterior cruciate ligament (ACL) injuries, rotator cuff tears, ankle sprains, hamstring muscle tears, meniscal and labral lesions; </p> </li> <li> <p>tendinopathies (acute or chronic), for example, Achilles 'tendinitis', lateral epicondylitis (tennis elbow), rotator cuff 'tendinitis', patellar 'tendinitis' (jumper's knee). </p> </li> </ol> </p> <p>We did not place any restrictions in terms of the diagnostic methods or criteria used by individual studies, or the duration of the injury. We excluded trials that focused on treating osteoarthritis. </p> </section> <section id="CD010071-sec-0032"> <h4 class="title">Types of interventions</h4> <p>We considered studies in which platelet‐rich therapies were used as the only treatment, or as an additional or adjunctive treatment to conservative or surgical treatment that was provided to all trial participants. Such studies compared platelet‐rich therapy (intervention) with no platelet‐rich therapy or placebo. There was no restriction based on treatment dosage, usage and number of procedures or injections. We excluded studies that evaluated only other blood‐derived alternatives, such as whole blood injections. Subsequent to the protocol, we accepted trials that used whole blood injection or dry needling controls. However, we excluded trials with active agent controls such as steroid injections, as used in <a href="./references#CD010071-bbs2-0063" title="PeerboomsJC , SluimerJ , BruijnDJ , GosensT . Positive effect of an autologous platelet concentrate in lateral epicondylitis in a double‐blind randomized controlled trial: platelet‐rich plasma versus corticosteroid injection with a 1‐year follow‐up. American Journal of Sports Medicine2010;38(2):255‐62. ">Peerbooms 2010</a>. </p> </section> <section id="CD010071-sec-0033"> <h4 class="title">Types of outcome measures</h4> <p>We categorised the outcome measurements as short term (up to 12 weeks follow‐up), medium term (between 12 weeks and one year follow‐up) and long term (more than one year follow‐up). </p> <section id="CD010071-sec-0034"> <h5 class="title">Primary outcomes</h5> <p> <ol id="CD010071-list-0002"> <li> <p>Functional evaluation (assessed by subjective assessment questionnaires such as Disabilities of the Arm, Shoulder and Hand questionnaire (<a href="./references#CD010071-bbs2-0053" title="HudakPL , AmadioPC , BombardierC , BolandA , FischerT , FlatowEL , et al. Development of an upper extremity outcome measure: the DASH (disabilities of the arm, shoulder and hand) [corrected]. The Upper Extremity Collaborative Group (UECG). American Journal of Industrial Medicine1996;29(6):602‐8. ">Hudak 1996</a>), Victorian Institute of Sports Assessment ‐ Achilles questionnaire (VISA‐A) (<a href="./references#CD010071-bbs2-0066" title="RobinsonJM , CookJL , PurdamC , VisentiniPJ , RossJ , MaffulliN , et al. The VISA‐A questionnaire: a valid and reliable index of the clinical severity of Achilles tendinopathy. British Journal of Sports Medicine2001;35(5):335‐41. ">Robinson 2001</a>), and American Orthopaedic Foot and Ankle Society (AOFAS) foot questionnaire (<a href="./references#CD010071-bbs2-0055" title="KitaokaH , AlexanderI , AdelaarR , NunleyJ , MyersonM , SandersM . Clinical rating systems for the ankle‐hindfoot, midfoot, hallux, and lesser toes. Foot &amp; Ankle International1994;15(7):349‐53. ">Kitaoka 1994</a>)). </p> </li> <li> <p>Pain (assessed by subjective scales such as visual analogue scales (VAS) (<a href="./references#CD010071-bbs2-0064" title="RevillSI , RobinsonJO , RosenM , HoggMI . The reliability of a linear analogue for evaluating pain. Anaesthesia1976;31(9):1191‐8. ">Revill 1976</a>)). </p> </li> <li> <p>Local and systemic adverse effects of platelet‐rich therapy (or placebo) administration (including infection and anaphylactic reaction). </p> </li> </ol> </p> </section> <section id="CD010071-sec-0035"> <h5 class="title">Secondary outcomes</h5> <p> <ol id="CD010071-list-0003"> <li> <p>Recovery time: return to sports, and return to day‐to‐day or work activities.</p> </li> <li> <p>Non‐return to previous activities: sports, work or decrease in the level of activity.</p> </li> <li> <p>Quality of life (assessed by subjective assessment questionnaires such as Short Form (36) Health Survey (SF‐36) (<a href="./references#CD010071-bbs2-0040" title="BrazierJE , HarperR , JonesNM , O'CathainA , ThomasKJ , UsherwoodT , et al. Validating the SF‐36 health survey questionnaire: new outcome measure for primary care. BMJ1992;305(6846):160‐4. ">Brazier 1992</a>) and World Health Organization Quality of Life (WHOQoL) (<a href="./references#CD010071-bbs2-0061" title="MasthoffE , TrompenaarsF , VanHeckG , HodiamontP , DeVriesJ . Validation of the WHO Quality of Life assessment instrument (WHOQOL‐100) in a population of Dutch adult psychiatric outpatients. European Psychiatry2005;20(7):465‐73. ">Masthoff 2005</a>). </p> </li> <li> <p>Recurrence of the condition.</p> </li> <li> <p>Need for a secondary treatment procedure (for example, surgery).</p> </li> <li> <p>Participant satisfaction.</p> </li> </ol> </p> </section> </section> </section> <section id="CD010071-sec-0036"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD010071-sec-0037"> <h4 class="title">Electronic searches</h4> <p>We searched the Cochrane Bone, Joint and Muscle Trauma Group Specialised Register (25 March 2013), the Cochrane Central Register of Controlled Trials (2013 Issue 2), MEDLINE (1946 to March Week 2 2013), MEDLINE In‐Process &amp; Other Non‐Indexed Citations (March 2013), EMBASE (1980 to 2013 Week 12), and LILACS (1982 to March 2013). No language restrictions were applied. We also searched <a href="http://www.controlled-trials.com/" target="_blank">Current Controlled Trials</a> and the <a href="http://www.who.int/ictrp/en/" target="_blank">WHO International Clinical Trials Registry Platform</a> for ongoing and recently completed trials (until March Week 2 2013). </p> <p>In MEDLINE (Ovid Online), we combined the subject‐specific search with the Cochrane Highly Sensitive Search Strategy for identifying randomised trials (sensitivity‐maximising version) (<a href="./references#CD010071-bbs2-0059" title="LefebvreC , ManheimerE , GlanvilleJ . Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Lefebvre 2011</a>). Search strategies for <i>The Cochrane Library</i> (CENTRAL), MEDLINE, EMBASE and LILACS are shown in <a href="./appendices#CD010071-sec-0121">Appendix 1</a>. </p> </section> <section id="CD010071-sec-0038"> <h4 class="title">Searching other resources</h4> <p>We searched reference lists of articles, reviews and non‐scholarly Internet sources for relevant studies. Additionally, we contacted other researchers or experts in the field for relevant data in terms of published, unpublished or ongoing studies. We searched the conference abstracts of the following conferences (2005 to March 2012): SICOT (Société Internationale de Chirurgie Orthopédique et de Traumatologie), AOSSM (American Orthopaedic Society for Sports Medicine) and AAOS (American Academy of Orthopaedic Surgeons). </p> </section> </section> <section id="CD010071-sec-0039"> <h3 class="title" id="CD010071-sec-0039">Data collection and analysis</h3> <section id="CD010071-sec-0040"> <h4 class="title">Selection of studies</h4> <p>Two review authors (VM and MT) independently screened titles and abstracts of the references identified by the searches. We retrieved full copies of all potentially relevant studies. The same two authors independently performed study selection. Any disagreements were resolved by discussion or, when necessary, by involving a third author (JB or ML). </p> </section> <section id="CD010071-sec-0041"> <h4 class="title">Data extraction and management</h4> <p>Two review authors (VM and MT) independently extracted data using a pre‐piloted data extraction form. Any disagreements were resolved by discussion or, when necessary, by involving a third author (JB). </p> </section> <section id="CD010071-sec-0042"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>The risk of bias of the included studies was assessed independently by two review authors (VM and ML) using The Cochrane Collaboration's 'Risk of bias' tool (<a href="./references#CD010071-bbs2-0051" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). Disagreements were resolved by discussion or by involving a third author (JB). The following domains were assessed: sequence generation, allocation concealment, blinding of participants and personnel, blinding of outcome assessment, incomplete outcome data, selective outcome reporting and other bias (for example, differences in follow‐up procedures between the intervention groups that might result in 'different diagnostic activity’). Each domain was judged in terms of whether it was at 'high', 'low' or 'unclear' risk of bias. </p> </section> <section id="CD010071-sec-0043"> <h4 class="title">Measures of treatment effect</h4> <p>We presented risk ratios with 95% confidence intervals (CI) for dichotomous outcomes and mean differences (MD) with 95% CIs for continuous outcomes. We presented standardised mean differences (SMD) when pooling continuous data from outcomes that used different scales. Where appropriate in future, we intend to report the number needed to treat for an additional beneficial outcome (NNTB) and the number needed to treat for an additional harmful outcome (NNTH) both with 95% CIs. </p> </section> <section id="CD010071-sec-0044"> <h4 class="title">Unit of analysis issues</h4> <p>The unit of randomisation in all studies included in this review was the individual participant. If we include cluster randomised trials in a future update, we will opt if possible to consider data at the level of the group, keeping the unit of analysis the same as the unit of randomisation. Where appropriate corrections have not been made, or cannot be obtained from trial authors, we will consider presenting the data for such trials where the disparity between the units of analysis and randomisation is small. We avoided unit of analysis issues relating to repeated observations, such as by performing separate analyses for different follow‐up times, and issues relating to the reporting of outcome by studies that tested multiple applications of platelet‐rich therapy over time. </p> </section> <section id="CD010071-sec-0045"> <h4 class="title">Dealing with missing data</h4> <p>We contacted trial authors with requests to supply any missing data, such as number of participants, details of dropouts, means, measures of uncertainty (standard deviation or error) or number of events. If we were unsuccessful in acquiring missing data, we presented the available data and did not impute missing values. </p> </section> <section id="CD010071-sec-0046"> <h4 class="title">Assessment of heterogeneity</h4> <p>We assessed heterogeneity by visual inspection of the forest plots. We used the I² test to provide an objective measurement of statistical heterogeneity. The heterogeneity was quantified using the I² statistic with a rough guide for interpretation as follows: 0% to 40% might not be important; 30% to 60% may represent moderate heterogeneity; 50% to 90% may represent substantial heterogeneity; and 75% to 100% considerable heterogeneity (<a href="./references#CD010071-bbs2-0046" title="DeeksJJ , HigginsJPT , Altman DG(editors) . Chapter 9: Analysing data and undertaking meta‐analyses. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. The Cochrane Collaboration. ">Deeks 2011</a>). </p> </section> <section id="CD010071-sec-0047"> <h4 class="title">Assessment of reporting biases</h4> <p>In meta‐analyses where there were more than 10 studies on a single condition, we planned to assess the potential for publication bias (small study effects) by generating funnel plots. </p> </section> <section id="CD010071-sec-0048"> <h4 class="title">Data synthesis</h4> <p>When appropriate, results of comparable groups of studies were pooled in meta‐analysis using the fixed‐effect model, except for standardised mean differences where a random‐effects model was used. We calculated pooled risk ratios with 95% CIs for dichotomous outcomes. When two or more studies presented continuous data derived from the same instrument of evaluation (with the same units of measurement), data were pooled as a mean difference with 95% CI. When the studies expressed the same variable using different instruments and different units of measurement, we used the standardised mean difference with 95% CI. </p> </section> <section id="CD010071-sec-0049"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We were unable to perform all the planned subgroup analyses due to lack of data (<i>see</i><a href="#CD010071-sec-0137">Differences between protocol and review</a>). We performed two subgroup analyses in order to explore different estimated effects. </p> <p> <ol id="CD010071-list-0004"> <li> <p>Grouping trials by condition (for example, rotator cuff tear, ACL reconstruction, chronic Achilles tendinopathy). </p> </li> <li> <p>Grouping trials according to whether platelet rich therapy (PRT) was the main treatment for tendinopathies or a surgical augmentation procedure. </p> </li> </ol> </p> <p>We investigated whether the results of subgroups were significantly different by inspecting the overlap of confidence intervals and performing the test for subgroup differences available in RevMan (<a href="./references#CD010071-bbs2-0065" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012. ">RevMan 2012</a>). </p> <p>We investigated heterogeneity further by seeing the effects of removing single trial outliers. </p> <p>Should sufficient data be available in future, we will consider conducting the following additional subgroup analyses. </p> <p> <ol id="CD010071-list-0005"> <li> <p>Acute versus chronic injuries.</p> </li> <li> <p>Different methods for PRTs (e.g. simple versus multiple doses; methods for PRT separation) (<a href="./references#CD010071-bbs2-0047" title="Dohan EhrenfestDM , RasmussonL , AlbrektssonT . Classification of platelet concentrates: from pure platelet‐rich plasma (P‐PRP) to leucocyte‐ and platelet‐rich fibrin (L‐PRF). Trends in Biotechnology2009;27(3):158‐67. ">Dohan 2009</a>). </p> </li> <li> <p>Modalities for using in surgical procedures (as an augmentation procedure after repair or reconstruction; utilisation in the harvesting or donor site). </p> </li> <li> <p>Groups at risk for non‐healing (e.g. smoking, diabetes).</p> </li> <li> <p>Commercial versus laboratory‐prepared kits.</p> </li> </ol> </p> </section> <section id="CD010071-sec-0050"> <h4 class="title">Sensitivity analysis</h4> <p>We performed sensitivity analyses to evaluate the impact of removing studies at high or unclear risk of selection bias (primarily in terms of inadequate allocation concealment) and detection bias (lack of assessor blinding) from the analysis. We also conducted sensitivity analyses to investigate the effects of missing data. </p> <section id="CD010071-sec-0051"> <h5 class="title">Quality assessment</h5> <p>We used the GRADE approach to assess the quality of evidence relating to the primary outcomes for overall result (section 12.2, <a href="./references#CD010071-bbs2-0051" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). </p> </section> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD010071-sec-0052" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD010071-sec-0052"></div> <section id="CD010071-sec-0053"> <h3 class="title">Description of studies</h3> <section id="CD010071-sec-0054"> <h4 class="title">Results of the search</h4> <p>The search was completed in March 2013. We screened records from the following databases: Cochrane Bone, Joint and Muscle Trauma Group Specialised Register (6 records); Cochrane Central Register of Controlled Trials (26), MEDLINE (98), EMBASE (99), LILACS (7), Current Controlled Trials (5) and the WHO International Clinical Trials Registry Platform (15). We also identified three potentially eligible studies from other sources (references search). </p> <p>The search identified a total of 39 studies for potential inclusion, for which full reports were obtained. Upon study selection, 19 were included (<a href="./references#CD010071-bbs2-0001" title="AlmeidaAM . Platelet‐rich plasma in the regeneration of the patellar ligament after harvesting its central third: a prospective randomised study [Efeito do plasma rico em plaquetas na regeneração do terço central do ligamento da patela: estudo prospectivo randomizado] (Thesis). São Paulo: Universidade de São Paulo, Faculdade de Medicina, 2013. AlmeidaAM , DemangeMK , SobradoMF , RodriguesMB , PedrinelliA , HernandezAJ . Patellar tendon healing with platelet‐rich plasma. American Journal of Sports Medicine2012;40(6):1283‐8. ">Almeida 2012</a>; <a href="./references#CD010071-bbs2-0002" title="AntunaS , BarcoR , MartinezJM , SanchezJM . Effect of platelet‐rich fibrin on rotator cuff repair (PRP‐Fibrin). http://clinicaltrials.gov/show/NCT01612845 (accessed 04 December 2013). AntunaSA , Barco LaaksoR , Martinez DiezJM , Sanchez MarquezJMM . PRP‐fibrin for arthroscopically repaired massive rotator cuff tears: a prospective randomized clinical trial. In: American Academy of Orthopaedic Surgeons Annual Meeting; 2012 Mar 7‐11; San Francisco (Ca)2012. AntuñaS , BarcoJ , Martínez DíesJM , Sánchez MárquezJM . Platelet‐rich fibrin in arthroscopic repair of massive rotator cuff tears: A prospective randomized pilot clinical trial. Acta Orthopaedica Belgica2013;79:25‐30. MoraesV . Personal communication. Email to: S Antuna 18 April 2013. ">Antuna 2013</a>; <a href="./references#CD010071-bbs2-0003" title="CastriciniR , LongoUG , BenedettoM , PanfoliN , PiraniN , ZiniR , et al. Platelet‐rich plasma augmentation for arthroscopic rotator cuff repair: a randomized controlled trial. American Journal of Sports Medicine2011;39(2):258‐65. [DOI: 10.1177/0363546510390780] ">Castricini 2011</a>; <a href="./references#CD010071-bbs2-0004" title="CervellinM , GirolamoL , BaitC , DentiM , VoltiP . Autologous platelet‐rich plasma gel to reduce donor‐site morbidity after patellar tendon graft harvesting for anterior cruciate ligamente reconstruction: a randomized, controlled clinical study. Knee Surgery, Sports Traumatology, Arthroscopy2012;20(1):114‐20. [DOI: 10.1007/s00167‐011‐1570‐5] ">Cervellin 2012</a>; <a href="./references#CD010071-bbs2-0005" title="CreaneyL , WallaceA , CurtisM , ConnellD . Growth factor‐based therapies provide additional benefit beyond physical therapy in resistant elbow tendinopathy: a prospective, single‐blind, randomised trial of autologous blood injections versus platelet‐rich plasma injections. British Journal of Sports Medicine2011;45(12):966‐71. [DOI: 10.1136/bjsm.2010.082503] ">Creaney 2011</a>; <a href="./references#CD010071-bbs2-0006" title="DeJongeS , DeVosRJ , WeirA , VanSchieHT , Bierma‐ZeinstraSM , VerhaarJA , et al. One‐year follow‐up of platelet‐rich plasma treatment in chronic Achilles tendinopathy. American Journal of Sports Medicine2011;39(8):1623‐9. deVosRJ , WeirA , TolJL , VerhaarJA , WeinansH , vanSchieHT . No effects of PRP on ultrasonographic tendon structure and neovascularization in chronic midportion Achilles tendinopathy. British Journal of Sports Medicine2011;45(5):387‐92. [DOI: 10.1136/bjsm.2010.076398] deVosRJ , WeirA , vanSchieHT , Bierma‐ZeinstraSM , VerhaarJA , WeinansH , et al. Platelet‐rich plasma injection for chronic Achilles tendinopathy. JAMA2010;303(2):144‐9. ">De Vos 2010</a>; <a href="./references#CD010071-bbs2-0007" title="EvertsPA , DevileeRJ , MahoneyCB , vanErpA , OosterbosCJ , StellenboomM , et al. Exogenous application of platelet‐leukocyte gel during open subacromial decompression contributes to improved patient outcome. European Surgical Research2008;40(2):203‐10. [DOI: 10.1159/000110862] ">Everts 2008</a>; <a href="./references#CD010071-bbs2-0008" title="GuminaS , CampagnaV , FerrazzaG , GiannicolaG , FratalocchiF , MilaniA , et al. Use of platelet‐leukocyte membrane in arthroscopic repair of large rotator cuff tears. Journal of Bone and Joint Surgery ‐ American Volume2012;94(15):1345‐52. [DOI: 10.2106/JBJS.K.00394] ">Gumina 2012</a>; <a href="./references#CD010071-bbs2-0009" title="KroghTP , FredbergU , Stengaard‐PedersenK , ChristensenR , JensenP , EllingsenT . Treatment of lateral epicondylitis with platelet‐rich plasma, glucocorticoid, or saline: a randomized, double‐blind, placebo‐controlled trial. American Journal of Sports Medicine2013;41(3):625‐35. [DOI: 10.1177/0363546512472975] ">Krogh 2013</a>; <a href="./references#CD010071-bbs2-0010" title="MalavoltaE , Ferreira NetoAA . Platelet rich plasma on arthroscopic repair of the complete rotator cuff lesions: a prospective and randomized study. http://clinicaltrials.gov/ct2/show/NCT01029574 (accessed 26 August 2013). MoraesV . Personal communication. Email to: E Malavolta. ">NCT01029574</a>; <a href="./references#CD010071-bbs2-0011" title="OrregoM , LarrainC , RosalesJ , ValenzuelaL , MatasJ , DurrutyJ , et al. Effects of platelet concentrate and a bone plug on the healing of hamstring tendons in a bone tunnel. Arthroscopy2008;24(12):1373‐80. [DOI: 10.1016/j.arthro.2008.07.016] ">Orrego 2008</a>; <a href="./references#CD010071-bbs2-0012" title="RandelliP , ArrigoniP , RagoneV , AliprandiA , CabitzaP . Platelet rich plasma in arthroscopic rotator cuff repair: a prospective RCT study, 2‐year follow‐up. Journal of Shoulder and Elbow Surgery2011;20(4):518‐28. [DOI: 10.1016/j.jse.2011.02.008] ">Randelli 2011</a>; <a href="./references#CD010071-bbs2-0013" title="RodeoSA , DelosD , WilliamsRJ , AdlerRS , PearleA , WarrenRF . The effect of platelet‐rich fibrin matrix on rotator cuff tendon healing: a prospective, randomized clinical study. American Journal of Sports Medicine2012;40(6):1234‐41. [DOI: 10.1177/0363546512442924] ">Rodeo 2012</a>; <a href="./references#CD010071-bbs2-0014" title="SchepullT , KvistJ , NorrmanH , TrinksM , BerlinG , AspenbergP . Autologous platelet have no effect on the healing of human achilles tendon ruptures: a randomized single‐blind study. American Journal of Sports Medicine2011;39(1):38‐47. [DOI: 10.1177/0363546510383515] ">Schepull 2010</a>; <a href="./references#CD010071-bbs2-0015" title="ThanasasC , PapadimitriouG , CharalambidisC , ParaskevopoulosI , PapanikolaouA . Platelet‐rich plasma versus autologous whole blood for the treatment of chronic lateral elbow epicondylitis: a randomized controlled clinical trial. American Journal of Sports Medicine2011;39(10):2130‐4. [DOI: 10.1177/0363546511417113] ">Thanasas 2011</a>; <a href="./references#CD010071-bbs2-0016" title="VadalàA , IorioR , DeCarliA , FerrettiM , ParavaniD , CapernaL , et al. Platelet‐rich plasma: does it help reduce tunnel widening after ACL reconstruction?. Knee Surgery Sports Traumatology Arthroscopy2013;21(4):824‐9. [DOI: 10.1007/s00167‐012‐1980‐z] ">Vadalà 2013</a>; <a href="./references#CD010071-bbs2-0017" title="Valentí NínJR , GasqueGM , AzcárateAV , BeolaJD , GonzalezMH . Has platelet‐rich plasma any role in anterior cruciate ligament allograft healing?. Arthroscopy2009;25(11):1206‐13. [DOI: 10.1016/j.arthro.2009.06.002] ">Valenti Nín 2009</a>; <a href="./references#CD010071-bbs2-0018" title="VogrinM , RuprehtM , CrnjacA , DinevskiD , KrajncZ , RecnikG . The effect of platelet‐derived growth factors on knee stability after anterior cruciate ligament reconstruction: a prospective randomized clinical study. Wiener Klinische Wochenschrift2010;122(Suppl 2):91‐5. [DOI: 10.1007/s00508‐010‐1340‐2] ">Vogrin 2010</a>; <a href="./references#CD010071-bbs2-0019" title="WasterlainA , DragooJ . Platelet‐rich plasma as a treatment for patellar tendinopathy: a double‐blind randomized controlled trial. Individual patient data (as supplied June 2013). Data on file. ">Wasterlain 2013</a>), four were excluded (<a href="./references#CD010071-bbs2-0020" title="FerreroG , FabbroE , OrlandiD , MartiniC , LacelliF , SerafiniG , et al. Ultrasound‐guided injection of platelet‐rich plasma in chronic Achilles and patellar tendinopathy. Journal of Ultrasound2012;15(4):260‐6. [DOI: 10.1016/j.jus.2012.09.006] ">Ferrero 2012</a>; <a href="./references#CD010071-bbs2-0021" title="FigueroaD , MeleanP , CalvoR , VasimanA , ZillerueloN , FigueroaF , et al. Magnetic resonance imaging evaluation of the integration and maturation of semitendinosus‐gracilis graft in anterior cruciate ligament reconstruction using autologous platelet concentrate. Arthroscopy2010;26(10):1318‐25. [DOI: 10.1016/j.arthro.2010.02.010] ">Figueroa 2010</a>; <a href="./references#CD010071-bbs2-0022" title="RadiceF , YánezR , GutiérrezV , RosalesJ , PinedoM , CodaS . Comparison of magnetic resonance findings in anterior cruciate ligament grafts with or without autologous platelet‐derived growth factors. Arthroscopy2010;26(1):50‐7. [DOI: 10.1016/j.arthro.2009.06.030] ">Radice 2009</a>; <a href="./references#CD010071-bbs2-0023" title="SilvaA , SampaioR . Anatomic ACL reconstruction: does the platelet‐rich plasma accelerate tendon healing?. Knee Surgery, Sports Traumatology, Arthroscopy2009;17(6):676‐82. [DOI: 10.1007/s00167‐009‐0762‐8] ">Silva 2009</a>) and 16 are ongoing studies (<a href="./references#CD010071-bbs2-0024" title="ThompsonG . Northland lateral hip pain platelet‐rich plasma treatment study. https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=12612000982819 (accessed 26 August 2013). ">ACTRN12612000982819</a>; <a href="./references#CD010071-bbs2-0025" title="GomesJI . Pilot randomised trial to assess the safety and potential efficacy of platelet rich plasma tenotomy for the treatment of chronic epicondylitis. https://www.clinicaltrialsregister.eu/ctr‐search/search?query=eudract_number:2013‐000478‐32 (accessed 26 August 2013). [EudraCT: 2013‐000478‐32 ] ">EUCTR201300047832ES</a>; <a href="./references#CD010071-bbs2-0026" title="RaeissadatSA . Study of the effects of local platelet‐rich plasma (PRP) injection versus autologous blood injection in patients with lateral epicondylitis in PM &amp; R clinic of Modarres hospital from 2011 to 2013. http://www.irct.ir/searchresult.php?id=13442&amp;number=1 (accessed 26 August 2013). ">IRCT2013052313442N1</a>; <a href="./references#CD010071-bbs2-0027" title="CarrA . Platelet rich plasma and rotator cuff tendons. http://www.controlled‐trials.com/ISRCTN10464365/ (accessed 26 August 2013). ">ISRCTN10464365</a>; <a href="./references#CD010071-bbs2-0028" title="CostaM . Achilles tendinopathy management: platelet rich plasma versus eccentric loading programme. http://www.controlled‐trials.com/ISRCTN95369715/ (accessed 26 August 2013). ">ISRCTN95369715</a>; <a href="./references#CD010071-bbs2-0029" title="RazmjouH . Impact of autologous platelet rich plasma on healing of rotator cuff repairs. http://clinicaltrials.gov/ct2/show/record/NCT01000935 (accessed 26 August 2013). ">NCT01000935</a>; <a href="./references#CD010071-bbs2-0030" title="BhandariM . Arthroscopic surgery and platelet rich plasma in rotator cuff tear evaluation (A.S.P.I.R.E.): the use of platelet rich plasma following arthroscopic repair of rotator cuff tears, a pilot study. http://clinicaltrials.gov/show/NCT01170312 (accessed 26 August 2013). ">NCT01170312</a>; <a href="./references#CD010071-bbs2-0031" title="Martínez‐ZapataMJ . Multicenter double blind, with evaluator blinding, parallel, randomized clinical trial, to assess the efficacy of platelet rich plasma for treatment of muscle rupture with haematoma. http://clinicaltrials.gov/show/NCT01440725 (accessed 26 August 2013). ">NCT01440725</a>; <a href="./references#CD010071-bbs2-0032" title="NedergaardB . Treatment of plantar fasciitis with injection af platelet rich plasma into the origin of the plantar fascia. http://clinicaltrials.gov/ct2/show/NCT01509274 (accessed 26 August 2013). ">NCT01509274</a>; <a href="./references#CD010071-bbs2-0033" title="RowdenA . A doubleblind, randomized, placebo controlled study evaluating the use of platelet rich plasma therapy for acute ankle sprains in the emergency department. http://clinicaltrials.gov/show/NCT01518335 (accessed 26 August 2013). ">NCT01518335</a>; <a href="./references#CD010071-bbs2-0034" title="JacobsonJ . A prospective comparison of ultrasound‐guided percutaneous platelet‐rich plasma injection versus tenotomy for treatment of gluteus minimus and medius tendinosis. http://clinicaltrials.gov/ct2/show/NCT01600326. ">NCT01600326</a>; <a href="./references#CD010071-bbs2-0035" title="ChiavarasM . Comparison of platelet rich plasma and alternative therapies for the treatment of tennis elbow (lateral epicondylitis) (IMPROVE). http://clinicaltrials.gov/ct2/show/NCT01668953 (accessed 26 August 2013). ">NCT01668953</a>; <a href="./references#CD010071-bbs2-0036" title="WaltersB . Effect of intraoperative application of autologous PRP on post operative morbidity in ACL reconstruction using autologous bone patellar tendon bone graft harvest. http://clinicaltrials.gov/show/NCT01765712 (accessed 26 August 2013). ">NCT01765712</a>; <a href="./references#CD010071-bbs2-0037" title="TolJ . Use of platelet rich plasma in the management of acute hamstring muscle strain injury. http://clinicaltrials.gov/show/NCT01812564 (accessed 26 August 2013). ">NCT01812564</a>; <a href="./references#CD010071-bbs2-0038" title="VoigtA . Percutaneous needle tenotomy (PNT) versus platelet rich plasma (PRP) with pnt in the treatment of chronic tendinosis. http://clinicaltrials.gov/show/NCT01833598 (accessed 26 August 2013). ">NCT01833598</a>; <a href="./references#CD010071-bbs2-0039" title="LeppänenOV . The effect of platelet rich plasma on lateral epicondylitis. http://clinicaltrials.gov/show/NCT01851044 (accessed 26 August 2013). ">NCT01851044</a>). No studies await classification. Further details of the process of screening and selecting studies for inclusion in the review are illustrated in <a href="#CD010071-fig-0001">Figure 1</a>. </p> <div class="figure" id="CD010071-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram" data-id="CD010071-fig-0001" src="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram</p> </div> </div> </div> </section> <section id="CD010071-sec-0055"> <h4 class="title">Included studies</h4> <p>Individual characteristics of the 19 studies are described in the <a href="./references#CD010071-sec-0140" title="">Characteristics of included studies</a> section. One study was reported in three reports from the same population (<a href="./references#CD010071-bbs2-0006" title="DeJongeS , DeVosRJ , WeirA , VanSchieHT , Bierma‐ZeinstraSM , VerhaarJA , et al. One‐year follow‐up of platelet‐rich plasma treatment in chronic Achilles tendinopathy. American Journal of Sports Medicine2011;39(8):1623‐9. deVosRJ , WeirA , TolJL , VerhaarJA , WeinansH , vanSchieHT . No effects of PRP on ultrasonographic tendon structure and neovascularization in chronic midportion Achilles tendinopathy. British Journal of Sports Medicine2011;45(5):387‐92. [DOI: 10.1136/bjsm.2010.076398] deVosRJ , WeirA , vanSchieHT , Bierma‐ZeinstraSM , VerhaarJA , WeinansH , et al. Platelet‐rich plasma injection for chronic Achilles tendinopathy. JAMA2010;303(2):144‐9. ">De Vos 2010</a>). All but two studies were published as full reports (<a href="./references#CD010071-bbs2-0010" title="MalavoltaE , Ferreira NetoAA . Platelet rich plasma on arthroscopic repair of the complete rotator cuff lesions: a prospective and randomized study. http://clinicaltrials.gov/ct2/show/NCT01029574 (accessed 26 August 2013). MoraesV . Personal communication. Email to: E Malavolta. ">NCT01029574</a>; <a href="./references#CD010071-bbs2-0019" title="WasterlainA , DragooJ . Platelet‐rich plasma as a treatment for patellar tendinopathy: a double‐blind randomized controlled trial. Individual patient data (as supplied June 2013). Data on file. ">Wasterlain 2013</a>); data for the two exceptions were collected by direct contact. <a href="./references#CD010071-bbs2-0002" title="AntunaS , BarcoR , MartinezJM , SanchezJM . Effect of platelet‐rich fibrin on rotator cuff repair (PRP‐Fibrin). http://clinicaltrials.gov/show/NCT01612845 (accessed 04 December 2013). AntunaSA , Barco LaaksoR , Martinez DiezJM , Sanchez MarquezJMM . PRP‐fibrin for arthroscopically repaired massive rotator cuff tears: a prospective randomized clinical trial. In: American Academy of Orthopaedic Surgeons Annual Meeting; 2012 Mar 7‐11; San Francisco (Ca)2012. AntuñaS , BarcoJ , Martínez DíesJM , Sánchez MárquezJM . Platelet‐rich fibrin in arthroscopic repair of massive rotator cuff tears: A prospective randomized pilot clinical trial. Acta Orthopaedica Belgica2013;79:25‐30. MoraesV . Personal communication. Email to: S Antuna 18 April 2013. ">Antuna 2013</a> also provided extra data. All studies were published in English. </p> <section id="CD010071-sec-0056"> <h5 class="title">Design</h5> <p>Seventeen studies were randomised and two were quasi‐randomised (<a href="./references#CD010071-bbs2-0011" title="OrregoM , LarrainC , RosalesJ , ValenzuelaL , MatasJ , DurrutyJ , et al. Effects of platelet concentrate and a bone plug on the healing of hamstring tendons in a bone tunnel. Arthroscopy2008;24(12):1373‐80. [DOI: 10.1016/j.arthro.2008.07.016] ">Orrego 2008</a>; <a href="./references#CD010071-bbs2-0018" title="VogrinM , RuprehtM , CrnjacA , DinevskiD , KrajncZ , RecnikG . The effect of platelet‐derived growth factors on knee stability after anterior cruciate ligament reconstruction: a prospective randomized clinical study. Wiener Klinische Wochenschrift2010;122(Suppl 2):91‐5. [DOI: 10.1007/s00508‐010‐1340‐2] ">Vogrin 2010</a>). Most of the studies were conducted from 2005 to 2013. Ten studies did not have a pre‐published protocol/trial registration document (<a href="./references#CD010071-bbs2-0004" title="CervellinM , GirolamoL , BaitC , DentiM , VoltiP . Autologous platelet‐rich plasma gel to reduce donor‐site morbidity after patellar tendon graft harvesting for anterior cruciate ligamente reconstruction: a randomized, controlled clinical study. Knee Surgery, Sports Traumatology, Arthroscopy2012;20(1):114‐20. [DOI: 10.1007/s00167‐011‐1570‐5] ">Cervellin 2012</a>; <a href="./references#CD010071-bbs2-0005" title="CreaneyL , WallaceA , CurtisM , ConnellD . Growth factor‐based therapies provide additional benefit beyond physical therapy in resistant elbow tendinopathy: a prospective, single‐blind, randomised trial of autologous blood injections versus platelet‐rich plasma injections. British Journal of Sports Medicine2011;45(12):966‐71. [DOI: 10.1136/bjsm.2010.082503] ">Creaney 2011</a>; <a href="./references#CD010071-bbs2-0007" title="EvertsPA , DevileeRJ , MahoneyCB , vanErpA , OosterbosCJ , StellenboomM , et al. Exogenous application of platelet‐leukocyte gel during open subacromial decompression contributes to improved patient outcome. European Surgical Research2008;40(2):203‐10. [DOI: 10.1159/000110862] ">Everts 2008</a>; <a href="./references#CD010071-bbs2-0011" title="OrregoM , LarrainC , RosalesJ , ValenzuelaL , MatasJ , DurrutyJ , et al. Effects of platelet concentrate and a bone plug on the healing of hamstring tendons in a bone tunnel. Arthroscopy2008;24(12):1373‐80. [DOI: 10.1016/j.arthro.2008.07.016] ">Orrego 2008</a>; <a href="./references#CD010071-bbs2-0012" title="RandelliP , ArrigoniP , RagoneV , AliprandiA , CabitzaP . Platelet rich plasma in arthroscopic rotator cuff repair: a prospective RCT study, 2‐year follow‐up. Journal of Shoulder and Elbow Surgery2011;20(4):518‐28. [DOI: 10.1016/j.jse.2011.02.008] ">Randelli 2011</a>; <a href="./references#CD010071-bbs2-0014" title="SchepullT , KvistJ , NorrmanH , TrinksM , BerlinG , AspenbergP . Autologous platelet have no effect on the healing of human achilles tendon ruptures: a randomized single‐blind study. American Journal of Sports Medicine2011;39(1):38‐47. [DOI: 10.1177/0363546510383515] ">Schepull 2010</a>; <a href="./references#CD010071-bbs2-0015" title="ThanasasC , PapadimitriouG , CharalambidisC , ParaskevopoulosI , PapanikolaouA . Platelet‐rich plasma versus autologous whole blood for the treatment of chronic lateral elbow epicondylitis: a randomized controlled clinical trial. American Journal of Sports Medicine2011;39(10):2130‐4. [DOI: 10.1177/0363546511417113] ">Thanasas 2011</a>; <a href="./references#CD010071-bbs2-0016" title="VadalàA , IorioR , DeCarliA , FerrettiM , ParavaniD , CapernaL , et al. Platelet‐rich plasma: does it help reduce tunnel widening after ACL reconstruction?. Knee Surgery Sports Traumatology Arthroscopy2013;21(4):824‐9. [DOI: 10.1007/s00167‐012‐1980‐z] ">Vadalà 2013</a>; <a href="./references#CD010071-bbs2-0017" title="Valentí NínJR , GasqueGM , AzcárateAV , BeolaJD , GonzalezMH . Has platelet‐rich plasma any role in anterior cruciate ligament allograft healing?. Arthroscopy2009;25(11):1206‐13. [DOI: 10.1016/j.arthro.2009.06.002] ">Valenti Nín 2009</a>; <a href="./references#CD010071-bbs2-0018" title="VogrinM , RuprehtM , CrnjacA , DinevskiD , KrajncZ , RecnikG . The effect of platelet‐derived growth factors on knee stability after anterior cruciate ligament reconstruction: a prospective randomized clinical study. Wiener Klinische Wochenschrift2010;122(Suppl 2):91‐5. [DOI: 10.1007/s00508‐010‐1340‐2] ">Vogrin 2010</a>). The randomisation methods were described in most of the trials; however, in some studies reporting was unclear (<a href="./references#CD010071-bbs2-0004" title="CervellinM , GirolamoL , BaitC , DentiM , VoltiP . Autologous platelet‐rich plasma gel to reduce donor‐site morbidity after patellar tendon graft harvesting for anterior cruciate ligamente reconstruction: a randomized, controlled clinical study. Knee Surgery, Sports Traumatology, Arthroscopy2012;20(1):114‐20. [DOI: 10.1007/s00167‐011‐1570‐5] ">Cervellin 2012</a>; <a href="./references#CD010071-bbs2-0005" title="CreaneyL , WallaceA , CurtisM , ConnellD . Growth factor‐based therapies provide additional benefit beyond physical therapy in resistant elbow tendinopathy: a prospective, single‐blind, randomised trial of autologous blood injections versus platelet‐rich plasma injections. British Journal of Sports Medicine2011;45(12):966‐71. [DOI: 10.1136/bjsm.2010.082503] ">Creaney 2011</a>; <a href="./references#CD010071-bbs2-0016" title="VadalàA , IorioR , DeCarliA , FerrettiM , ParavaniD , CapernaL , et al. Platelet‐rich plasma: does it help reduce tunnel widening after ACL reconstruction?. Knee Surgery Sports Traumatology Arthroscopy2013;21(4):824‐9. [DOI: 10.1007/s00167‐012‐1980‐z] ">Vadalà 2013</a>). Most of the studies failed partially or entirely in the blinding procedure, as described in the <a href="./references#CD010071-sec-0140" title="">Characteristics of included studies</a>. Additionally, some studies did not report the platelet concentration (number of platelets per mm³), indicating that the authors did not quantify the platelet concentrations or its products. </p> </section> <section id="CD010071-sec-0057"> <h5 class="title">Setting</h5> <p>Studies were conducted in different settings in Europe: Italy (<a href="./references#CD010071-bbs2-0003" title="CastriciniR , LongoUG , BenedettoM , PanfoliN , PiraniN , ZiniR , et al. Platelet‐rich plasma augmentation for arthroscopic rotator cuff repair: a randomized controlled trial. American Journal of Sports Medicine2011;39(2):258‐65. [DOI: 10.1177/0363546510390780] ">Castricini 2011</a>; <a href="./references#CD010071-bbs2-0004" title="CervellinM , GirolamoL , BaitC , DentiM , VoltiP . Autologous platelet‐rich plasma gel to reduce donor‐site morbidity after patellar tendon graft harvesting for anterior cruciate ligamente reconstruction: a randomized, controlled clinical study. Knee Surgery, Sports Traumatology, Arthroscopy2012;20(1):114‐20. [DOI: 10.1007/s00167‐011‐1570‐5] ">Cervellin 2012</a>; <a href="./references#CD010071-bbs2-0008" title="GuminaS , CampagnaV , FerrazzaG , GiannicolaG , FratalocchiF , MilaniA , et al. Use of platelet‐leukocyte membrane in arthroscopic repair of large rotator cuff tears. Journal of Bone and Joint Surgery ‐ American Volume2012;94(15):1345‐52. [DOI: 10.2106/JBJS.K.00394] ">Gumina 2012</a>; <a href="./references#CD010071-bbs2-0012" title="RandelliP , ArrigoniP , RagoneV , AliprandiA , CabitzaP . Platelet rich plasma in arthroscopic rotator cuff repair: a prospective RCT study, 2‐year follow‐up. Journal of Shoulder and Elbow Surgery2011;20(4):518‐28. [DOI: 10.1016/j.jse.2011.02.008] ">Randelli 2011</a>; <a href="./references#CD010071-bbs2-0016" title="VadalàA , IorioR , DeCarliA , FerrettiM , ParavaniD , CapernaL , et al. Platelet‐rich plasma: does it help reduce tunnel widening after ACL reconstruction?. Knee Surgery Sports Traumatology Arthroscopy2013;21(4):824‐9. [DOI: 10.1007/s00167‐012‐1980‐z] ">Vadalà 2013</a>); Spain (<a href="./references#CD010071-bbs2-0002" title="AntunaS , BarcoR , MartinezJM , SanchezJM . Effect of platelet‐rich fibrin on rotator cuff repair (PRP‐Fibrin). http://clinicaltrials.gov/show/NCT01612845 (accessed 04 December 2013). AntunaSA , Barco LaaksoR , Martinez DiezJM , Sanchez MarquezJMM . PRP‐fibrin for arthroscopically repaired massive rotator cuff tears: a prospective randomized clinical trial. In: American Academy of Orthopaedic Surgeons Annual Meeting; 2012 Mar 7‐11; San Francisco (Ca)2012. AntuñaS , BarcoJ , Martínez DíesJM , Sánchez MárquezJM . Platelet‐rich fibrin in arthroscopic repair of massive rotator cuff tears: A prospective randomized pilot clinical trial. Acta Orthopaedica Belgica2013;79:25‐30. MoraesV . Personal communication. Email to: S Antuna 18 April 2013. ">Antuna 2013</a>; <a href="./references#CD010071-bbs2-0017" title="Valentí NínJR , GasqueGM , AzcárateAV , BeolaJD , GonzalezMH . Has platelet‐rich plasma any role in anterior cruciate ligament allograft healing?. Arthroscopy2009;25(11):1206‐13. [DOI: 10.1016/j.arthro.2009.06.002] ">Valenti Nín 2009</a>); The Netherlands (<a href="./references#CD010071-bbs2-0006" title="DeJongeS , DeVosRJ , WeirA , VanSchieHT , Bierma‐ZeinstraSM , VerhaarJA , et al. One‐year follow‐up of platelet‐rich plasma treatment in chronic Achilles tendinopathy. American Journal of Sports Medicine2011;39(8):1623‐9. deVosRJ , WeirA , TolJL , VerhaarJA , WeinansH , vanSchieHT . No effects of PRP on ultrasonographic tendon structure and neovascularization in chronic midportion Achilles tendinopathy. British Journal of Sports Medicine2011;45(5):387‐92. [DOI: 10.1136/bjsm.2010.076398] deVosRJ , WeirA , vanSchieHT , Bierma‐ZeinstraSM , VerhaarJA , WeinansH , et al. Platelet‐rich plasma injection for chronic Achilles tendinopathy. JAMA2010;303(2):144‐9. ">De Vos 2010</a>; <a href="./references#CD010071-bbs2-0007" title="EvertsPA , DevileeRJ , MahoneyCB , vanErpA , OosterbosCJ , StellenboomM , et al. Exogenous application of platelet‐leukocyte gel during open subacromial decompression contributes to improved patient outcome. European Surgical Research2008;40(2):203‐10. [DOI: 10.1159/000110862] ">Everts 2008</a>); Denmark (<a href="./references#CD010071-bbs2-0009" title="KroghTP , FredbergU , Stengaard‐PedersenK , ChristensenR , JensenP , EllingsenT . Treatment of lateral epicondylitis with platelet‐rich plasma, glucocorticoid, or saline: a randomized, double‐blind, placebo‐controlled trial. American Journal of Sports Medicine2013;41(3):625‐35. [DOI: 10.1177/0363546512472975] ">Krogh 2013</a>); Greece (<a href="./references#CD010071-bbs2-0015" title="ThanasasC , PapadimitriouG , CharalambidisC , ParaskevopoulosI , PapanikolaouA . Platelet‐rich plasma versus autologous whole blood for the treatment of chronic lateral elbow epicondylitis: a randomized controlled clinical trial. American Journal of Sports Medicine2011;39(10):2130‐4. [DOI: 10.1177/0363546511417113] ">Thanasas 2011</a>); UK (<a href="./references#CD010071-bbs2-0005" title="CreaneyL , WallaceA , CurtisM , ConnellD . Growth factor‐based therapies provide additional benefit beyond physical therapy in resistant elbow tendinopathy: a prospective, single‐blind, randomised trial of autologous blood injections versus platelet‐rich plasma injections. British Journal of Sports Medicine2011;45(12):966‐71. [DOI: 10.1136/bjsm.2010.082503] ">Creaney 2011</a>); Slovenia (<a href="./references#CD010071-bbs2-0018" title="VogrinM , RuprehtM , CrnjacA , DinevskiD , KrajncZ , RecnikG . The effect of platelet‐derived growth factors on knee stability after anterior cruciate ligament reconstruction: a prospective randomized clinical study. Wiener Klinische Wochenschrift2010;122(Suppl 2):91‐5. [DOI: 10.1007/s00508‐010‐1340‐2] ">Vogrin 2010</a>); Sweden (<a href="./references#CD010071-bbs2-0014" title="SchepullT , KvistJ , NorrmanH , TrinksM , BerlinG , AspenbergP . Autologous platelet have no effect on the healing of human achilles tendon ruptures: a randomized single‐blind study. American Journal of Sports Medicine2011;39(1):38‐47. [DOI: 10.1177/0363546510383515] ">Schepull 2010</a>); and in the Americas: Brazil (<a href="./references#CD010071-bbs2-0001" title="AlmeidaAM . Platelet‐rich plasma in the regeneration of the patellar ligament after harvesting its central third: a prospective randomised study [Efeito do plasma rico em plaquetas na regeneração do terço central do ligamento da patela: estudo prospectivo randomizado] (Thesis). São Paulo: Universidade de São Paulo, Faculdade de Medicina, 2013. AlmeidaAM , DemangeMK , SobradoMF , RodriguesMB , PedrinelliA , HernandezAJ . Patellar tendon healing with platelet‐rich plasma. American Journal of Sports Medicine2012;40(6):1283‐8. ">Almeida 2012</a>; <a href="./references#CD010071-bbs2-0010" title="MalavoltaE , Ferreira NetoAA . Platelet rich plasma on arthroscopic repair of the complete rotator cuff lesions: a prospective and randomized study. http://clinicaltrials.gov/ct2/show/NCT01029574 (accessed 26 August 2013). MoraesV . Personal communication. Email to: E Malavolta. ">NCT01029574</a>); Chile (<a href="./references#CD010071-bbs2-0011" title="OrregoM , LarrainC , RosalesJ , ValenzuelaL , MatasJ , DurrutyJ , et al. Effects of platelet concentrate and a bone plug on the healing of hamstring tendons in a bone tunnel. Arthroscopy2008;24(12):1373‐80. [DOI: 10.1016/j.arthro.2008.07.016] ">Orrego 2008</a>); and the USA (<a href="./references#CD010071-bbs2-0013" title="RodeoSA , DelosD , WilliamsRJ , AdlerRS , PearleA , WarrenRF . The effect of platelet‐rich fibrin matrix on rotator cuff tendon healing: a prospective, randomized clinical study. American Journal of Sports Medicine2012;40(6):1234‐41. [DOI: 10.1177/0363546512442924] ">Rodeo 2012</a>; <a href="./references#CD010071-bbs2-0019" title="WasterlainA , DragooJ . Platelet‐rich plasma as a treatment for patellar tendinopathy: a double‐blind randomized controlled trial. Individual patient data (as supplied June 2013). Data on file. ">Wasterlain 2013</a>). All were single‐centre trials. </p> </section> <section id="CD010071-sec-0058"> <h5 class="title">Sample sizes</h5> <p>The studies included a total of 1088 participants, with 59 participants being lost during follow‐up. Trials population sizes ranged from 23 (<a href="./references#CD010071-bbs2-0019" title="WasterlainA , DragooJ . Platelet‐rich plasma as a treatment for patellar tendinopathy: a double‐blind randomized controlled trial. Individual patient data (as supplied June 2013). Data on file. ">Wasterlain 2013</a>), to 150 (<a href="./references#CD010071-bbs2-0005" title="CreaneyL , WallaceA , CurtisM , ConnellD . Growth factor‐based therapies provide additional benefit beyond physical therapy in resistant elbow tendinopathy: a prospective, single‐blind, randomised trial of autologous blood injections versus platelet‐rich plasma injections. British Journal of Sports Medicine2011;45(12):966‐71. [DOI: 10.1136/bjsm.2010.082503] ">Creaney 2011</a>). One trial had an substantial loss to follow‐up after three months (27 participants out of 40) and only reported full follow‐up data for this period (<a href="./references#CD010071-bbs2-0009" title="KroghTP , FredbergU , Stengaard‐PedersenK , ChristensenR , JensenP , EllingsenT . Treatment of lateral epicondylitis with platelet‐rich plasma, glucocorticoid, or saline: a randomized, double‐blind, placebo‐controlled trial. American Journal of Sports Medicine2013;41(3):625‐35. [DOI: 10.1177/0363546512472975] ">Krogh 2013</a>). </p> </section> <section id="CD010071-sec-0059"> <h5 class="title">Participants</h5> <p>Participant characteristics differed among study populations often reflecting the different clinical conditions covered by these trials. Populations in studies concerning mainly sports injuries (lateral epicondylitis, ACL reconstruction, patellar tendinopathy, Achilles tendinopathy and Achilles ruptures) included mainly young and active adults, whereas studies concerning degenerative conditions (chronic impingement syndrome and rotator cuff tears) mainly included an older population. Studies mainly included men. However, for rotator cuff ruptures, elbow epicondylitis and Achilles tendinopathies, there were similar proportions of male and female participants. Most of the studies did not specify whether the participants had a previous history of sports activity. This information was mostly available for ACL and Achilles tendon injuries, where sports activity status is a major concern. Three trials reported that their population included people with some level of sports activity (<a href="./references#CD010071-bbs2-0004" title="CervellinM , GirolamoL , BaitC , DentiM , VoltiP . Autologous platelet‐rich plasma gel to reduce donor‐site morbidity after patellar tendon graft harvesting for anterior cruciate ligamente reconstruction: a randomized, controlled clinical study. Knee Surgery, Sports Traumatology, Arthroscopy2012;20(1):114‐20. [DOI: 10.1007/s00167‐011‐1570‐5] ">Cervellin 2012</a>; <a href="./references#CD010071-bbs2-0006" title="DeJongeS , DeVosRJ , WeirA , VanSchieHT , Bierma‐ZeinstraSM , VerhaarJA , et al. One‐year follow‐up of platelet‐rich plasma treatment in chronic Achilles tendinopathy. American Journal of Sports Medicine2011;39(8):1623‐9. deVosRJ , WeirA , TolJL , VerhaarJA , WeinansH , vanSchieHT . No effects of PRP on ultrasonographic tendon structure and neovascularization in chronic midportion Achilles tendinopathy. British Journal of Sports Medicine2011;45(5):387‐92. [DOI: 10.1136/bjsm.2010.076398] deVosRJ , WeirA , vanSchieHT , Bierma‐ZeinstraSM , VerhaarJA , WeinansH , et al. Platelet‐rich plasma injection for chronic Achilles tendinopathy. JAMA2010;303(2):144‐9. ">De Vos 2010</a>; <a href="./references#CD010071-bbs2-0014" title="SchepullT , KvistJ , NorrmanH , TrinksM , BerlinG , AspenbergP . Autologous platelet have no effect on the healing of human achilles tendon ruptures: a randomized single‐blind study. American Journal of Sports Medicine2011;39(1):38‐47. [DOI: 10.1177/0363546510383515] ">Schepull 2010</a>). <a href="./references#CD010071-bbs2-0004" title="CervellinM , GirolamoL , BaitC , DentiM , VoltiP . Autologous platelet‐rich plasma gel to reduce donor‐site morbidity after patellar tendon graft harvesting for anterior cruciate ligamente reconstruction: a randomized, controlled clinical study. Knee Surgery, Sports Traumatology, Arthroscopy2012;20(1):114‐20. [DOI: 10.1007/s00167‐011‐1570‐5] ">Cervellin 2012</a> reported that all participants were at a 'high level' of sports activity. A study‐by‐study description of age, gender and sport activity can be found in the 'Participants' sections of the <a href="./references#CD010071-sec-0140" title="">Characteristics of included studies</a>. </p> </section> <section id="CD010071-sec-0060"> <h5 class="title">Conditions and interventions</h5> <p>The conditions and main treatment of included trials were grouped into the following seven categories, one category being further subdivided into two. Notably, there were no included trials on sprains or muscle injuries. Further details of the various PRT interventions can be found in the <a href="./references#CD010071-sec-0140" title="">Characteristics of included studies</a> table. </p> <section id="CD010071-sec-0061"> <h6 class="title">Rotator cuff tears (surgical repair)</h6> <p>Six studies assessed the application of platelet‐rich plasma (PRP) to the repair site after arthroscopic rotator cuff repair (<a href="./references#CD010071-bbs2-0002" title="AntunaS , BarcoR , MartinezJM , SanchezJM . Effect of platelet‐rich fibrin on rotator cuff repair (PRP‐Fibrin). http://clinicaltrials.gov/show/NCT01612845 (accessed 04 December 2013). AntunaSA , Barco LaaksoR , Martinez DiezJM , Sanchez MarquezJMM . PRP‐fibrin for arthroscopically repaired massive rotator cuff tears: a prospective randomized clinical trial. In: American Academy of Orthopaedic Surgeons Annual Meeting; 2012 Mar 7‐11; San Francisco (Ca)2012. AntuñaS , BarcoJ , Martínez DíesJM , Sánchez MárquezJM . Platelet‐rich fibrin in arthroscopic repair of massive rotator cuff tears: A prospective randomized pilot clinical trial. Acta Orthopaedica Belgica2013;79:25‐30. MoraesV . Personal communication. Email to: S Antuna 18 April 2013. ">Antuna 2013</a>; <a href="./references#CD010071-bbs2-0003" title="CastriciniR , LongoUG , BenedettoM , PanfoliN , PiraniN , ZiniR , et al. Platelet‐rich plasma augmentation for arthroscopic rotator cuff repair: a randomized controlled trial. American Journal of Sports Medicine2011;39(2):258‐65. [DOI: 10.1177/0363546510390780] ">Castricini 2011</a>; <a href="./references#CD010071-bbs2-0008" title="GuminaS , CampagnaV , FerrazzaG , GiannicolaG , FratalocchiF , MilaniA , et al. Use of platelet‐leukocyte membrane in arthroscopic repair of large rotator cuff tears. Journal of Bone and Joint Surgery ‐ American Volume2012;94(15):1345‐52. [DOI: 10.2106/JBJS.K.00394] ">Gumina 2012</a>; <a href="./references#CD010071-bbs2-0010" title="MalavoltaE , Ferreira NetoAA . Platelet rich plasma on arthroscopic repair of the complete rotator cuff lesions: a prospective and randomized study. http://clinicaltrials.gov/ct2/show/NCT01029574 (accessed 26 August 2013). MoraesV . Personal communication. Email to: E Malavolta. ">NCT01029574</a>; <a href="./references#CD010071-bbs2-0012" title="RandelliP , ArrigoniP , RagoneV , AliprandiA , CabitzaP . Platelet rich plasma in arthroscopic rotator cuff repair: a prospective RCT study, 2‐year follow‐up. Journal of Shoulder and Elbow Surgery2011;20(4):518‐28. [DOI: 10.1016/j.jse.2011.02.008] ">Randelli 2011</a>; <a href="./references#CD010071-bbs2-0013" title="RodeoSA , DelosD , WilliamsRJ , AdlerRS , PearleA , WarrenRF . The effect of platelet‐rich fibrin matrix on rotator cuff tendon healing: a prospective, randomized clinical study. American Journal of Sports Medicine2012;40(6):1234‐41. [DOI: 10.1177/0363546512442924] ">Rodeo 2012</a>). Three studies included participants with complete rotator cuff tears (<a href="./references#CD010071-bbs2-0002" title="AntunaS , BarcoR , MartinezJM , SanchezJM . Effect of platelet‐rich fibrin on rotator cuff repair (PRP‐Fibrin). http://clinicaltrials.gov/show/NCT01612845 (accessed 04 December 2013). AntunaSA , Barco LaaksoR , Martinez DiezJM , Sanchez MarquezJMM . PRP‐fibrin for arthroscopically repaired massive rotator cuff tears: a prospective randomized clinical trial. In: American Academy of Orthopaedic Surgeons Annual Meeting; 2012 Mar 7‐11; San Francisco (Ca)2012. AntuñaS , BarcoJ , Martínez DíesJM , Sánchez MárquezJM . Platelet‐rich fibrin in arthroscopic repair of massive rotator cuff tears: A prospective randomized pilot clinical trial. Acta Orthopaedica Belgica2013;79:25‐30. MoraesV . Personal communication. Email to: S Antuna 18 April 2013. ">Antuna 2013</a>; <a href="./references#CD010071-bbs2-0012" title="RandelliP , ArrigoniP , RagoneV , AliprandiA , CabitzaP . Platelet rich plasma in arthroscopic rotator cuff repair: a prospective RCT study, 2‐year follow‐up. Journal of Shoulder and Elbow Surgery2011;20(4):518‐28. [DOI: 10.1016/j.jse.2011.02.008] ">Randelli 2011</a>; <a href="./references#CD010071-bbs2-0013" title="RodeoSA , DelosD , WilliamsRJ , AdlerRS , PearleA , WarrenRF . The effect of platelet‐rich fibrin matrix on rotator cuff tendon healing: a prospective, randomized clinical study. American Journal of Sports Medicine2012;40(6):1234‐41. [DOI: 10.1177/0363546512442924] ">Rodeo 2012</a>). Two studies included participants with large rotator cuff tears (<a href="./references#CD010071-bbs2-0008" title="GuminaS , CampagnaV , FerrazzaG , GiannicolaG , FratalocchiF , MilaniA , et al. Use of platelet‐leukocyte membrane in arthroscopic repair of large rotator cuff tears. Journal of Bone and Joint Surgery ‐ American Volume2012;94(15):1345‐52. [DOI: 10.2106/JBJS.K.00394] ">Gumina 2012</a>; <a href="./references#CD010071-bbs2-0010" title="MalavoltaE , Ferreira NetoAA . Platelet rich plasma on arthroscopic repair of the complete rotator cuff lesions: a prospective and randomized study. http://clinicaltrials.gov/ct2/show/NCT01029574 (accessed 26 August 2013). MoraesV . Personal communication. Email to: E Malavolta. ">NCT01029574</a>), and one study included small and moderate tears (<a href="./references#CD010071-bbs2-0003" title="CastriciniR , LongoUG , BenedettoM , PanfoliN , PiraniN , ZiniR , et al. Platelet‐rich plasma augmentation for arthroscopic rotator cuff repair: a randomized controlled trial. American Journal of Sports Medicine2011;39(2):258‐65. [DOI: 10.1177/0363546510390780] ">Castricini 2011</a>). Studies mostly assessed rotator cuff tears before surgery by means of physical examination and magnetic resonance imaging (MRI). In all studies, PRP was applied at the time of, or after, arthroscopic repair and with the aid of the arthroscopic device (PRP was applied mostly through one of the portals and its positioning checked by the arthroscope) and its preparation was carried out using a specific kit. In <a href="./references#CD010071-bbs2-0003" title="CastriciniR , LongoUG , BenedettoM , PanfoliN , PiraniN , ZiniR , et al. Platelet‐rich plasma augmentation for arthroscopic rotator cuff repair: a randomized controlled trial. American Journal of Sports Medicine2011;39(2):258‐65. [DOI: 10.1177/0363546510390780] ">Castricini 2011</a>, <a href="./references#CD010071-bbs2-0008" title="GuminaS , CampagnaV , FerrazzaG , GiannicolaG , FratalocchiF , MilaniA , et al. Use of platelet‐leukocyte membrane in arthroscopic repair of large rotator cuff tears. Journal of Bone and Joint Surgery ‐ American Volume2012;94(15):1345‐52. [DOI: 10.2106/JBJS.K.00394] ">Gumina 2012</a> and <a href="./references#CD010071-bbs2-0013" title="RodeoSA , DelosD , WilliamsRJ , AdlerRS , PearleA , WarrenRF . The effect of platelet‐rich fibrin matrix on rotator cuff tendon healing: a prospective, randomized clinical study. American Journal of Sports Medicine2012;40(6):1234‐41. [DOI: 10.1177/0363546512442924] ">Rodeo 2012</a>, the PRP matrix was attached to the suture anchor, which was then passed down the arthroscopic cannula to the repair site. In the other three trials, PRP was applied directly to the repair site (with syringe and needles) (<a href="./references#CD010071-bbs2-0002" title="AntunaS , BarcoR , MartinezJM , SanchezJM . Effect of platelet‐rich fibrin on rotator cuff repair (PRP‐Fibrin). http://clinicaltrials.gov/show/NCT01612845 (accessed 04 December 2013). AntunaSA , Barco LaaksoR , Martinez DiezJM , Sanchez MarquezJMM . PRP‐fibrin for arthroscopically repaired massive rotator cuff tears: a prospective randomized clinical trial. In: American Academy of Orthopaedic Surgeons Annual Meeting; 2012 Mar 7‐11; San Francisco (Ca)2012. AntuñaS , BarcoJ , Martínez DíesJM , Sánchez MárquezJM . Platelet‐rich fibrin in arthroscopic repair of massive rotator cuff tears: A prospective randomized pilot clinical trial. Acta Orthopaedica Belgica2013;79:25‐30. MoraesV . Personal communication. Email to: S Antuna 18 April 2013. ">Antuna 2013</a>; <a href="./references#CD010071-bbs2-0010" title="MalavoltaE , Ferreira NetoAA . Platelet rich plasma on arthroscopic repair of the complete rotator cuff lesions: a prospective and randomized study. http://clinicaltrials.gov/ct2/show/NCT01029574 (accessed 26 August 2013). MoraesV . Personal communication. Email to: E Malavolta. ">NCT01029574</a>; <a href="./references#CD010071-bbs2-0012" title="RandelliP , ArrigoniP , RagoneV , AliprandiA , CabitzaP . Platelet rich plasma in arthroscopic rotator cuff repair: a prospective RCT study, 2‐year follow‐up. Journal of Shoulder and Elbow Surgery2011;20(4):518‐28. [DOI: 10.1016/j.jse.2011.02.008] ">Randelli 2011</a>). In all six trials, PRP was applied in a single procedure to the suture site before closure of the surgical wounds. </p> </section> <section id="CD010071-sec-0062"> <h6 class="title">Shoulder impingement syndrome (surgery)</h6> <p>One study assessed PRP application after open decompression for shoulder impingement syndrome (<a href="./references#CD010071-bbs2-0007" title="EvertsPA , DevileeRJ , MahoneyCB , vanErpA , OosterbosCJ , StellenboomM , et al. Exogenous application of platelet‐leukocyte gel during open subacromial decompression contributes to improved patient outcome. European Surgical Research2008;40(2):203‐10. [DOI: 10.1159/000110862] ">Everts 2008</a>), with no intervention as a control. The surgeons inserted a needle into the subacromial space after open decompression and PRP was applied intracapsularly after deltoid and subcutaneous layers were closed. Before skin closure, the researcher also applied a small quantity (3 mL) into the subcutaneous layer. </p> </section> <section id="CD010071-sec-0063"> <h6 class="title">Elbow epicondylitis</h6> <p>The three studies on lateral epicondylitis used ultrasound‐guided application of PRP to the origin of the elbow tendons as the intervention (<a href="./references#CD010071-bbs2-0005" title="CreaneyL , WallaceA , CurtisM , ConnellD . Growth factor‐based therapies provide additional benefit beyond physical therapy in resistant elbow tendinopathy: a prospective, single‐blind, randomised trial of autologous blood injections versus platelet‐rich plasma injections. British Journal of Sports Medicine2011;45(12):966‐71. [DOI: 10.1136/bjsm.2010.082503] ">Creaney 2011</a>; <a href="./references#CD010071-bbs2-0009" title="KroghTP , FredbergU , Stengaard‐PedersenK , ChristensenR , JensenP , EllingsenT . Treatment of lateral epicondylitis with platelet‐rich plasma, glucocorticoid, or saline: a randomized, double‐blind, placebo‐controlled trial. American Journal of Sports Medicine2013;41(3):625‐35. [DOI: 10.1177/0363546512472975] ">Krogh 2013</a>; <a href="./references#CD010071-bbs2-0015" title="ThanasasC , PapadimitriouG , CharalambidisC , ParaskevopoulosI , PapanikolaouA . Platelet‐rich plasma versus autologous whole blood for the treatment of chronic lateral elbow epicondylitis: a randomized controlled clinical trial. American Journal of Sports Medicine2011;39(10):2130‐4. [DOI: 10.1177/0363546511417113] ">Thanasas 2011</a>). The studies differed with regard to the time span between symptoms and intervention. <a href="./references#CD010071-bbs2-0005" title="CreaneyL , WallaceA , CurtisM , ConnellD . Growth factor‐based therapies provide additional benefit beyond physical therapy in resistant elbow tendinopathy: a prospective, single‐blind, randomised trial of autologous blood injections versus platelet‐rich plasma injections. British Journal of Sports Medicine2011;45(12):966‐71. [DOI: 10.1136/bjsm.2010.082503] ">Creaney 2011</a> included participants with at least six months of symptoms who had been treated unsuccessfully with physiotherapy. <a href="./references#CD010071-bbs2-0009" title="KroghTP , FredbergU , Stengaard‐PedersenK , ChristensenR , JensenP , EllingsenT . Treatment of lateral epicondylitis with platelet‐rich plasma, glucocorticoid, or saline: a randomized, double‐blind, placebo‐controlled trial. American Journal of Sports Medicine2013;41(3):625‐35. [DOI: 10.1177/0363546512472975] ">Krogh 2013</a> and <a href="./references#CD010071-bbs2-0015" title="ThanasasC , PapadimitriouG , CharalambidisC , ParaskevopoulosI , PapanikolaouA . Platelet‐rich plasma versus autologous whole blood for the treatment of chronic lateral elbow epicondylitis: a randomized controlled clinical trial. American Journal of Sports Medicine2011;39(10):2130‐4. [DOI: 10.1177/0363546511417113] ">Thanasas 2011</a> included participants with at least three months of symptoms and permitted the inclusion of participants who had had previous injections as treatment. None of the studies reported on prior sports participation. One study reported that the procedure was aided by an experienced radiologist and two applications were performed over the time span of one month (<a href="./references#CD010071-bbs2-0005" title="CreaneyL , WallaceA , CurtisM , ConnellD . Growth factor‐based therapies provide additional benefit beyond physical therapy in resistant elbow tendinopathy: a prospective, single‐blind, randomised trial of autologous blood injections versus platelet‐rich plasma injections. British Journal of Sports Medicine2011;45(12):966‐71. [DOI: 10.1136/bjsm.2010.082503] ">Creaney 2011</a>). Two studies considered autologous whole blood as a control (<a href="./references#CD010071-bbs2-0005" title="CreaneyL , WallaceA , CurtisM , ConnellD . Growth factor‐based therapies provide additional benefit beyond physical therapy in resistant elbow tendinopathy: a prospective, single‐blind, randomised trial of autologous blood injections versus platelet‐rich plasma injections. British Journal of Sports Medicine2011;45(12):966‐71. [DOI: 10.1136/bjsm.2010.082503] ">Creaney 2011</a>; <a href="./references#CD010071-bbs2-0015" title="ThanasasC , PapadimitriouG , CharalambidisC , ParaskevopoulosI , PapanikolaouA . Platelet‐rich plasma versus autologous whole blood for the treatment of chronic lateral elbow epicondylitis: a randomized controlled clinical trial. American Journal of Sports Medicine2011;39(10):2130‐4. [DOI: 10.1177/0363546511417113] ">Thanasas 2011</a>), and one considered dry needling using a peppering technique as a control (<a href="./references#CD010071-bbs2-0009" title="KroghTP , FredbergU , Stengaard‐PedersenK , ChristensenR , JensenP , EllingsenT . Treatment of lateral epicondylitis with platelet‐rich plasma, glucocorticoid, or saline: a randomized, double‐blind, placebo‐controlled trial. American Journal of Sports Medicine2013;41(3):625‐35. [DOI: 10.1177/0363546512472975] ">Krogh 2013</a>). <a href="./references#CD010071-bbs2-0005" title="CreaneyL , WallaceA , CurtisM , ConnellD . Growth factor‐based therapies provide additional benefit beyond physical therapy in resistant elbow tendinopathy: a prospective, single‐blind, randomised trial of autologous blood injections versus platelet‐rich plasma injections. British Journal of Sports Medicine2011;45(12):966‐71. [DOI: 10.1136/bjsm.2010.082503] ">Creaney 2011</a> did not state whether they used a specific kit for PRP preparation. </p> </section> <section id="CD010071-sec-0064"> <h6 class="title">Anterior cruciate ligament (ACL) reconstruction</h6> <section id="CD010071-sec-0065"> <p><b>Graft donor site</b></p> <p><a href="./references#CD010071-bbs2-0001" title="AlmeidaAM . Platelet‐rich plasma in the regeneration of the patellar ligament after harvesting its central third: a prospective randomised study [Efeito do plasma rico em plaquetas na regeneração do terço central do ligamento da patela: estudo prospectivo randomizado] (Thesis). São Paulo: Universidade de São Paulo, Faculdade de Medicina, 2013. AlmeidaAM , DemangeMK , SobradoMF , RodriguesMB , PedrinelliA , HernandezAJ . Patellar tendon healing with platelet‐rich plasma. American Journal of Sports Medicine2012;40(6):1283‐8. ">Almeida 2012</a> and <a href="./references#CD010071-bbs2-0004" title="CervellinM , GirolamoL , BaitC , DentiM , VoltiP . Autologous platelet‐rich plasma gel to reduce donor‐site morbidity after patellar tendon graft harvesting for anterior cruciate ligamente reconstruction: a randomized, controlled clinical study. Knee Surgery, Sports Traumatology, Arthroscopy2012;20(1):114‐20. [DOI: 10.1007/s00167‐011‐1570‐5] ">Cervellin 2012</a> used a PRP preparation with the aim of reducing the morbidity of the ACL reconstruction donor site. Both studies used patellar tendons (bone‐tendon‐bone) as grafts and performed PRP applications after tendon harvesting, as a part of the operative procedure (before surgical wound closing). Both studies considered the standard procedure as the control intervention ‐ with no dedicated intervention in the tendon harvest site. Co‐interventions between the groups were similar in both studies. </p> </section> <section id="CD010071-sec-0066"> <p><b>Anterior cruciate ligament reconstruction (augmentation procedure)</b></p> <p>Four studies used PRP in the arthroscopic reconstruction procedure (<a href="./references#CD010071-bbs2-0011" title="OrregoM , LarrainC , RosalesJ , ValenzuelaL , MatasJ , DurrutyJ , et al. Effects of platelet concentrate and a bone plug on the healing of hamstring tendons in a bone tunnel. Arthroscopy2008;24(12):1373‐80. [DOI: 10.1016/j.arthro.2008.07.016] ">Orrego 2008</a>; <a href="./references#CD010071-bbs2-0016" title="VadalàA , IorioR , DeCarliA , FerrettiM , ParavaniD , CapernaL , et al. Platelet‐rich plasma: does it help reduce tunnel widening after ACL reconstruction?. Knee Surgery Sports Traumatology Arthroscopy2013;21(4):824‐9. [DOI: 10.1007/s00167‐012‐1980‐z] ">Vadalà 2013</a>; <a href="./references#CD010071-bbs2-0017" title="Valentí NínJR , GasqueGM , AzcárateAV , BeolaJD , GonzalezMH . Has platelet‐rich plasma any role in anterior cruciate ligament allograft healing?. Arthroscopy2009;25(11):1206‐13. [DOI: 10.1016/j.arthro.2009.06.002] ">Valenti Nín 2009</a>; <a href="./references#CD010071-bbs2-0018" title="VogrinM , RuprehtM , CrnjacA , DinevskiD , KrajncZ , RecnikG . The effect of platelet‐derived growth factors on knee stability after anterior cruciate ligament reconstruction: a prospective randomized clinical study. Wiener Klinische Wochenschrift2010;122(Suppl 2):91‐5. [DOI: 10.1007/s00508‐010‐1340‐2] ">Vogrin 2010</a>). All studies but <a href="./references#CD010071-bbs2-0017" title="Valentí NínJR , GasqueGM , AzcárateAV , BeolaJD , GonzalezMH . Has platelet‐rich plasma any role in anterior cruciate ligament allograft healing?. Arthroscopy2009;25(11):1206‐13. [DOI: 10.1016/j.arthro.2009.06.002] ">Valenti Nín 2009</a> used hamstring tendons as grafts. <a href="./references#CD010071-bbs2-0017" title="Valentí NínJR , GasqueGM , AzcárateAV , BeolaJD , GonzalezMH . Has platelet‐rich plasma any role in anterior cruciate ligament allograft healing?. Arthroscopy2009;25(11):1206‐13. [DOI: 10.1016/j.arthro.2009.06.002] ">Valenti Nín 2009</a> used patellar (bone‐tendon‐bone) graft. All studies considered the standard procedure as the control intervention, with no additional therapy in the course of reconstruction. A specific kit was used for PRP preparation. <a href="./references#CD010071-bbs2-0011" title="OrregoM , LarrainC , RosalesJ , ValenzuelaL , MatasJ , DurrutyJ , et al. Effects of platelet concentrate and a bone plug on the healing of hamstring tendons in a bone tunnel. Arthroscopy2008;24(12):1373‐80. [DOI: 10.1016/j.arthro.2008.07.016] ">Orrego 2008</a>, <a href="./references#CD010071-bbs2-0016" title="VadalàA , IorioR , DeCarliA , FerrettiM , ParavaniD , CapernaL , et al. Platelet‐rich plasma: does it help reduce tunnel widening after ACL reconstruction?. Knee Surgery Sports Traumatology Arthroscopy2013;21(4):824‐9. [DOI: 10.1007/s00167‐012‐1980‐z] ">Vadalà 2013</a> and <a href="./references#CD010071-bbs2-0017" title="Valentí NínJR , GasqueGM , AzcárateAV , BeolaJD , GonzalezMH . Has platelet‐rich plasma any role in anterior cruciate ligament allograft healing?. Arthroscopy2009;25(11):1206‐13. [DOI: 10.1016/j.arthro.2009.06.002] ">Valenti Nín 2009</a> applied PRP in the graft before insertion (as they awaited the formation of a clot). After insertion, it was also applied into the bone tunnels with the aid of the arthroscope, prior to closing wounds. The procedure in <a href="./references#CD010071-bbs2-0018" title="VogrinM , RuprehtM , CrnjacA , DinevskiD , KrajncZ , RecnikG . The effect of platelet‐derived growth factors on knee stability after anterior cruciate ligament reconstruction: a prospective randomized clinical study. Wiener Klinische Wochenschrift2010;122(Suppl 2):91‐5. [DOI: 10.1007/s00508‐010‐1340‐2] ">Vogrin 2010</a> differed, as they applied PRP after graft insertion. </p> </section> </section> <section id="CD010071-sec-0067"> <h6 class="title">Patellar tendinopathy</h6> <p>One study compared a single ultrasound‐guided application of PRP with dry needling control in patellar tendinopathy (<a href="./references#CD010071-bbs2-0019" title="WasterlainA , DragooJ . Platelet‐rich plasma as a treatment for patellar tendinopathy: a double‐blind randomized controlled trial. Individual patient data (as supplied June 2013). Data on file. ">Wasterlain 2013</a>). They used a specific kit for PRP preparation. After the procedure, all participants were instructed to undergo an eccentric (muscular activation in which the muscle fibres lengthen to lower a load) five‐phase exercise programme. </p> </section> <section id="CD010071-sec-0068"> <h6 class="title">Chronic Achilles tendinopathy</h6> <p>One study assessed the results of PRP application in participants with chronic Achilles tendinopathy and used saline injections as controls (<a href="./references#CD010071-bbs2-0006" title="DeJongeS , DeVosRJ , WeirA , VanSchieHT , Bierma‐ZeinstraSM , VerhaarJA , et al. One‐year follow‐up of platelet‐rich plasma treatment in chronic Achilles tendinopathy. American Journal of Sports Medicine2011;39(8):1623‐9. deVosRJ , WeirA , TolJL , VerhaarJA , WeinansH , vanSchieHT . No effects of PRP on ultrasonographic tendon structure and neovascularization in chronic midportion Achilles tendinopathy. British Journal of Sports Medicine2011;45(5):387‐92. [DOI: 10.1136/bjsm.2010.076398] deVosRJ , WeirA , vanSchieHT , Bierma‐ZeinstraSM , VerhaarJA , WeinansH , et al. Platelet‐rich plasma injection for chronic Achilles tendinopathy. JAMA2010;303(2):144‐9. ">De Vos 2010</a>). A blinded physician performed the injections under ultrasound guidance, making five small deposits at various sites of the degenerated area of the tendon through each of three puncture locations. After the procedure, all participants were instructed to carry out the usual care, which consisted of a pre‐defined eccentric exercise programme. </p> </section> <section id="CD010071-sec-0069"> <h6 class="title">Acute Achilles tendon rupture (surgical repair)</h6> <p>One study compared the intraoperative application of PRP in Achilles tendon ruptures after standard repair (<a href="./references#CD010071-bbs2-0014" title="SchepullT , KvistJ , NorrmanH , TrinksM , BerlinG , AspenbergP . Autologous platelet have no effect on the healing of human achilles tendon ruptures: a randomized single‐blind study. American Journal of Sports Medicine2011;39(1):38‐47. [DOI: 10.1177/0363546510383515] ">Schepull 2010</a>). Application consisted of the application of PRP to the repair site and, after closure, transdermally. Standard repair with no PRP was used as a control. The researchers added two tantalum beads proximally and distally to the ruptured tendon ends with the aim of measuring tendon properties, such as elasticity modulus, using roentgen stereophotogrammetric analysis. </p> </section> <section id="CD010071-sec-0070"> <h6 class="title">Grouping by basic treatment categories</h6> <p>These studies could be grouped also into two categories: main treatment for 'tendinopathies' and surgical augmentation procedures. Studies were considered to belong in the tendinopathy group when the main treatment was injections and no surgery was performed (repair or reconstruction). This included the following selection from the above conditions: elbow epicondylitis (<a href="./references#CD010071-bbs2-0005" title="CreaneyL , WallaceA , CurtisM , ConnellD . Growth factor‐based therapies provide additional benefit beyond physical therapy in resistant elbow tendinopathy: a prospective, single‐blind, randomised trial of autologous blood injections versus platelet‐rich plasma injections. British Journal of Sports Medicine2011;45(12):966‐71. [DOI: 10.1136/bjsm.2010.082503] ">Creaney 2011</a>; <a href="./references#CD010071-bbs2-0009" title="KroghTP , FredbergU , Stengaard‐PedersenK , ChristensenR , JensenP , EllingsenT . Treatment of lateral epicondylitis with platelet‐rich plasma, glucocorticoid, or saline: a randomized, double‐blind, placebo‐controlled trial. American Journal of Sports Medicine2013;41(3):625‐35. [DOI: 10.1177/0363546512472975] ">Krogh 2013</a>; <a href="./references#CD010071-bbs2-0015" title="ThanasasC , PapadimitriouG , CharalambidisC , ParaskevopoulosI , PapanikolaouA . Platelet‐rich plasma versus autologous whole blood for the treatment of chronic lateral elbow epicondylitis: a randomized controlled clinical trial. American Journal of Sports Medicine2011;39(10):2130‐4. [DOI: 10.1177/0363546511417113] ">Thanasas 2011</a>), patellar tendinopathies (<a href="./references#CD010071-bbs2-0019" title="WasterlainA , DragooJ . Platelet‐rich plasma as a treatment for patellar tendinopathy: a double‐blind randomized controlled trial. Individual patient data (as supplied June 2013). Data on file. ">Wasterlain 2013</a>) and chronic Achilles tendinopathies (<a href="./references#CD010071-bbs2-0006" title="DeJongeS , DeVosRJ , WeirA , VanSchieHT , Bierma‐ZeinstraSM , VerhaarJA , et al. One‐year follow‐up of platelet‐rich plasma treatment in chronic Achilles tendinopathy. American Journal of Sports Medicine2011;39(8):1623‐9. deVosRJ , WeirA , TolJL , VerhaarJA , WeinansH , vanSchieHT . No effects of PRP on ultrasonographic tendon structure and neovascularization in chronic midportion Achilles tendinopathy. British Journal of Sports Medicine2011;45(5):387‐92. [DOI: 10.1136/bjsm.2010.076398] deVosRJ , WeirA , vanSchieHT , Bierma‐ZeinstraSM , VerhaarJA , WeinansH , et al. Platelet‐rich plasma injection for chronic Achilles tendinopathy. JAMA2010;303(2):144‐9. ">De Vos 2010</a>). Studies were considered for the surgical augmentation group when surgery was the main treatment procedure. This included the following selection from the above conditions: rotator cuff tears repair (<a href="./references#CD010071-bbs2-0002" title="AntunaS , BarcoR , MartinezJM , SanchezJM . Effect of platelet‐rich fibrin on rotator cuff repair (PRP‐Fibrin). http://clinicaltrials.gov/show/NCT01612845 (accessed 04 December 2013). AntunaSA , Barco LaaksoR , Martinez DiezJM , Sanchez MarquezJMM . PRP‐fibrin for arthroscopically repaired massive rotator cuff tears: a prospective randomized clinical trial. In: American Academy of Orthopaedic Surgeons Annual Meeting; 2012 Mar 7‐11; San Francisco (Ca)2012. AntuñaS , BarcoJ , Martínez DíesJM , Sánchez MárquezJM . Platelet‐rich fibrin in arthroscopic repair of massive rotator cuff tears: A prospective randomized pilot clinical trial. Acta Orthopaedica Belgica2013;79:25‐30. MoraesV . Personal communication. Email to: S Antuna 18 April 2013. ">Antuna 2013</a>; <a href="./references#CD010071-bbs2-0003" title="CastriciniR , LongoUG , BenedettoM , PanfoliN , PiraniN , ZiniR , et al. Platelet‐rich plasma augmentation for arthroscopic rotator cuff repair: a randomized controlled trial. American Journal of Sports Medicine2011;39(2):258‐65. [DOI: 10.1177/0363546510390780] ">Castricini 2011</a>; <a href="./references#CD010071-bbs2-0008" title="GuminaS , CampagnaV , FerrazzaG , GiannicolaG , FratalocchiF , MilaniA , et al. Use of platelet‐leukocyte membrane in arthroscopic repair of large rotator cuff tears. Journal of Bone and Joint Surgery ‐ American Volume2012;94(15):1345‐52. [DOI: 10.2106/JBJS.K.00394] ">Gumina 2012</a>; <a href="./references#CD010071-bbs2-0010" title="MalavoltaE , Ferreira NetoAA . Platelet rich plasma on arthroscopic repair of the complete rotator cuff lesions: a prospective and randomized study. http://clinicaltrials.gov/ct2/show/NCT01029574 (accessed 26 August 2013). MoraesV . Personal communication. Email to: E Malavolta. ">NCT01029574</a>; <a href="./references#CD010071-bbs2-0012" title="RandelliP , ArrigoniP , RagoneV , AliprandiA , CabitzaP . Platelet rich plasma in arthroscopic rotator cuff repair: a prospective RCT study, 2‐year follow‐up. Journal of Shoulder and Elbow Surgery2011;20(4):518‐28. [DOI: 10.1016/j.jse.2011.02.008] ">Randelli 2011</a>; <a href="./references#CD010071-bbs2-0013" title="RodeoSA , DelosD , WilliamsRJ , AdlerRS , PearleA , WarrenRF . The effect of platelet‐rich fibrin matrix on rotator cuff tendon healing: a prospective, randomized clinical study. American Journal of Sports Medicine2012;40(6):1234‐41. [DOI: 10.1177/0363546512442924] ">Rodeo 2012</a>), shoulder impingement syndrome surgery (<a href="./references#CD010071-bbs2-0007" title="EvertsPA , DevileeRJ , MahoneyCB , vanErpA , OosterbosCJ , StellenboomM , et al. Exogenous application of platelet‐leukocyte gel during open subacromial decompression contributes to improved patient outcome. European Surgical Research2008;40(2):203‐10. [DOI: 10.1159/000110862] ">Everts 2008</a>), ACL reconstruction (<a href="./references#CD010071-bbs2-0001" title="AlmeidaAM . Platelet‐rich plasma in the regeneration of the patellar ligament after harvesting its central third: a prospective randomised study [Efeito do plasma rico em plaquetas na regeneração do terço central do ligamento da patela: estudo prospectivo randomizado] (Thesis). São Paulo: Universidade de São Paulo, Faculdade de Medicina, 2013. AlmeidaAM , DemangeMK , SobradoMF , RodriguesMB , PedrinelliA , HernandezAJ . Patellar tendon healing with platelet‐rich plasma. American Journal of Sports Medicine2012;40(6):1283‐8. ">Almeida 2012</a>; <a href="./references#CD010071-bbs2-0004" title="CervellinM , GirolamoL , BaitC , DentiM , VoltiP . Autologous platelet‐rich plasma gel to reduce donor‐site morbidity after patellar tendon graft harvesting for anterior cruciate ligamente reconstruction: a randomized, controlled clinical study. Knee Surgery, Sports Traumatology, Arthroscopy2012;20(1):114‐20. [DOI: 10.1007/s00167‐011‐1570‐5] ">Cervellin 2012</a>; <a href="./references#CD010071-bbs2-0011" title="OrregoM , LarrainC , RosalesJ , ValenzuelaL , MatasJ , DurrutyJ , et al. Effects of platelet concentrate and a bone plug on the healing of hamstring tendons in a bone tunnel. Arthroscopy2008;24(12):1373‐80. [DOI: 10.1016/j.arthro.2008.07.016] ">Orrego 2008</a>; <a href="./references#CD010071-bbs2-0016" title="VadalàA , IorioR , DeCarliA , FerrettiM , ParavaniD , CapernaL , et al. Platelet‐rich plasma: does it help reduce tunnel widening after ACL reconstruction?. Knee Surgery Sports Traumatology Arthroscopy2013;21(4):824‐9. [DOI: 10.1007/s00167‐012‐1980‐z] ">Vadalà 2013</a>; <a href="./references#CD010071-bbs2-0017" title="Valentí NínJR , GasqueGM , AzcárateAV , BeolaJD , GonzalezMH . Has platelet‐rich plasma any role in anterior cruciate ligament allograft healing?. Arthroscopy2009;25(11):1206‐13. [DOI: 10.1016/j.arthro.2009.06.002] ">Valenti Nín 2009</a>; <a href="./references#CD010071-bbs2-0018" title="VogrinM , RuprehtM , CrnjacA , DinevskiD , KrajncZ , RecnikG . The effect of platelet‐derived growth factors on knee stability after anterior cruciate ligament reconstruction: a prospective randomized clinical study. Wiener Klinische Wochenschrift2010;122(Suppl 2):91‐5. [DOI: 10.1007/s00508‐010‐1340‐2] ">Vogrin 2010</a>), and surgical repair of acute Achilles rupture (<a href="./references#CD010071-bbs2-0014" title="SchepullT , KvistJ , NorrmanH , TrinksM , BerlinG , AspenbergP . Autologous platelet have no effect on the healing of human achilles tendon ruptures: a randomized single‐blind study. American Journal of Sports Medicine2011;39(1):38‐47. [DOI: 10.1177/0363546510383515] ">Schepull 2010</a>). </p> </section> </section> <section id="CD010071-sec-0071"> <h5 class="title">Outcomes</h5> <p>The primary outcomes listed in our protocol were mostly reported in the studies. All the studies assessed function or pain, or both, using at least one validated instrument. Complications and adverse effects related to PRT were assessed in nine trials (<a href="./references#CD010071-bbs2-0001" title="AlmeidaAM . Platelet‐rich plasma in the regeneration of the patellar ligament after harvesting its central third: a prospective randomised study [Efeito do plasma rico em plaquetas na regeneração do terço central do ligamento da patela: estudo prospectivo randomizado] (Thesis). São Paulo: Universidade de São Paulo, Faculdade de Medicina, 2013. AlmeidaAM , DemangeMK , SobradoMF , RodriguesMB , PedrinelliA , HernandezAJ . Patellar tendon healing with platelet‐rich plasma. American Journal of Sports Medicine2012;40(6):1283‐8. ">Almeida 2012</a>; <a href="./references#CD010071-bbs2-0002" title="AntunaS , BarcoR , MartinezJM , SanchezJM . Effect of platelet‐rich fibrin on rotator cuff repair (PRP‐Fibrin). http://clinicaltrials.gov/show/NCT01612845 (accessed 04 December 2013). AntunaSA , Barco LaaksoR , Martinez DiezJM , Sanchez MarquezJMM . PRP‐fibrin for arthroscopically repaired massive rotator cuff tears: a prospective randomized clinical trial. In: American Academy of Orthopaedic Surgeons Annual Meeting; 2012 Mar 7‐11; San Francisco (Ca)2012. AntuñaS , BarcoJ , Martínez DíesJM , Sánchez MárquezJM . Platelet‐rich fibrin in arthroscopic repair of massive rotator cuff tears: A prospective randomized pilot clinical trial. Acta Orthopaedica Belgica2013;79:25‐30. MoraesV . Personal communication. Email to: S Antuna 18 April 2013. ">Antuna 2013</a>; <a href="./references#CD010071-bbs2-0003" title="CastriciniR , LongoUG , BenedettoM , PanfoliN , PiraniN , ZiniR , et al. Platelet‐rich plasma augmentation for arthroscopic rotator cuff repair: a randomized controlled trial. American Journal of Sports Medicine2011;39(2):258‐65. [DOI: 10.1177/0363546510390780] ">Castricini 2011</a>; <a href="./references#CD010071-bbs2-0004" title="CervellinM , GirolamoL , BaitC , DentiM , VoltiP . Autologous platelet‐rich plasma gel to reduce donor‐site morbidity after patellar tendon graft harvesting for anterior cruciate ligamente reconstruction: a randomized, controlled clinical study. Knee Surgery, Sports Traumatology, Arthroscopy2012;20(1):114‐20. [DOI: 10.1007/s00167‐011‐1570‐5] ">Cervellin 2012</a>; <a href="./references#CD010071-bbs2-0006" title="DeJongeS , DeVosRJ , WeirA , VanSchieHT , Bierma‐ZeinstraSM , VerhaarJA , et al. One‐year follow‐up of platelet‐rich plasma treatment in chronic Achilles tendinopathy. American Journal of Sports Medicine2011;39(8):1623‐9. deVosRJ , WeirA , TolJL , VerhaarJA , WeinansH , vanSchieHT . No effects of PRP on ultrasonographic tendon structure and neovascularization in chronic midportion Achilles tendinopathy. British Journal of Sports Medicine2011;45(5):387‐92. [DOI: 10.1136/bjsm.2010.076398] deVosRJ , WeirA , vanSchieHT , Bierma‐ZeinstraSM , VerhaarJA , WeinansH , et al. Platelet‐rich plasma injection for chronic Achilles tendinopathy. JAMA2010;303(2):144‐9. ">De Vos 2010</a>; <a href="./references#CD010071-bbs2-0007" title="EvertsPA , DevileeRJ , MahoneyCB , vanErpA , OosterbosCJ , StellenboomM , et al. Exogenous application of platelet‐leukocyte gel during open subacromial decompression contributes to improved patient outcome. European Surgical Research2008;40(2):203‐10. [DOI: 10.1159/000110862] ">Everts 2008</a>; <a href="./references#CD010071-bbs2-0009" title="KroghTP , FredbergU , Stengaard‐PedersenK , ChristensenR , JensenP , EllingsenT . Treatment of lateral epicondylitis with platelet‐rich plasma, glucocorticoid, or saline: a randomized, double‐blind, placebo‐controlled trial. American Journal of Sports Medicine2013;41(3):625‐35. [DOI: 10.1177/0363546512472975] ">Krogh 2013</a>; <a href="./references#CD010071-bbs2-0014" title="SchepullT , KvistJ , NorrmanH , TrinksM , BerlinG , AspenbergP . Autologous platelet have no effect on the healing of human achilles tendon ruptures: a randomized single‐blind study. American Journal of Sports Medicine2011;39(1):38‐47. [DOI: 10.1177/0363546510383515] ">Schepull 2010</a>; <a href="./references#CD010071-bbs2-0016" title="VadalàA , IorioR , DeCarliA , FerrettiM , ParavaniD , CapernaL , et al. Platelet‐rich plasma: does it help reduce tunnel widening after ACL reconstruction?. Knee Surgery Sports Traumatology Arthroscopy2013;21(4):824‐9. [DOI: 10.1007/s00167‐012‐1980‐z] ">Vadalà 2013</a>). </p> <p>Outcomes that are not reported by this review but that were part of the outcome assessment in the included trials are briefly summarised here for completeness. In particular, several trials prospectively collected imaging data and objective physical measures of function. </p> <p><a href="./references#CD010071-bbs2-0001" title="AlmeidaAM . Platelet‐rich plasma in the regeneration of the patellar ligament after harvesting its central third: a prospective randomised study [Efeito do plasma rico em plaquetas na regeneração do terço central do ligamento da patela: estudo prospectivo randomizado] (Thesis). São Paulo: Universidade de São Paulo, Faculdade de Medicina, 2013. AlmeidaAM , DemangeMK , SobradoMF , RodriguesMB , PedrinelliA , HernandezAJ . Patellar tendon healing with platelet‐rich plasma. American Journal of Sports Medicine2012;40(6):1283‐8. ">Almeida 2012</a> and <a href="./references#CD010071-bbs2-0004" title="CervellinM , GirolamoL , BaitC , DentiM , VoltiP . Autologous platelet‐rich plasma gel to reduce donor‐site morbidity after patellar tendon graft harvesting for anterior cruciate ligamente reconstruction: a randomized, controlled clinical study. Knee Surgery, Sports Traumatology, Arthroscopy2012;20(1):114‐20. [DOI: 10.1007/s00167‐011‐1570‐5] ">Cervellin 2012</a> assessed patellar tendon harvest site healing by MRI (measurement of gap area from the harvest site, gap filling, assessment of new bone formation) and <a href="./references#CD010071-bbs2-0001" title="AlmeidaAM . Platelet‐rich plasma in the regeneration of the patellar ligament after harvesting its central third: a prospective randomised study [Efeito do plasma rico em plaquetas na regeneração do terço central do ligamento da patela: estudo prospectivo randomizado] (Thesis). São Paulo: Universidade de São Paulo, Faculdade de Medicina, 2013. AlmeidaAM , DemangeMK , SobradoMF , RodriguesMB , PedrinelliA , HernandezAJ . Patellar tendon healing with platelet‐rich plasma. American Journal of Sports Medicine2012;40(6):1283‐8. ">Almeida 2012</a> also assessed the patellar height by using the Insall‐Savati index derived from plain radiographs. </p> <p>Three studies assessed the integrity of the rotator cuff repair using MRI (<a href="./references#CD010071-bbs2-0002" title="AntunaS , BarcoR , MartinezJM , SanchezJM . Effect of platelet‐rich fibrin on rotator cuff repair (PRP‐Fibrin). http://clinicaltrials.gov/show/NCT01612845 (accessed 04 December 2013). AntunaSA , Barco LaaksoR , Martinez DiezJM , Sanchez MarquezJMM . PRP‐fibrin for arthroscopically repaired massive rotator cuff tears: a prospective randomized clinical trial. In: American Academy of Orthopaedic Surgeons Annual Meeting; 2012 Mar 7‐11; San Francisco (Ca)2012. AntuñaS , BarcoJ , Martínez DíesJM , Sánchez MárquezJM . Platelet‐rich fibrin in arthroscopic repair of massive rotator cuff tears: A prospective randomized pilot clinical trial. Acta Orthopaedica Belgica2013;79:25‐30. MoraesV . Personal communication. Email to: S Antuna 18 April 2013. ">Antuna 2013</a>; <a href="./references#CD010071-bbs2-0003" title="CastriciniR , LongoUG , BenedettoM , PanfoliN , PiraniN , ZiniR , et al. Platelet‐rich plasma augmentation for arthroscopic rotator cuff repair: a randomized controlled trial. American Journal of Sports Medicine2011;39(2):258‐65. [DOI: 10.1177/0363546510390780] ">Castricini 2011</a>; <a href="./references#CD010071-bbs2-0010" title="MalavoltaE , Ferreira NetoAA . Platelet rich plasma on arthroscopic repair of the complete rotator cuff lesions: a prospective and randomized study. http://clinicaltrials.gov/ct2/show/NCT01029574 (accessed 26 August 2013). MoraesV . Personal communication. Email to: E Malavolta. ">NCT01029574</a>). One study used ultrasound assessment to evaluate tendon healing (<a href="./references#CD010071-bbs2-0013" title="RodeoSA , DelosD , WilliamsRJ , AdlerRS , PearleA , WarrenRF . The effect of platelet‐rich fibrin matrix on rotator cuff tendon healing: a prospective, randomized clinical study. American Journal of Sports Medicine2012;40(6):1234‐41. [DOI: 10.1177/0363546512442924] ">Rodeo 2012</a>). <a href="./references#CD010071-bbs2-0009" title="KroghTP , FredbergU , Stengaard‐PedersenK , ChristensenR , JensenP , EllingsenT . Treatment of lateral epicondylitis with platelet‐rich plasma, glucocorticoid, or saline: a randomized, double‐blind, placebo‐controlled trial. American Journal of Sports Medicine2013;41(3):625‐35. [DOI: 10.1177/0363546512472975] ">Krogh 2013</a> performed ultrasound assessment of elbow tendons and evaluated doppler changes and tendon thickness. </p> <p><a href="./references#CD010071-bbs2-0011" title="OrregoM , LarrainC , RosalesJ , ValenzuelaL , MatasJ , DurrutyJ , et al. Effects of platelet concentrate and a bone plug on the healing of hamstring tendons in a bone tunnel. Arthroscopy2008;24(12):1373‐80. [DOI: 10.1016/j.arthro.2008.07.016] ">Orrego 2008</a> and <a href="./references#CD010071-bbs2-0017" title="Valentí NínJR , GasqueGM , AzcárateAV , BeolaJD , GonzalezMH . Has platelet‐rich plasma any role in anterior cruciate ligament allograft healing?. Arthroscopy2009;25(11):1206‐13. [DOI: 10.1016/j.arthro.2009.06.002] ">Valenti Nín 2009</a> performed MRI assessments after ACL reconstructions to establish the maturation status of the graft (graft signal intensity, osteo‐ligamentous interface, tunnel widening), and <a href="./references#CD010071-bbs2-0016" title="VadalàA , IorioR , DeCarliA , FerrettiM , ParavaniD , CapernaL , et al. Platelet‐rich plasma: does it help reduce tunnel widening after ACL reconstruction?. Knee Surgery Sports Traumatology Arthroscopy2013;21(4):824‐9. [DOI: 10.1007/s00167‐012‐1980‐z] ">Vadalà 2013</a> evaluated the femoral and tunnel enlargement (assessed by computed tomography (CT)) after reconstruction. </p> <p><a href="./references#CD010071-bbs2-0014" title="SchepullT , KvistJ , NorrmanH , TrinksM , BerlinG , AspenbergP . Autologous platelet have no effect on the healing of human achilles tendon ruptures: a randomized single‐blind study. American Journal of Sports Medicine2011;39(1):38‐47. [DOI: 10.1177/0363546510383515] ">Schepull 2010</a> performed a roentgen stereophotogrammetric analysis (using tantalum beads) as a method to quantify Achilles tendon strain per load and also estimated of elasticity modulus (using callus dimensions from CT). <a href="./references#CD010071-bbs2-0006" title="DeJongeS , DeVosRJ , WeirA , VanSchieHT , Bierma‐ZeinstraSM , VerhaarJA , et al. One‐year follow‐up of platelet‐rich plasma treatment in chronic Achilles tendinopathy. American Journal of Sports Medicine2011;39(8):1623‐9. deVosRJ , WeirA , TolJL , VerhaarJA , WeinansH , vanSchieHT . No effects of PRP on ultrasonographic tendon structure and neovascularization in chronic midportion Achilles tendinopathy. British Journal of Sports Medicine2011;45(5):387‐92. [DOI: 10.1136/bjsm.2010.076398] deVosRJ , WeirA , vanSchieHT , Bierma‐ZeinstraSM , VerhaarJA , WeinansH , et al. Platelet‐rich plasma injection for chronic Achilles tendinopathy. JAMA2010;303(2):144‐9. ">De Vos 2010</a> performed a sonographic evaluation to assess Achilles tendon structure and neovascularisation. </p> <p>Shoulder strength was measured by <a href="./references#CD010071-bbs2-0012" title="RandelliP , ArrigoniP , RagoneV , AliprandiA , CabitzaP . Platelet rich plasma in arthroscopic rotator cuff repair: a prospective RCT study, 2‐year follow‐up. Journal of Shoulder and Elbow Surgery2011;20(4):518‐28. [DOI: 10.1016/j.jse.2011.02.008] ">Randelli 2011</a> and <a href="./references#CD010071-bbs2-0013" title="RodeoSA , DelosD , WilliamsRJ , AdlerRS , PearleA , WarrenRF . The effect of platelet‐rich fibrin matrix on rotator cuff tendon healing: a prospective, randomized clinical study. American Journal of Sports Medicine2012;40(6):1234‐41. [DOI: 10.1177/0363546512442924] ">Rodeo 2012</a>. Range of shoulder motion was assessed by <a href="./references#CD010071-bbs2-0007" title="EvertsPA , DevileeRJ , MahoneyCB , vanErpA , OosterbosCJ , StellenboomM , et al. Exogenous application of platelet‐leukocyte gel during open subacromial decompression contributes to improved patient outcome. European Surgical Research2008;40(2):203‐10. [DOI: 10.1159/000110862] ">Everts 2008</a>. Knee isokinetic testing was performed by <a href="./references#CD010071-bbs2-0001" title="AlmeidaAM . Platelet‐rich plasma in the regeneration of the patellar ligament after harvesting its central third: a prospective randomised study [Efeito do plasma rico em plaquetas na regeneração do terço central do ligamento da patela: estudo prospectivo randomizado] (Thesis). São Paulo: Universidade de São Paulo, Faculdade de Medicina, 2013. AlmeidaAM , DemangeMK , SobradoMF , RodriguesMB , PedrinelliA , HernandezAJ . Patellar tendon healing with platelet‐rich plasma. American Journal of Sports Medicine2012;40(6):1283‐8. ">Almeida 2012</a>. Objective knee anterior laxity following ACL reconstruction was assessed by <a href="./references#CD010071-bbs2-0017" title="Valentí NínJR , GasqueGM , AzcárateAV , BeolaJD , GonzalezMH . Has platelet‐rich plasma any role in anterior cruciate ligament allograft healing?. Arthroscopy2009;25(11):1206‐13. [DOI: 10.1016/j.arthro.2009.06.002] ">Valenti Nín 2009</a> and <a href="./references#CD010071-bbs2-0018" title="VogrinM , RuprehtM , CrnjacA , DinevskiD , KrajncZ , RecnikG . The effect of platelet‐derived growth factors on knee stability after anterior cruciate ligament reconstruction: a prospective randomized clinical study. Wiener Klinische Wochenschrift2010;122(Suppl 2):91‐5. [DOI: 10.1007/s00508‐010‐1340‐2] ">Vogrin 2010</a>. </p> </section> </section> <section id="CD010071-sec-0072"> <h4 class="title">Excluded studies</h4> <p>We excluded four studies due to the lack of randomisation (<a href="./references#CD010071-bbs2-0020" title="FerreroG , FabbroE , OrlandiD , MartiniC , LacelliF , SerafiniG , et al. Ultrasound‐guided injection of platelet‐rich plasma in chronic Achilles and patellar tendinopathy. Journal of Ultrasound2012;15(4):260‐6. [DOI: 10.1016/j.jus.2012.09.006] ">Ferrero 2012</a>; <a href="./references#CD010071-bbs2-0021" title="FigueroaD , MeleanP , CalvoR , VasimanA , ZillerueloN , FigueroaF , et al. Magnetic resonance imaging evaluation of the integration and maturation of semitendinosus‐gracilis graft in anterior cruciate ligament reconstruction using autologous platelet concentrate. Arthroscopy2010;26(10):1318‐25. [DOI: 10.1016/j.arthro.2010.02.010] ">Figueroa 2010</a>; <a href="./references#CD010071-bbs2-0022" title="RadiceF , YánezR , GutiérrezV , RosalesJ , PinedoM , CodaS . Comparison of magnetic resonance findings in anterior cruciate ligament grafts with or without autologous platelet‐derived growth factors. Arthroscopy2010;26(1):50‐7. [DOI: 10.1016/j.arthro.2009.06.030] ">Radice 2009</a>; <a href="./references#CD010071-bbs2-0023" title="SilvaA , SampaioR . Anatomic ACL reconstruction: does the platelet‐rich plasma accelerate tendon healing?. Knee Surgery, Sports Traumatology, Arthroscopy2009;17(6):676‐82. [DOI: 10.1007/s00167‐009‐0762‐8] ">Silva 2009</a>), as described in <a href="./references#CD010071-sec-0141" title="">Characteristics of excluded studies</a>. </p> <section id="CD010071-sec-0073"> <h5 class="title">Ongoing studies</h5> <p>PRP effectiveness for 'new' indications are currently being studied in six ongoing studies: greater trochanteric pain syndrome (<a href="./references#CD010071-bbs2-0024" title="ThompsonG . Northland lateral hip pain platelet‐rich plasma treatment study. https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=12612000982819 (accessed 26 August 2013). ">ACTRN12612000982819</a>); gluteus muscle tendinitis (<a href="./references#CD010071-bbs2-0034" title="JacobsonJ . A prospective comparison of ultrasound‐guided percutaneous platelet‐rich plasma injection versus tenotomy for treatment of gluteus minimus and medius tendinosis. http://clinicaltrials.gov/ct2/show/NCT01600326. ">NCT01600326</a>); muscle strains or ruptures (<a href="./references#CD010071-bbs2-0031" title="Martínez‐ZapataMJ . Multicenter double blind, with evaluator blinding, parallel, randomized clinical trial, to assess the efficacy of platelet rich plasma for treatment of muscle rupture with haematoma. http://clinicaltrials.gov/show/NCT01440725 (accessed 26 August 2013). ">NCT01440725</a>; <a href="./references#CD010071-bbs2-0037" title="TolJ . Use of platelet rich plasma in the management of acute hamstring muscle strain injury. http://clinicaltrials.gov/show/NCT01812564 (accessed 26 August 2013). ">NCT01812564</a>); plantar fascitis (<a href="./references#CD010071-bbs2-0032" title="NedergaardB . Treatment of plantar fasciitis with injection af platelet rich plasma into the origin of the plantar fascia. http://clinicaltrials.gov/ct2/show/NCT01509274 (accessed 26 August 2013). ">NCT01509274</a>); and ankle sprains (<a href="./references#CD010071-bbs2-0033" title="RowdenA . A doubleblind, randomized, placebo controlled study evaluating the use of platelet rich plasma therapy for acute ankle sprains in the emergency department. http://clinicaltrials.gov/show/NCT01518335 (accessed 26 August 2013). ">NCT01518335</a>). </p> <p>Evidence from other ongoing studies should enhance the available evidence for: elbow epicondylitis (<a href="./references#CD010071-bbs2-0025" title="GomesJI . Pilot randomised trial to assess the safety and potential efficacy of platelet rich plasma tenotomy for the treatment of chronic epicondylitis. https://www.clinicaltrialsregister.eu/ctr‐search/search?query=eudract_number:2013‐000478‐32 (accessed 26 August 2013). [EudraCT: 2013‐000478‐32 ] ">EUCTR201300047832ES</a>; <a href="./references#CD010071-bbs2-0035" title="ChiavarasM . Comparison of platelet rich plasma and alternative therapies for the treatment of tennis elbow (lateral epicondylitis) (IMPROVE). http://clinicaltrials.gov/ct2/show/NCT01668953 (accessed 26 August 2013). ">NCT01668953</a>; <a href="./references#CD010071-bbs2-0038" title="VoigtA . Percutaneous needle tenotomy (PNT) versus platelet rich plasma (PRP) with pnt in the treatment of chronic tendinosis. http://clinicaltrials.gov/show/NCT01833598 (accessed 26 August 2013). ">NCT01833598</a>; <a href="./references#CD010071-bbs2-0039" title="LeppänenOV . The effect of platelet rich plasma on lateral epicondylitis. http://clinicaltrials.gov/show/NCT01851044 (accessed 26 August 2013). ">NCT01851044</a>); rotator cuff tears treatment (<a href="./references#CD010071-bbs2-0026" title="RaeissadatSA . Study of the effects of local platelet‐rich plasma (PRP) injection versus autologous blood injection in patients with lateral epicondylitis in PM &amp; R clinic of Modarres hospital from 2011 to 2013. http://www.irct.ir/searchresult.php?id=13442&amp;number=1 (accessed 26 August 2013). ">IRCT2013052313442N1</a>), and surgery (<a href="./references#CD010071-bbs2-0027" title="CarrA . Platelet rich plasma and rotator cuff tendons. http://www.controlled‐trials.com/ISRCTN10464365/ (accessed 26 August 2013). ">ISRCTN10464365</a>; <a href="./references#CD010071-bbs2-0029" title="RazmjouH . Impact of autologous platelet rich plasma on healing of rotator cuff repairs. http://clinicaltrials.gov/ct2/show/record/NCT01000935 (accessed 26 August 2013). ">NCT01000935</a>; <a href="./references#CD010071-bbs2-0030" title="BhandariM . Arthroscopic surgery and platelet rich plasma in rotator cuff tear evaluation (A.S.P.I.R.E.): the use of platelet rich plasma following arthroscopic repair of rotator cuff tears, a pilot study. http://clinicaltrials.gov/show/NCT01170312 (accessed 26 August 2013). ">NCT01170312</a>); Achilles tendinopathies (<a href="./references#CD010071-bbs2-0028" title="CostaM . Achilles tendinopathy management: platelet rich plasma versus eccentric loading programme. http://www.controlled‐trials.com/ISRCTN95369715/ (accessed 26 August 2013). ">ISRCTN95369715</a>), and ACL reconstruction (<a href="./references#CD010071-bbs2-0036" title="WaltersB . Effect of intraoperative application of autologous PRP on post operative morbidity in ACL reconstruction using autologous bone patellar tendon bone graft harvest. http://clinicaltrials.gov/show/NCT01765712 (accessed 26 August 2013). ">NCT01765712</a>). </p> <p>Details of the 16 ongoing studies are described in <a href="./references#CD010071-sec-0142" title="">Characteristics of ongoing studies</a>. </p> </section> </section> </section> <section id="CD010071-sec-0074"> <h3 class="title">Risk of bias in included studies</h3> <p>The review authors' judgements of the risk of bias for each domain listed in <a href="#CD010071-sec-0042">Assessment of risk of bias in included studies</a> are detailed below and summarised for each trial in <a href="#CD010071-fig-0002">Figure 2</a>. </p> <div class="figure" id="CD010071-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study" data-id="CD010071-fig-0002" src="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study </p> </div> </div> </div> <section id="CD010071-sec-0075"> <h4 class="title">Allocation</h4> <p>Selection bias of individual trials was assessed mainly by judging the method of allocation concealment and verifying the similarity of the treatment groups by inspecting baseline characteristics. Most studies reported the use of sequentially‐numbered opaque envelopes. Three studies failed to report the process of allocation to groups (<a href="./references#CD010071-bbs2-0015" title="ThanasasC , PapadimitriouG , CharalambidisC , ParaskevopoulosI , PapanikolaouA . Platelet‐rich plasma versus autologous whole blood for the treatment of chronic lateral elbow epicondylitis: a randomized controlled clinical trial. American Journal of Sports Medicine2011;39(10):2130‐4. [DOI: 10.1177/0363546511417113] ">Thanasas 2011</a>; <a href="./references#CD010071-bbs2-0016" title="VadalàA , IorioR , DeCarliA , FerrettiM , ParavaniD , CapernaL , et al. Platelet‐rich plasma: does it help reduce tunnel widening after ACL reconstruction?. Knee Surgery Sports Traumatology Arthroscopy2013;21(4):824‐9. [DOI: 10.1007/s00167‐012‐1980‐z] ">Vadalà 2013</a>; <a href="./references#CD010071-bbs2-0017" title="Valentí NínJR , GasqueGM , AzcárateAV , BeolaJD , GonzalezMH . Has platelet‐rich plasma any role in anterior cruciate ligament allograft healing?. Arthroscopy2009;25(11):1206‐13. [DOI: 10.1016/j.arthro.2009.06.002] ">Valenti Nín 2009</a>), and two studies were quasi‐randomised (<a href="./references#CD010071-bbs2-0011" title="OrregoM , LarrainC , RosalesJ , ValenzuelaL , MatasJ , DurrutyJ , et al. Effects of platelet concentrate and a bone plug on the healing of hamstring tendons in a bone tunnel. Arthroscopy2008;24(12):1373‐80. [DOI: 10.1016/j.arthro.2008.07.016] ">Orrego 2008</a>; <a href="./references#CD010071-bbs2-0018" title="VogrinM , RuprehtM , CrnjacA , DinevskiD , KrajncZ , RecnikG . The effect of platelet‐derived growth factors on knee stability after anterior cruciate ligament reconstruction: a prospective randomized clinical study. Wiener Klinische Wochenschrift2010;122(Suppl 2):91‐5. [DOI: 10.1007/s00508‐010‐1340‐2] ">Vogrin 2010</a>). <a href="./references#CD010071-bbs2-0011" title="OrregoM , LarrainC , RosalesJ , ValenzuelaL , MatasJ , DurrutyJ , et al. Effects of platelet concentrate and a bone plug on the healing of hamstring tendons in a bone tunnel. Arthroscopy2008;24(12):1373‐80. [DOI: 10.1016/j.arthro.2008.07.016] ">Orrego 2008</a> allocated participants following a "constant rotation" and <a href="./references#CD010071-bbs2-0018" title="VogrinM , RuprehtM , CrnjacA , DinevskiD , KrajncZ , RecnikG . The effect of platelet‐derived growth factors on knee stability after anterior cruciate ligament reconstruction: a prospective randomized clinical study. Wiener Klinische Wochenschrift2010;122(Suppl 2):91‐5. [DOI: 10.1007/s00508‐010‐1340‐2] ">Vogrin 2010</a> allocated participants by odd or even numbers. One study reported that the envelope was opened three days prior to surgery (<a href="./references#CD010071-bbs2-0008" title="GuminaS , CampagnaV , FerrazzaG , GiannicolaG , FratalocchiF , MilaniA , et al. Use of platelet‐leukocyte membrane in arthroscopic repair of large rotator cuff tears. Journal of Bone and Joint Surgery ‐ American Volume2012;94(15):1345‐52. [DOI: 10.2106/JBJS.K.00394] ">Gumina 2012</a>). Three studies demonstrated homogeneity of baseline characteristics between groups (<a href="./references#CD010071-bbs2-0015" title="ThanasasC , PapadimitriouG , CharalambidisC , ParaskevopoulosI , PapanikolaouA . Platelet‐rich plasma versus autologous whole blood for the treatment of chronic lateral elbow epicondylitis: a randomized controlled clinical trial. American Journal of Sports Medicine2011;39(10):2130‐4. [DOI: 10.1177/0363546511417113] ">Thanasas 2011</a>; <a href="./references#CD010071-bbs2-0017" title="Valentí NínJR , GasqueGM , AzcárateAV , BeolaJD , GonzalezMH . Has platelet‐rich plasma any role in anterior cruciate ligament allograft healing?. Arthroscopy2009;25(11):1206‐13. [DOI: 10.1016/j.arthro.2009.06.002] ">Valenti Nín 2009</a>; <a href="./references#CD010071-bbs2-0018" title="VogrinM , RuprehtM , CrnjacA , DinevskiD , KrajncZ , RecnikG . The effect of platelet‐derived growth factors on knee stability after anterior cruciate ligament reconstruction: a prospective randomized clinical study. Wiener Klinische Wochenschrift2010;122(Suppl 2):91‐5. [DOI: 10.1007/s00508‐010‐1340‐2] ">Vogrin 2010</a>), two studies did not perform a priori analysis (<a href="./references#CD010071-bbs2-0011" title="OrregoM , LarrainC , RosalesJ , ValenzuelaL , MatasJ , DurrutyJ , et al. Effects of platelet concentrate and a bone plug on the healing of hamstring tendons in a bone tunnel. Arthroscopy2008;24(12):1373‐80. [DOI: 10.1016/j.arthro.2008.07.016] ">Orrego 2008</a>; <a href="./references#CD010071-bbs2-0016" title="VadalàA , IorioR , DeCarliA , FerrettiM , ParavaniD , CapernaL , et al. Platelet‐rich plasma: does it help reduce tunnel widening after ACL reconstruction?. Knee Surgery Sports Traumatology Arthroscopy2013;21(4):824‐9. [DOI: 10.1007/s00167‐012‐1980‐z] ">Vadalà 2013</a>), and one study reported that groups were not the same with regard to age and baseline Constant scores (<a href="./references#CD010071-bbs2-0008" title="GuminaS , CampagnaV , FerrazzaG , GiannicolaG , FratalocchiF , MilaniA , et al. Use of platelet‐leukocyte membrane in arthroscopic repair of large rotator cuff tears. Journal of Bone and Joint Surgery ‐ American Volume2012;94(15):1345‐52. [DOI: 10.2106/JBJS.K.00394] ">Gumina 2012</a>). We judged that three trials were at high risk of selection bias (<a href="./references#CD010071-bbs2-0008" title="GuminaS , CampagnaV , FerrazzaG , GiannicolaG , FratalocchiF , MilaniA , et al. Use of platelet‐leukocyte membrane in arthroscopic repair of large rotator cuff tears. Journal of Bone and Joint Surgery ‐ American Volume2012;94(15):1345‐52. [DOI: 10.2106/JBJS.K.00394] ">Gumina 2012</a>; <a href="./references#CD010071-bbs2-0011" title="OrregoM , LarrainC , RosalesJ , ValenzuelaL , MatasJ , DurrutyJ , et al. Effects of platelet concentrate and a bone plug on the healing of hamstring tendons in a bone tunnel. Arthroscopy2008;24(12):1373‐80. [DOI: 10.1016/j.arthro.2008.07.016] ">Orrego 2008</a>; <a href="./references#CD010071-bbs2-0018" title="VogrinM , RuprehtM , CrnjacA , DinevskiD , KrajncZ , RecnikG . The effect of platelet‐derived growth factors on knee stability after anterior cruciate ligament reconstruction: a prospective randomized clinical study. Wiener Klinische Wochenschrift2010;122(Suppl 2):91‐5. [DOI: 10.1007/s00508‐010‐1340‐2] ">Vogrin 2010</a>). </p> </section> <section id="CD010071-sec-0076"> <h4 class="title">Blinding</h4> <p>Eleven trials reported that participants and follow‐up assessors were blinded or partially blinded to the procedure (<a href="./references#CD010071-bbs2-0002" title="AntunaS , BarcoR , MartinezJM , SanchezJM . Effect of platelet‐rich fibrin on rotator cuff repair (PRP‐Fibrin). http://clinicaltrials.gov/show/NCT01612845 (accessed 04 December 2013). AntunaSA , Barco LaaksoR , Martinez DiezJM , Sanchez MarquezJMM . PRP‐fibrin for arthroscopically repaired massive rotator cuff tears: a prospective randomized clinical trial. In: American Academy of Orthopaedic Surgeons Annual Meeting; 2012 Mar 7‐11; San Francisco (Ca)2012. AntuñaS , BarcoJ , Martínez DíesJM , Sánchez MárquezJM . Platelet‐rich fibrin in arthroscopic repair of massive rotator cuff tears: A prospective randomized pilot clinical trial. Acta Orthopaedica Belgica2013;79:25‐30. MoraesV . Personal communication. Email to: S Antuna 18 April 2013. ">Antuna 2013</a>; <a href="./references#CD010071-bbs2-0005" title="CreaneyL , WallaceA , CurtisM , ConnellD . Growth factor‐based therapies provide additional benefit beyond physical therapy in resistant elbow tendinopathy: a prospective, single‐blind, randomised trial of autologous blood injections versus platelet‐rich plasma injections. British Journal of Sports Medicine2011;45(12):966‐71. [DOI: 10.1136/bjsm.2010.082503] ">Creaney 2011</a>; <a href="./references#CD010071-bbs2-0006" title="DeJongeS , DeVosRJ , WeirA , VanSchieHT , Bierma‐ZeinstraSM , VerhaarJA , et al. One‐year follow‐up of platelet‐rich plasma treatment in chronic Achilles tendinopathy. American Journal of Sports Medicine2011;39(8):1623‐9. deVosRJ , WeirA , TolJL , VerhaarJA , WeinansH , vanSchieHT . No effects of PRP on ultrasonographic tendon structure and neovascularization in chronic midportion Achilles tendinopathy. British Journal of Sports Medicine2011;45(5):387‐92. [DOI: 10.1136/bjsm.2010.076398] deVosRJ , WeirA , vanSchieHT , Bierma‐ZeinstraSM , VerhaarJA , WeinansH , et al. Platelet‐rich plasma injection for chronic Achilles tendinopathy. JAMA2010;303(2):144‐9. ">De Vos 2010</a>; <a href="./references#CD010071-bbs2-0007" title="EvertsPA , DevileeRJ , MahoneyCB , vanErpA , OosterbosCJ , StellenboomM , et al. Exogenous application of platelet‐leukocyte gel during open subacromial decompression contributes to improved patient outcome. European Surgical Research2008;40(2):203‐10. [DOI: 10.1159/000110862] ">Everts 2008</a>; <a href="./references#CD010071-bbs2-0009" title="KroghTP , FredbergU , Stengaard‐PedersenK , ChristensenR , JensenP , EllingsenT . Treatment of lateral epicondylitis with platelet‐rich plasma, glucocorticoid, or saline: a randomized, double‐blind, placebo‐controlled trial. American Journal of Sports Medicine2013;41(3):625‐35. [DOI: 10.1177/0363546512472975] ">Krogh 2013</a>; <a href="./references#CD010071-bbs2-0010" title="MalavoltaE , Ferreira NetoAA . Platelet rich plasma on arthroscopic repair of the complete rotator cuff lesions: a prospective and randomized study. http://clinicaltrials.gov/ct2/show/NCT01029574 (accessed 26 August 2013). MoraesV . Personal communication. Email to: E Malavolta. ">NCT01029574</a>; <a href="./references#CD010071-bbs2-0012" title="RandelliP , ArrigoniP , RagoneV , AliprandiA , CabitzaP . Platelet rich plasma in arthroscopic rotator cuff repair: a prospective RCT study, 2‐year follow‐up. Journal of Shoulder and Elbow Surgery2011;20(4):518‐28. [DOI: 10.1016/j.jse.2011.02.008] ">Randelli 2011</a>; <a href="./references#CD010071-bbs2-0013" title="RodeoSA , DelosD , WilliamsRJ , AdlerRS , PearleA , WarrenRF . The effect of platelet‐rich fibrin matrix on rotator cuff tendon healing: a prospective, randomized clinical study. American Journal of Sports Medicine2012;40(6):1234‐41. [DOI: 10.1177/0363546512442924] ">Rodeo 2012</a>; <a href="./references#CD010071-bbs2-0014" title="SchepullT , KvistJ , NorrmanH , TrinksM , BerlinG , AspenbergP . Autologous platelet have no effect on the healing of human achilles tendon ruptures: a randomized single‐blind study. American Journal of Sports Medicine2011;39(1):38‐47. [DOI: 10.1177/0363546510383515] ">Schepull 2010</a>; <a href="./references#CD010071-bbs2-0016" title="VadalàA , IorioR , DeCarliA , FerrettiM , ParavaniD , CapernaL , et al. Platelet‐rich plasma: does it help reduce tunnel widening after ACL reconstruction?. Knee Surgery Sports Traumatology Arthroscopy2013;21(4):824‐9. [DOI: 10.1007/s00167‐012‐1980‐z] ">Vadalà 2013</a>; <a href="./references#CD010071-bbs2-0019" title="WasterlainA , DragooJ . Platelet‐rich plasma as a treatment for patellar tendinopathy: a double‐blind randomized controlled trial. Individual patient data (as supplied June 2013). Data on file. ">Wasterlain 2013</a>). Two studies reported that only the MRI assessor was blinded (<a href="./references#CD010071-bbs2-0011" title="OrregoM , LarrainC , RosalesJ , ValenzuelaL , MatasJ , DurrutyJ , et al. Effects of platelet concentrate and a bone plug on the healing of hamstring tendons in a bone tunnel. Arthroscopy2008;24(12):1373‐80. [DOI: 10.1016/j.arthro.2008.07.016] ">Orrego 2008</a>; <a href="./references#CD010071-bbs2-0017" title="Valentí NínJR , GasqueGM , AzcárateAV , BeolaJD , GonzalezMH . Has platelet‐rich plasma any role in anterior cruciate ligament allograft healing?. Arthroscopy2009;25(11):1206‐13. [DOI: 10.1016/j.arthro.2009.06.002] ">Valenti Nín 2009</a>). As this review concerns mostly patient‐reported outcomes and not imaging outcomes, both studies were judged as being at high risk of detection bias. </p> <p><a href="./references#CD010071-bbs2-0015" title="ThanasasC , PapadimitriouG , CharalambidisC , ParaskevopoulosI , PapanikolaouA . Platelet‐rich plasma versus autologous whole blood for the treatment of chronic lateral elbow epicondylitis: a randomized controlled clinical trial. American Journal of Sports Medicine2011;39(10):2130‐4. [DOI: 10.1177/0363546511417113] ">Thanasas 2011</a> reported that the participants were not blinded to the procedure, but the follow‐up assessor was. In <a href="./references#CD010071-bbs2-0018" title="VogrinM , RuprehtM , CrnjacA , DinevskiD , KrajncZ , RecnikG . The effect of platelet‐derived growth factors on knee stability after anterior cruciate ligament reconstruction: a prospective randomized clinical study. Wiener Klinische Wochenschrift2010;122(Suppl 2):91‐5. [DOI: 10.1007/s00508‐010‐1340‐2] ">Vogrin 2010</a>, neither participants nor assessors were blinded. In four studies (<a href="./references#CD010071-bbs2-0001" title="AlmeidaAM . Platelet‐rich plasma in the regeneration of the patellar ligament after harvesting its central third: a prospective randomised study [Efeito do plasma rico em plaquetas na regeneração do terço central do ligamento da patela: estudo prospectivo randomizado] (Thesis). São Paulo: Universidade de São Paulo, Faculdade de Medicina, 2013. AlmeidaAM , DemangeMK , SobradoMF , RodriguesMB , PedrinelliA , HernandezAJ . Patellar tendon healing with platelet‐rich plasma. American Journal of Sports Medicine2012;40(6):1283‐8. ">Almeida 2012</a>; <a href="./references#CD010071-bbs2-0003" title="CastriciniR , LongoUG , BenedettoM , PanfoliN , PiraniN , ZiniR , et al. Platelet‐rich plasma augmentation for arthroscopic rotator cuff repair: a randomized controlled trial. American Journal of Sports Medicine2011;39(2):258‐65. [DOI: 10.1177/0363546510390780] ">Castricini 2011</a>; <a href="./references#CD010071-bbs2-0004" title="CervellinM , GirolamoL , BaitC , DentiM , VoltiP . Autologous platelet‐rich plasma gel to reduce donor‐site morbidity after patellar tendon graft harvesting for anterior cruciate ligamente reconstruction: a randomized, controlled clinical study. Knee Surgery, Sports Traumatology, Arthroscopy2012;20(1):114‐20. [DOI: 10.1007/s00167‐011‐1570‐5] ">Cervellin 2012</a>; <a href="./references#CD010071-bbs2-0008" title="GuminaS , CampagnaV , FerrazzaG , GiannicolaG , FratalocchiF , MilaniA , et al. Use of platelet‐leukocyte membrane in arthroscopic repair of large rotator cuff tears. Journal of Bone and Joint Surgery ‐ American Volume2012;94(15):1345‐52. [DOI: 10.2106/JBJS.K.00394] ">Gumina 2012</a>), there was a lack of information regarding which of the assessors were blinded, or blinding, or the blinding procedure was not reported. </p> <p>Our considerations of performance bias do not appear in the risk of bias tables. Most of the studies reported the same co‐interventions (mainly post‐intervention care and rehabilitation) in each treatment group and thus were at low risk. Additionally, interventions were mostly performed by surgeons (one or two in each trial) or radiologists with ultrasound guidance. The three studies that did not state who carried out the intervention were judged as being at unclear risk of performance bias (<a href="./references#CD010071-bbs2-0004" title="CervellinM , GirolamoL , BaitC , DentiM , VoltiP . Autologous platelet‐rich plasma gel to reduce donor‐site morbidity after patellar tendon graft harvesting for anterior cruciate ligamente reconstruction: a randomized, controlled clinical study. Knee Surgery, Sports Traumatology, Arthroscopy2012;20(1):114‐20. [DOI: 10.1007/s00167‐011‐1570‐5] ">Cervellin 2012</a>; <a href="./references#CD010071-bbs2-0014" title="SchepullT , KvistJ , NorrmanH , TrinksM , BerlinG , AspenbergP . Autologous platelet have no effect on the healing of human achilles tendon ruptures: a randomized single‐blind study. American Journal of Sports Medicine2011;39(1):38‐47. [DOI: 10.1177/0363546510383515] ">Schepull 2010</a>; <a href="./references#CD010071-bbs2-0015" title="ThanasasC , PapadimitriouG , CharalambidisC , ParaskevopoulosI , PapanikolaouA . Platelet‐rich plasma versus autologous whole blood for the treatment of chronic lateral elbow epicondylitis: a randomized controlled clinical trial. American Journal of Sports Medicine2011;39(10):2130‐4. [DOI: 10.1177/0363546511417113] ">Thanasas 2011</a>). </p> </section> <section id="CD010071-sec-0077"> <h4 class="title">Incomplete outcome data</h4> <p>Most of the studies reported no loss to follow‐up or small losses that were balanced between groups. Four studies (<a href="./references#CD010071-bbs2-0005" title="CreaneyL , WallaceA , CurtisM , ConnellD . Growth factor‐based therapies provide additional benefit beyond physical therapy in resistant elbow tendinopathy: a prospective, single‐blind, randomised trial of autologous blood injections versus platelet‐rich plasma injections. British Journal of Sports Medicine2011;45(12):966‐71. [DOI: 10.1136/bjsm.2010.082503] ">Creaney 2011</a>; <a href="./references#CD010071-bbs2-0009" title="KroghTP , FredbergU , Stengaard‐PedersenK , ChristensenR , JensenP , EllingsenT . Treatment of lateral epicondylitis with platelet‐rich plasma, glucocorticoid, or saline: a randomized, double‐blind, placebo‐controlled trial. American Journal of Sports Medicine2013;41(3):625‐35. [DOI: 10.1177/0363546512472975] ">Krogh 2013</a>; <a href="./references#CD010071-bbs2-0013" title="RodeoSA , DelosD , WilliamsRJ , AdlerRS , PearleA , WarrenRF . The effect of platelet‐rich fibrin matrix on rotator cuff tendon healing: a prospective, randomized clinical study. American Journal of Sports Medicine2012;40(6):1234‐41. [DOI: 10.1177/0363546512442924] ">Rodeo 2012</a>; <a href="./references#CD010071-bbs2-0014" title="SchepullT , KvistJ , NorrmanH , TrinksM , BerlinG , AspenbergP . Autologous platelet have no effect on the healing of human achilles tendon ruptures: a randomized single‐blind study. American Journal of Sports Medicine2011;39(1):38‐47. [DOI: 10.1177/0363546510383515] ">Schepull 2010</a>) were judged as being at high risk of attrition bias due either to data missing in an unbalanced manner between groups (<a href="./references#CD010071-bbs2-0005" title="CreaneyL , WallaceA , CurtisM , ConnellD . Growth factor‐based therapies provide additional benefit beyond physical therapy in resistant elbow tendinopathy: a prospective, single‐blind, randomised trial of autologous blood injections versus platelet‐rich plasma injections. British Journal of Sports Medicine2011;45(12):966‐71. [DOI: 10.1136/bjsm.2010.082503] ">Creaney 2011</a>; <a href="./references#CD010071-bbs2-0013" title="RodeoSA , DelosD , WilliamsRJ , AdlerRS , PearleA , WarrenRF . The effect of platelet‐rich fibrin matrix on rotator cuff tendon healing: a prospective, randomized clinical study. American Journal of Sports Medicine2012;40(6):1234‐41. [DOI: 10.1177/0363546512442924] ">Rodeo 2012</a>; <a href="./references#CD010071-bbs2-0014" title="SchepullT , KvistJ , NorrmanH , TrinksM , BerlinG , AspenbergP . Autologous platelet have no effect on the healing of human achilles tendon ruptures: a randomized single‐blind study. American Journal of Sports Medicine2011;39(1):38‐47. [DOI: 10.1177/0363546510383515] ">Schepull 2010</a>), or to the study suffering great losses to follow‐up in the long term (<a href="./references#CD010071-bbs2-0009" title="KroghTP , FredbergU , Stengaard‐PedersenK , ChristensenR , JensenP , EllingsenT . Treatment of lateral epicondylitis with platelet‐rich plasma, glucocorticoid, or saline: a randomized, double‐blind, placebo‐controlled trial. American Journal of Sports Medicine2013;41(3):625‐35. [DOI: 10.1177/0363546512472975] ">Krogh 2013</a>). One study failed to report the characteristics of the losses to follow‐up (<a href="./references#CD010071-bbs2-0011" title="OrregoM , LarrainC , RosalesJ , ValenzuelaL , MatasJ , DurrutyJ , et al. Effects of platelet concentrate and a bone plug on the healing of hamstring tendons in a bone tunnel. Arthroscopy2008;24(12):1373‐80. [DOI: 10.1016/j.arthro.2008.07.016] ">Orrego 2008</a>). As most of the studies did not suffer important losses (and thus were at low risk of bias), this is a minor concern in this review. We presented only the short‐term findings (no follow‐up losses) for <a href="./references#CD010071-bbs2-0009" title="KroghTP , FredbergU , Stengaard‐PedersenK , ChristensenR , JensenP , EllingsenT . Treatment of lateral epicondylitis with platelet‐rich plasma, glucocorticoid, or saline: a randomized, double‐blind, placebo‐controlled trial. American Journal of Sports Medicine2013;41(3):625‐35. [DOI: 10.1177/0363546512472975] ">Krogh 2013</a> in our analyses. </p> </section> <section id="CD010071-sec-0078"> <h4 class="title">Selective reporting</h4> <p>Ten of the included studies did not provide any a priori protocol or trial registration details for the study (<a href="http://archie.cochrane.org/sections/documents/view?version=z1312041036293802408843420607707%26format=REVMAN#STD-Cervellin-2012" target="_blank">Cervellin 2012</a>; <a href="http://archie.cochrane.org/sections/documents/view?version=z1312041036293802408843420607707%26format=REVMAN#STD-Creaney-2011" target="_blank">Creaney 2011</a>; <a href="http://archie.cochrane.org/sections/documents/view?version=z1312041036293802408843420607707%26format=REVMAN#STD-Everts-2008" target="_blank">Everts 2008</a>; <a href="http://archie.cochrane.org/sections/documents/view?version=z1312041036293802408843420607707%26format=REVMAN#STD-Orrego-2008" target="_blank">Orrego 2008</a>; <a href="http://archie.cochrane.org/sections/documents/view?version=z1312041036293802408843420607707%26format=REVMAN#STD-Randelli-2011" target="_blank">Randelli 2011</a>; <a href="http://archie.cochrane.org/sections/documents/view?version=z1312041036293802408843420607707%26format=REVMAN#STD-Schepull-2010" target="_blank">Schepull 2010</a>; <a href="http://archie.cochrane.org/sections/documents/view?version=z1312041036293802408843420607707%26format=REVMAN#STD-Thanasas-2011" target="_blank">Thanasas 2011</a>; <a href="http://archie.cochrane.org/sections/documents/view?version=z1312041036293802408843420607707%26format=REVMAN#STD-Vadal_x00e0_-2013" target="_blank">Vadalà 2013</a>; <a href="http://archie.cochrane.org/sections/documents/view?version=z1312041036293802408843420607707%26format=REVMAN#STD-Valenti-N_x00ed_n-2009" target="_blank">Valenti Nín 2009</a>; <a href="http://archie.cochrane.org/sections/documents/view?version=z1312041036293802408843420607707%26format=REVMAN#STD-Vogrin-2010" target="_blank">Vogrin 2010</a>); these were judged to be at unclear or high risk of selective reporting bias. Although studies reported the outcomes described in their methodology sections, some did not provide key endpoints during the follow‐up, such as pain (<a href="http://archie.cochrane.org/sections/documents/view?version=z1312041036293802408843420607707%26format=REVMAN#STD-Almeida-2012" target="_blank">Almeida 2012</a>), and functional scales (<a href="http://archie.cochrane.org/sections/documents/view?version=z1312041036293802408843420607707%26format=REVMAN#STD-Vadal_x00e0_-2013" target="_blank">Vadalà 2013</a>). As protocols and outcome assessments were not ideally reported or conducted, some important outcomes, such as adverse effects, may have been under‐recognised or under‐reported (high risk of bias). </p> </section> <section id="CD010071-sec-0079"> <h4 class="title">Other potential sources of bias</h4> <p>As co‐interventions were mainly the same in the study groups and, for most studies, participants were unable to change interventions, there were no cross‐overs or differences between groups in the other care provided. As an exception, participants recruited for <a href="./references#CD010071-bbs2-0005" title="CreaneyL , WallaceA , CurtisM , ConnellD . Growth factor‐based therapies provide additional benefit beyond physical therapy in resistant elbow tendinopathy: a prospective, single‐blind, randomised trial of autologous blood injections versus platelet‐rich plasma injections. British Journal of Sports Medicine2011;45(12):966‐71. [DOI: 10.1136/bjsm.2010.082503] ">Creaney 2011</a> and <a href="./references#CD010071-bbs2-0019" title="WasterlainA , DragooJ . Platelet‐rich plasma as a treatment for patellar tendinopathy: a double‐blind randomized controlled trial. Individual patient data (as supplied June 2013). Data on file. ">Wasterlain 2013</a> changed treatments after failure had occurred. However, these studies remained at low risk of other bias as the authors conducted intention‐to‐treat analyses. </p> <section id="CD010071-sec-0080"> <h5 class="title">Additional quality assessment</h5> <p>We systematically assessed two other items (sample size calculations and validation of the platelet‐rich concentrate) that related more to trial quality than bias. The findings for individual trials are reported in the <a href="./references#CD010071-sec-0140" title="">Characteristics of included studies</a>. These assessments contributed to our consideration of the evidence in terms of imprecision and applicability. </p> <p>Sample size calculations were reported in 11 trials (<a href="./references#CD010071-bbs2-0003" title="CastriciniR , LongoUG , BenedettoM , PanfoliN , PiraniN , ZiniR , et al. Platelet‐rich plasma augmentation for arthroscopic rotator cuff repair: a randomized controlled trial. American Journal of Sports Medicine2011;39(2):258‐65. [DOI: 10.1177/0363546510390780] ">Castricini 2011</a>; <a href="./references#CD010071-bbs2-0004" title="CervellinM , GirolamoL , BaitC , DentiM , VoltiP . Autologous platelet‐rich plasma gel to reduce donor‐site morbidity after patellar tendon graft harvesting for anterior cruciate ligamente reconstruction: a randomized, controlled clinical study. Knee Surgery, Sports Traumatology, Arthroscopy2012;20(1):114‐20. [DOI: 10.1007/s00167‐011‐1570‐5] ">Cervellin 2012</a>; <a href="./references#CD010071-bbs2-0005" title="CreaneyL , WallaceA , CurtisM , ConnellD . Growth factor‐based therapies provide additional benefit beyond physical therapy in resistant elbow tendinopathy: a prospective, single‐blind, randomised trial of autologous blood injections versus platelet‐rich plasma injections. British Journal of Sports Medicine2011;45(12):966‐71. [DOI: 10.1136/bjsm.2010.082503] ">Creaney 2011</a>; <a href="./references#CD010071-bbs2-0006" title="DeJongeS , DeVosRJ , WeirA , VanSchieHT , Bierma‐ZeinstraSM , VerhaarJA , et al. One‐year follow‐up of platelet‐rich plasma treatment in chronic Achilles tendinopathy. American Journal of Sports Medicine2011;39(8):1623‐9. deVosRJ , WeirA , TolJL , VerhaarJA , WeinansH , vanSchieHT . No effects of PRP on ultrasonographic tendon structure and neovascularization in chronic midportion Achilles tendinopathy. British Journal of Sports Medicine2011;45(5):387‐92. [DOI: 10.1136/bjsm.2010.076398] deVosRJ , WeirA , vanSchieHT , Bierma‐ZeinstraSM , VerhaarJA , WeinansH , et al. Platelet‐rich plasma injection for chronic Achilles tendinopathy. JAMA2010;303(2):144‐9. ">De Vos 2010</a>; <a href="./references#CD010071-bbs2-0009" title="KroghTP , FredbergU , Stengaard‐PedersenK , ChristensenR , JensenP , EllingsenT . Treatment of lateral epicondylitis with platelet‐rich plasma, glucocorticoid, or saline: a randomized, double‐blind, placebo‐controlled trial. American Journal of Sports Medicine2013;41(3):625‐35. [DOI: 10.1177/0363546512472975] ">Krogh 2013</a>; <a href="./references#CD010071-bbs2-0010" title="MalavoltaE , Ferreira NetoAA . Platelet rich plasma on arthroscopic repair of the complete rotator cuff lesions: a prospective and randomized study. http://clinicaltrials.gov/ct2/show/NCT01029574 (accessed 26 August 2013). MoraesV . Personal communication. Email to: E Malavolta. ">NCT01029574</a>; <a href="./references#CD010071-bbs2-0012" title="RandelliP , ArrigoniP , RagoneV , AliprandiA , CabitzaP . Platelet rich plasma in arthroscopic rotator cuff repair: a prospective RCT study, 2‐year follow‐up. Journal of Shoulder and Elbow Surgery2011;20(4):518‐28. [DOI: 10.1016/j.jse.2011.02.008] ">Randelli 2011</a>; <a href="./references#CD010071-bbs2-0013" title="RodeoSA , DelosD , WilliamsRJ , AdlerRS , PearleA , WarrenRF . The effect of platelet‐rich fibrin matrix on rotator cuff tendon healing: a prospective, randomized clinical study. American Journal of Sports Medicine2012;40(6):1234‐41. [DOI: 10.1177/0363546512442924] ">Rodeo 2012</a>; <a href="./references#CD010071-bbs2-0015" title="ThanasasC , PapadimitriouG , CharalambidisC , ParaskevopoulosI , PapanikolaouA . Platelet‐rich plasma versus autologous whole blood for the treatment of chronic lateral elbow epicondylitis: a randomized controlled clinical trial. American Journal of Sports Medicine2011;39(10):2130‐4. [DOI: 10.1177/0363546511417113] ">Thanasas 2011</a>; <a href="./references#CD010071-bbs2-0016" title="VadalàA , IorioR , DeCarliA , FerrettiM , ParavaniD , CapernaL , et al. Platelet‐rich plasma: does it help reduce tunnel widening after ACL reconstruction?. Knee Surgery Sports Traumatology Arthroscopy2013;21(4):824‐9. [DOI: 10.1007/s00167‐012‐1980‐z] ">Vadalà 2013</a>; <a href="./references#CD010071-bbs2-0019" title="WasterlainA , DragooJ . Platelet‐rich plasma as a treatment for patellar tendinopathy: a double‐blind randomized controlled trial. Individual patient data (as supplied June 2013). Data on file. ">Wasterlain 2013</a>). However, only nine of these applied to the primary outcomes of our review (<a href="./references#CD010071-bbs2-0003" title="CastriciniR , LongoUG , BenedettoM , PanfoliN , PiraniN , ZiniR , et al. Platelet‐rich plasma augmentation for arthroscopic rotator cuff repair: a randomized controlled trial. American Journal of Sports Medicine2011;39(2):258‐65. [DOI: 10.1177/0363546510390780] ">Castricini 2011</a>; <a href="./references#CD010071-bbs2-0004" title="CervellinM , GirolamoL , BaitC , DentiM , VoltiP . Autologous platelet‐rich plasma gel to reduce donor‐site morbidity after patellar tendon graft harvesting for anterior cruciate ligamente reconstruction: a randomized, controlled clinical study. Knee Surgery, Sports Traumatology, Arthroscopy2012;20(1):114‐20. [DOI: 10.1007/s00167‐011‐1570‐5] ">Cervellin 2012</a>; <a href="./references#CD010071-bbs2-0005" title="CreaneyL , WallaceA , CurtisM , ConnellD . Growth factor‐based therapies provide additional benefit beyond physical therapy in resistant elbow tendinopathy: a prospective, single‐blind, randomised trial of autologous blood injections versus platelet‐rich plasma injections. British Journal of Sports Medicine2011;45(12):966‐71. [DOI: 10.1136/bjsm.2010.082503] ">Creaney 2011</a>; <a href="./references#CD010071-bbs2-0006" title="DeJongeS , DeVosRJ , WeirA , VanSchieHT , Bierma‐ZeinstraSM , VerhaarJA , et al. One‐year follow‐up of platelet‐rich plasma treatment in chronic Achilles tendinopathy. American Journal of Sports Medicine2011;39(8):1623‐9. deVosRJ , WeirA , TolJL , VerhaarJA , WeinansH , vanSchieHT . No effects of PRP on ultrasonographic tendon structure and neovascularization in chronic midportion Achilles tendinopathy. British Journal of Sports Medicine2011;45(5):387‐92. [DOI: 10.1136/bjsm.2010.076398] deVosRJ , WeirA , vanSchieHT , Bierma‐ZeinstraSM , VerhaarJA , WeinansH , et al. Platelet‐rich plasma injection for chronic Achilles tendinopathy. JAMA2010;303(2):144‐9. ">De Vos 2010</a>; <a href="./references#CD010071-bbs2-0009" title="KroghTP , FredbergU , Stengaard‐PedersenK , ChristensenR , JensenP , EllingsenT . Treatment of lateral epicondylitis with platelet‐rich plasma, glucocorticoid, or saline: a randomized, double‐blind, placebo‐controlled trial. American Journal of Sports Medicine2013;41(3):625‐35. [DOI: 10.1177/0363546512472975] ">Krogh 2013</a>; <a href="./references#CD010071-bbs2-0010" title="MalavoltaE , Ferreira NetoAA . Platelet rich plasma on arthroscopic repair of the complete rotator cuff lesions: a prospective and randomized study. http://clinicaltrials.gov/ct2/show/NCT01029574 (accessed 26 August 2013). MoraesV . Personal communication. Email to: E Malavolta. ">NCT01029574</a>; <a href="./references#CD010071-bbs2-0012" title="RandelliP , ArrigoniP , RagoneV , AliprandiA , CabitzaP . Platelet rich plasma in arthroscopic rotator cuff repair: a prospective RCT study, 2‐year follow‐up. Journal of Shoulder and Elbow Surgery2011;20(4):518‐28. [DOI: 10.1016/j.jse.2011.02.008] ">Randelli 2011</a>; <a href="./references#CD010071-bbs2-0015" title="ThanasasC , PapadimitriouG , CharalambidisC , ParaskevopoulosI , PapanikolaouA . Platelet‐rich plasma versus autologous whole blood for the treatment of chronic lateral elbow epicondylitis: a randomized controlled clinical trial. American Journal of Sports Medicine2011;39(10):2130‐4. [DOI: 10.1177/0363546511417113] ">Thanasas 2011</a>; <a href="./references#CD010071-bbs2-0019" title="WasterlainA , DragooJ . Platelet‐rich plasma as a treatment for patellar tendinopathy: a double‐blind randomized controlled trial. Individual patient data (as supplied June 2013). Data on file. ">Wasterlain 2013</a>). This consideration is important because studies that are underpowered are more likely to incur a type II error (where sample sizes were not sufficient to detect differences between the arms of comparison). </p> <p>Information about validation of the platelet‐rich concentrate through platelet quantification after preparation, was not available in eight studies (<a href="./references#CD010071-bbs2-0002" title="AntunaS , BarcoR , MartinezJM , SanchezJM . Effect of platelet‐rich fibrin on rotator cuff repair (PRP‐Fibrin). http://clinicaltrials.gov/show/NCT01612845 (accessed 04 December 2013). AntunaSA , Barco LaaksoR , Martinez DiezJM , Sanchez MarquezJMM . PRP‐fibrin for arthroscopically repaired massive rotator cuff tears: a prospective randomized clinical trial. In: American Academy of Orthopaedic Surgeons Annual Meeting; 2012 Mar 7‐11; San Francisco (Ca)2012. AntuñaS , BarcoJ , Martínez DíesJM , Sánchez MárquezJM . Platelet‐rich fibrin in arthroscopic repair of massive rotator cuff tears: A prospective randomized pilot clinical trial. Acta Orthopaedica Belgica2013;79:25‐30. MoraesV . Personal communication. Email to: S Antuna 18 April 2013. ">Antuna 2013</a>; <a href="./references#CD010071-bbs2-0003" title="CastriciniR , LongoUG , BenedettoM , PanfoliN , PiraniN , ZiniR , et al. Platelet‐rich plasma augmentation for arthroscopic rotator cuff repair: a randomized controlled trial. American Journal of Sports Medicine2011;39(2):258‐65. [DOI: 10.1177/0363546510390780] ">Castricini 2011</a>; <a href="./references#CD010071-bbs2-0004" title="CervellinM , GirolamoL , BaitC , DentiM , VoltiP . Autologous platelet‐rich plasma gel to reduce donor‐site morbidity after patellar tendon graft harvesting for anterior cruciate ligamente reconstruction: a randomized, controlled clinical study. Knee Surgery, Sports Traumatology, Arthroscopy2012;20(1):114‐20. [DOI: 10.1007/s00167‐011‐1570‐5] ">Cervellin 2012</a>; <a href="./references#CD010071-bbs2-0006" title="DeJongeS , DeVosRJ , WeirA , VanSchieHT , Bierma‐ZeinstraSM , VerhaarJA , et al. One‐year follow‐up of platelet‐rich plasma treatment in chronic Achilles tendinopathy. American Journal of Sports Medicine2011;39(8):1623‐9. deVosRJ , WeirA , TolJL , VerhaarJA , WeinansH , vanSchieHT . No effects of PRP on ultrasonographic tendon structure and neovascularization in chronic midportion Achilles tendinopathy. British Journal of Sports Medicine2011;45(5):387‐92. [DOI: 10.1136/bjsm.2010.076398] deVosRJ , WeirA , vanSchieHT , Bierma‐ZeinstraSM , VerhaarJA , WeinansH , et al. Platelet‐rich plasma injection for chronic Achilles tendinopathy. JAMA2010;303(2):144‐9. ">De Vos 2010</a>; <a href="./references#CD010071-bbs2-0011" title="OrregoM , LarrainC , RosalesJ , ValenzuelaL , MatasJ , DurrutyJ , et al. Effects of platelet concentrate and a bone plug on the healing of hamstring tendons in a bone tunnel. Arthroscopy2008;24(12):1373‐80. [DOI: 10.1016/j.arthro.2008.07.016] ">Orrego 2008</a>; <a href="./references#CD010071-bbs2-0012" title="RandelliP , ArrigoniP , RagoneV , AliprandiA , CabitzaP . Platelet rich plasma in arthroscopic rotator cuff repair: a prospective RCT study, 2‐year follow‐up. Journal of Shoulder and Elbow Surgery2011;20(4):518‐28. [DOI: 10.1016/j.jse.2011.02.008] ">Randelli 2011</a>; <a href="./references#CD010071-bbs2-0013" title="RodeoSA , DelosD , WilliamsRJ , AdlerRS , PearleA , WarrenRF . The effect of platelet‐rich fibrin matrix on rotator cuff tendon healing: a prospective, randomized clinical study. American Journal of Sports Medicine2012;40(6):1234‐41. [DOI: 10.1177/0363546512442924] ">Rodeo 2012</a>; <a href="./references#CD010071-bbs2-0016" title="VadalàA , IorioR , DeCarliA , FerrettiM , ParavaniD , CapernaL , et al. Platelet‐rich plasma: does it help reduce tunnel widening after ACL reconstruction?. Knee Surgery Sports Traumatology Arthroscopy2013;21(4):824‐9. [DOI: 10.1007/s00167‐012‐1980‐z] ">Vadalà 2013</a>). In one study (<a href="./references#CD010071-bbs2-0014" title="SchepullT , KvistJ , NorrmanH , TrinksM , BerlinG , AspenbergP . Autologous platelet have no effect on the healing of human achilles tendon ruptures: a randomized single‐blind study. American Journal of Sports Medicine2011;39(1):38‐47. [DOI: 10.1177/0363546510383515] ">Schepull 2010</a>), the authors prepared PRP the night before the intervention; however, the viability of the sample was checked before surgery. </p> </section> </section> </section> <section id="CD010071-sec-0081"> <h3 class="title" id="CD010071-sec-0081">Effects of interventions</h3> <p>In keeping with the intentions stated in our protocol, we first present the overall findings for the 19 trials. Given the sparse nature of the data, this is currently restricted to primary outcomes only. The results in the first set of analyses are subgrouped by the eight different conditions listed in <a href="#CD010071-sec-0055">Included studies</a>. We then present the overall findings subgrouped by whether PRT was the main treatment for a tendinopathy or an augmentation procedure for a condition requiring surgery. Finally, we present a complete summary of the evidence available for each of the eight individual conditions. </p> <p>The data for function and pain are presented for three time periods: short term (up to three months); medium term (over three months, under one year; usually six months); and long term (one year or more). </p> <section id="CD010071-sec-0082"> <h4 class="title">Overall analysis</h4> <section id="CD010071-sec-0083"> <h5 class="title">Function</h5> <p>Data, derived from four different functional scores, pooled from four trials assessing PRT for three clinical conditions, showed no statistically significant difference between PRT and control for short‐term function (SMD 0.26; 95% CI ‐0.19 to 0.71; P value 0.26; I² = 51%; 162 participants, four trials; positive values favour PRT; <i>see</i><a href="./references#CD010071-fig-0003" title="">Analysis 1.1</a>). The significant results of the test for subgroup differences (P value 0.06, I² = 64.6%) reflected the inclusion of the results from <a href="./references#CD010071-bbs2-0006" title="DeJongeS , DeVosRJ , WeirA , VanSchieHT , Bierma‐ZeinstraSM , VerhaarJA , et al. One‐year follow‐up of platelet‐rich plasma treatment in chronic Achilles tendinopathy. American Journal of Sports Medicine2011;39(8):1623‐9. deVosRJ , WeirA , TolJL , VerhaarJA , WeinansH , vanSchieHT . No effects of PRP on ultrasonographic tendon structure and neovascularization in chronic midportion Achilles tendinopathy. British Journal of Sports Medicine2011;45(5):387‐92. [DOI: 10.1136/bjsm.2010.076398] deVosRJ , WeirA , vanSchieHT , Bierma‐ZeinstraSM , VerhaarJA , WeinansH , et al. Platelet‐rich plasma injection for chronic Achilles tendinopathy. JAMA2010;303(2):144‐9. ">De Vos 2010</a> (54 participants), which differed in direction of effect from the other two subgroups. </p> <p>Data, derived from five different functional scores, pooled from five trials assessing PRT for five clinical conditions, showed no difference (P value 0.72) between PRT and control for medium‐term function (SMD ‐0.09, 95% CI ‐0.56 to 0.39; I² = 50%; 151 participants, five trials; <i>see</i><a href="./references#CD010071-fig-0004" title="">Analysis 1.2</a>). The significant result of the test for subgroup differences (P value 0.09, I² = 49.7%) reflects the spread of results for the five conditions evaluated here. </p> <p>Data on long‐term function derived from six different functional scores, pooled from 10 trials assessing PRT for five clinical conditions, showed no statistically significant difference between PRT and control (SMD 0.25, 95% CI ‐0.07 to 0.57; P value 0.12; I² = 66%; 484 participants, 10 trials; <i>see</i><a href="./references#CD010071-fig-0005" title="">Analysis 1.3</a>). The significant results of the test for subgroup differences (P value 0.009, I² = 70.3%), reflect the results from <a href="./references#CD010071-bbs2-0004" title="CervellinM , GirolamoL , BaitC , DentiM , VoltiP . Autologous platelet‐rich plasma gel to reduce donor‐site morbidity after patellar tendon graft harvesting for anterior cruciate ligamente reconstruction: a randomized, controlled clinical study. Knee Surgery, Sports Traumatology, Arthroscopy2012;20(1):114‐20. [DOI: 10.1007/s00167‐011‐1570‐5] ">Cervellin 2012</a>, which were strongly in favour of PRT. Upon removal of <a href="./references#CD010071-bbs2-0004" title="CervellinM , GirolamoL , BaitC , DentiM , VoltiP . Autologous platelet‐rich plasma gel to reduce donor‐site morbidity after patellar tendon graft harvesting for anterior cruciate ligamente reconstruction: a randomized, controlled clinical study. Knee Surgery, Sports Traumatology, Arthroscopy2012;20(1):114‐20. [DOI: 10.1007/s00167‐011‐1570‐5] ">Cervellin 2012</a> (40 participants), the pooled results showed less difference between the two groups (SMD 0.15, 95% CI ‐0.11 to 0.41) and the test for subgroup differences shows no difference (I² = 0%) (data not shown). The heterogeneity in the results for six trials (324 participants) of PRT for surgical repair of rotator cuff tears is also marked (P value 0.02, I² = 63%). As reported below, the pooled results of the five trials in this category reporting Constant scores showed a small but clinically non‐significant difference in favour of PRT. Thus the clinical significance of the upper 95% confidence limit of the pooled findings in <a href="./references#CD010071-fig-0005" title="">Analysis 1.3</a> is doubtful. </p> </section> <section id="CD010071-sec-0084"> <h5 class="title">Pain</h5> <p>Data pooled from four trials covering three conditions, showed a clinically small but statistically significant reduction in short‐term pain in favour of PRT (mean difference (MD) ‐0.95, 95% confidence interval (CI) ‐1.41 to ‐0.48; I² = 0%; 175 participants, four trials; see <a href="./references#CD010071-fig-0006" title="">Analysis 1.4</a>). Significantly heterogeneous data (P value 0.002; I² = 89.7%) for medium‐term pain were available from two trials (47 participants; two conditions), which reported in favour of PRT and control, respectively; we decided against pooling these data (<i>see</i><a href="./references#CD010071-fig-0007" title="">Analysis 1.5</a>). Similarly, we decided not to pool data for long‐term pain based on a similar finding of significant heterogeneity of the results of two trials on one condition (P value 0.08; I² = 67%; 81 participants) (<i>see</i><a href="./references#CD010071-fig-0008" title="">Analysis 1.6</a>). </p> </section> <section id="CD010071-sec-0085"> <h5 class="title">Adverse effects</h5> <p>Four trials reported adverse effects and a further seven trials reported that there were no adverse effects. Pooled data showed no evidence of a significant difference between the two groups (7/241 versus 5/245; risk ratio (RR) 1.31, 95% CI 0.48 to 3.59; I² = 0%; 486 participants, 11 trials; see <a href="./references#CD010071-fig-0009" title="">Analysis 1.7</a>). The adverse effects were concerns about persisting pain prompting clinical contact in <a href="./references#CD010071-bbs2-0009" title="KroghTP , FredbergU , Stengaard‐PedersenK , ChristensenR , JensenP , EllingsenT . Treatment of lateral epicondylitis with platelet‐rich plasma, glucocorticoid, or saline: a randomized, double‐blind, placebo‐controlled trial. American Journal of Sports Medicine2013;41(3):625‐35. [DOI: 10.1177/0363546512472975] ">Krogh 2013</a> (seven participants), one shoulder adhesive capsulitis in each group in <a href="./references#CD010071-bbs2-0010" title="MalavoltaE , Ferreira NetoAA . Platelet rich plasma on arthroscopic repair of the complete rotator cuff lesions: a prospective and randomized study. http://clinicaltrials.gov/ct2/show/NCT01029574 (accessed 26 August 2013). MoraesV . Personal communication. Email to: E Malavolta. ">NCT01029574</a>, one tendon repair rupture in the control group in <a href="./references#CD010071-bbs2-0012" title="RandelliP , ArrigoniP , RagoneV , AliprandiA , CabitzaP . Platelet rich plasma in arthroscopic rotator cuff repair: a prospective RCT study, 2‐year follow‐up. Journal of Shoulder and Elbow Surgery2011;20(4):518‐28. [DOI: 10.1016/j.jse.2011.02.008] ">Randelli 2011</a> and one re‐rupture and one deep infection in <a href="./references#CD010071-bbs2-0014" title="SchepullT , KvistJ , NorrmanH , TrinksM , BerlinG , AspenbergP . Autologous platelet have no effect on the healing of human achilles tendon ruptures: a randomized single‐blind study. American Journal of Sports Medicine2011;39(1):38‐47. [DOI: 10.1177/0363546510383515] ">Schepull 2010</a>. </p> </section> <section id="CD010071-sec-0086"> <h5 class="title">Other outcomes</h5> <p>Our secondary outcomes were reported in only a few trials. The results are presented under the separate conditions. </p> <p> <ol id="CD010071-list-0006"> <li> <p>Returns to sports: <a href="./references#CD010071-bbs2-0006" title="DeJongeS , DeVosRJ , WeirA , VanSchieHT , Bierma‐ZeinstraSM , VerhaarJA , et al. One‐year follow‐up of platelet‐rich plasma treatment in chronic Achilles tendinopathy. American Journal of Sports Medicine2011;39(8):1623‐9. deVosRJ , WeirA , TolJL , VerhaarJA , WeinansH , vanSchieHT . No effects of PRP on ultrasonographic tendon structure and neovascularization in chronic midportion Achilles tendinopathy. British Journal of Sports Medicine2011;45(5):387‐92. [DOI: 10.1136/bjsm.2010.076398] deVosRJ , WeirA , vanSchieHT , Bierma‐ZeinstraSM , VerhaarJA , WeinansH , et al. Platelet‐rich plasma injection for chronic Achilles tendinopathy. JAMA2010;303(2):144‐9. ">De Vos 2010</a> (chronic Achilles tendinopathy). </p> </li> <li> <p>Quality of life (SF‐12): <a href="./references#CD010071-bbs2-0019" title="WasterlainA , DragooJ . Platelet‐rich plasma as a treatment for patellar tendinopathy: a double‐blind randomized controlled trial. Individual patient data (as supplied June 2013). Data on file. ">Wasterlain 2013</a> (patellar tendinopathy). </p> </li> <li> <p>Recurrence (retear) of condition: <a href="./references#CD010071-bbs2-0002" title="AntunaS , BarcoR , MartinezJM , SanchezJM . Effect of platelet‐rich fibrin on rotator cuff repair (PRP‐Fibrin). http://clinicaltrials.gov/show/NCT01612845 (accessed 04 December 2013). AntunaSA , Barco LaaksoR , Martinez DiezJM , Sanchez MarquezJMM . PRP‐fibrin for arthroscopically repaired massive rotator cuff tears: a prospective randomized clinical trial. In: American Academy of Orthopaedic Surgeons Annual Meeting; 2012 Mar 7‐11; San Francisco (Ca)2012. AntuñaS , BarcoJ , Martínez DíesJM , Sánchez MárquezJM . Platelet‐rich fibrin in arthroscopic repair of massive rotator cuff tears: A prospective randomized pilot clinical trial. Acta Orthopaedica Belgica2013;79:25‐30. MoraesV . Personal communication. Email to: S Antuna 18 April 2013. ">Antuna 2013</a> and <a href="./references#CD010071-bbs2-0012" title="RandelliP , ArrigoniP , RagoneV , AliprandiA , CabitzaP . Platelet rich plasma in arthroscopic rotator cuff repair: a prospective RCT study, 2‐year follow‐up. Journal of Shoulder and Elbow Surgery2011;20(4):518‐28. [DOI: 10.1016/j.jse.2011.02.008] ">Randelli 2011</a> (rotator cuff tears) and <a href="./references#CD010071-bbs2-0014" title="SchepullT , KvistJ , NorrmanH , TrinksM , BerlinG , AspenbergP . Autologous platelet have no effect on the healing of human achilles tendon ruptures: a randomized single‐blind study. American Journal of Sports Medicine2011;39(1):38‐47. [DOI: 10.1177/0363546510383515] ">Schepull 2010</a> (Achilles tendon rupture). </p> </li> <li> <p>Patient satisfaction: <a href="./references#CD010071-bbs2-0002" title="AntunaS , BarcoR , MartinezJM , SanchezJM . Effect of platelet‐rich fibrin on rotator cuff repair (PRP‐Fibrin). http://clinicaltrials.gov/show/NCT01612845 (accessed 04 December 2013). AntunaSA , Barco LaaksoR , Martinez DiezJM , Sanchez MarquezJMM . PRP‐fibrin for arthroscopically repaired massive rotator cuff tears: a prospective randomized clinical trial. In: American Academy of Orthopaedic Surgeons Annual Meeting; 2012 Mar 7‐11; San Francisco (Ca)2012. AntuñaS , BarcoJ , Martínez DíesJM , Sánchez MárquezJM . Platelet‐rich fibrin in arthroscopic repair of massive rotator cuff tears: A prospective randomized pilot clinical trial. Acta Orthopaedica Belgica2013;79:25‐30. MoraesV . Personal communication. Email to: S Antuna 18 April 2013. ">Antuna 2013</a> (rotator cuff repair) and <a href="./references#CD010071-bbs2-0006" title="DeJongeS , DeVosRJ , WeirA , VanSchieHT , Bierma‐ZeinstraSM , VerhaarJA , et al. One‐year follow‐up of platelet‐rich plasma treatment in chronic Achilles tendinopathy. American Journal of Sports Medicine2011;39(8):1623‐9. deVosRJ , WeirA , TolJL , VerhaarJA , WeinansH , vanSchieHT . No effects of PRP on ultrasonographic tendon structure and neovascularization in chronic midportion Achilles tendinopathy. British Journal of Sports Medicine2011;45(5):387‐92. [DOI: 10.1136/bjsm.2010.076398] deVosRJ , WeirA , vanSchieHT , Bierma‐ZeinstraSM , VerhaarJA , WeinansH , et al. Platelet‐rich plasma injection for chronic Achilles tendinopathy. JAMA2010;303(2):144‐9. ">De Vos 2010</a> (chronic Achilles tendinopathy). </p> </li> </ol> </p> </section> </section> <section id="CD010071-sec-0087"> <h4 class="title">Subgroup analysis: PRT as a main treatment of tendinopathies versus as a surgical augmentation procedure for a musculoskeletal soft tissue injury </h4> <p>We subgrouped the trials into two categories: 'tendinopathies' in which PRT injections were the main treatment (<a href="./references#CD010071-bbs2-0005" title="CreaneyL , WallaceA , CurtisM , ConnellD . Growth factor‐based therapies provide additional benefit beyond physical therapy in resistant elbow tendinopathy: a prospective, single‐blind, randomised trial of autologous blood injections versus platelet‐rich plasma injections. British Journal of Sports Medicine2011;45(12):966‐71. [DOI: 10.1136/bjsm.2010.082503] ">Creaney 2011</a>; <a href="./references#CD010071-bbs2-0006" title="DeJongeS , DeVosRJ , WeirA , VanSchieHT , Bierma‐ZeinstraSM , VerhaarJA , et al. One‐year follow‐up of platelet‐rich plasma treatment in chronic Achilles tendinopathy. American Journal of Sports Medicine2011;39(8):1623‐9. deVosRJ , WeirA , TolJL , VerhaarJA , WeinansH , vanSchieHT . No effects of PRP on ultrasonographic tendon structure and neovascularization in chronic midportion Achilles tendinopathy. British Journal of Sports Medicine2011;45(5):387‐92. [DOI: 10.1136/bjsm.2010.076398] deVosRJ , WeirA , vanSchieHT , Bierma‐ZeinstraSM , VerhaarJA , WeinansH , et al. Platelet‐rich plasma injection for chronic Achilles tendinopathy. JAMA2010;303(2):144‐9. ">De Vos 2010</a>; <a href="./references#CD010071-bbs2-0009" title="KroghTP , FredbergU , Stengaard‐PedersenK , ChristensenR , JensenP , EllingsenT . Treatment of lateral epicondylitis with platelet‐rich plasma, glucocorticoid, or saline: a randomized, double‐blind, placebo‐controlled trial. American Journal of Sports Medicine2013;41(3):625‐35. [DOI: 10.1177/0363546512472975] ">Krogh 2013</a>; <a href="./references#CD010071-bbs2-0015" title="ThanasasC , PapadimitriouG , CharalambidisC , ParaskevopoulosI , PapanikolaouA . Platelet‐rich plasma versus autologous whole blood for the treatment of chronic lateral elbow epicondylitis: a randomized controlled clinical trial. American Journal of Sports Medicine2011;39(10):2130‐4. [DOI: 10.1177/0363546511417113] ">Thanasas 2011</a>; <a href="./references#CD010071-bbs2-0019" title="WasterlainA , DragooJ . Platelet‐rich plasma as a treatment for patellar tendinopathy: a double‐blind randomized controlled trial. Individual patient data (as supplied June 2013). Data on file. ">Wasterlain 2013</a>), and 'surgical augmentation procedures' where PRT was applied during surgery (<a href="./references#CD010071-bbs2-0001" title="AlmeidaAM . Platelet‐rich plasma in the regeneration of the patellar ligament after harvesting its central third: a prospective randomised study [Efeito do plasma rico em plaquetas na regeneração do terço central do ligamento da patela: estudo prospectivo randomizado] (Thesis). São Paulo: Universidade de São Paulo, Faculdade de Medicina, 2013. AlmeidaAM , DemangeMK , SobradoMF , RodriguesMB , PedrinelliA , HernandezAJ . Patellar tendon healing with platelet‐rich plasma. American Journal of Sports Medicine2012;40(6):1283‐8. ">Almeida 2012</a>; <a href="./references#CD010071-bbs2-0002" title="AntunaS , BarcoR , MartinezJM , SanchezJM . Effect of platelet‐rich fibrin on rotator cuff repair (PRP‐Fibrin). http://clinicaltrials.gov/show/NCT01612845 (accessed 04 December 2013). AntunaSA , Barco LaaksoR , Martinez DiezJM , Sanchez MarquezJMM . PRP‐fibrin for arthroscopically repaired massive rotator cuff tears: a prospective randomized clinical trial. In: American Academy of Orthopaedic Surgeons Annual Meeting; 2012 Mar 7‐11; San Francisco (Ca)2012. AntuñaS , BarcoJ , Martínez DíesJM , Sánchez MárquezJM . Platelet‐rich fibrin in arthroscopic repair of massive rotator cuff tears: A prospective randomized pilot clinical trial. Acta Orthopaedica Belgica2013;79:25‐30. MoraesV . Personal communication. Email to: S Antuna 18 April 2013. ">Antuna 2013</a>; <a href="./references#CD010071-bbs2-0003" title="CastriciniR , LongoUG , BenedettoM , PanfoliN , PiraniN , ZiniR , et al. Platelet‐rich plasma augmentation for arthroscopic rotator cuff repair: a randomized controlled trial. American Journal of Sports Medicine2011;39(2):258‐65. [DOI: 10.1177/0363546510390780] ">Castricini 2011</a>; <a href="./references#CD010071-bbs2-0004" title="CervellinM , GirolamoL , BaitC , DentiM , VoltiP . Autologous platelet‐rich plasma gel to reduce donor‐site morbidity after patellar tendon graft harvesting for anterior cruciate ligamente reconstruction: a randomized, controlled clinical study. Knee Surgery, Sports Traumatology, Arthroscopy2012;20(1):114‐20. [DOI: 10.1007/s00167‐011‐1570‐5] ">Cervellin 2012</a>; <a href="./references#CD010071-bbs2-0007" title="EvertsPA , DevileeRJ , MahoneyCB , vanErpA , OosterbosCJ , StellenboomM , et al. Exogenous application of platelet‐leukocyte gel during open subacromial decompression contributes to improved patient outcome. European Surgical Research2008;40(2):203‐10. [DOI: 10.1159/000110862] ">Everts 2008</a>; <a href="./references#CD010071-bbs2-0008" title="GuminaS , CampagnaV , FerrazzaG , GiannicolaG , FratalocchiF , MilaniA , et al. Use of platelet‐leukocyte membrane in arthroscopic repair of large rotator cuff tears. Journal of Bone and Joint Surgery ‐ American Volume2012;94(15):1345‐52. [DOI: 10.2106/JBJS.K.00394] ">Gumina 2012</a>; <a href="./references#CD010071-bbs2-0010" title="MalavoltaE , Ferreira NetoAA . Platelet rich plasma on arthroscopic repair of the complete rotator cuff lesions: a prospective and randomized study. http://clinicaltrials.gov/ct2/show/NCT01029574 (accessed 26 August 2013). MoraesV . Personal communication. Email to: E Malavolta. ">NCT01029574</a>; <a href="./references#CD010071-bbs2-0011" title="OrregoM , LarrainC , RosalesJ , ValenzuelaL , MatasJ , DurrutyJ , et al. Effects of platelet concentrate and a bone plug on the healing of hamstring tendons in a bone tunnel. Arthroscopy2008;24(12):1373‐80. [DOI: 10.1016/j.arthro.2008.07.016] ">Orrego 2008</a>; <a href="./references#CD010071-bbs2-0012" title="RandelliP , ArrigoniP , RagoneV , AliprandiA , CabitzaP . Platelet rich plasma in arthroscopic rotator cuff repair: a prospective RCT study, 2‐year follow‐up. Journal of Shoulder and Elbow Surgery2011;20(4):518‐28. [DOI: 10.1016/j.jse.2011.02.008] ">Randelli 2011</a>; <a href="./references#CD010071-bbs2-0013" title="RodeoSA , DelosD , WilliamsRJ , AdlerRS , PearleA , WarrenRF . The effect of platelet‐rich fibrin matrix on rotator cuff tendon healing: a prospective, randomized clinical study. American Journal of Sports Medicine2012;40(6):1234‐41. [DOI: 10.1177/0363546512442924] ">Rodeo 2012</a>; <a href="./references#CD010071-bbs2-0014" title="SchepullT , KvistJ , NorrmanH , TrinksM , BerlinG , AspenbergP . Autologous platelet have no effect on the healing of human achilles tendon ruptures: a randomized single‐blind study. American Journal of Sports Medicine2011;39(1):38‐47. [DOI: 10.1177/0363546510383515] ">Schepull 2010</a>; <a href="./references#CD010071-bbs2-0016" title="VadalàA , IorioR , DeCarliA , FerrettiM , ParavaniD , CapernaL , et al. Platelet‐rich plasma: does it help reduce tunnel widening after ACL reconstruction?. Knee Surgery Sports Traumatology Arthroscopy2013;21(4):824‐9. [DOI: 10.1007/s00167‐012‐1980‐z] ">Vadalà 2013</a>; <a href="./references#CD010071-bbs2-0017" title="Valentí NínJR , GasqueGM , AzcárateAV , BeolaJD , GonzalezMH . Has platelet‐rich plasma any role in anterior cruciate ligament allograft healing?. Arthroscopy2009;25(11):1206‐13. [DOI: 10.1016/j.arthro.2009.06.002] ">Valenti Nín 2009</a>; <a href="./references#CD010071-bbs2-0018" title="VogrinM , RuprehtM , CrnjacA , DinevskiD , KrajncZ , RecnikG . The effect of platelet‐derived growth factors on knee stability after anterior cruciate ligament reconstruction: a prospective randomized clinical study. Wiener Klinische Wochenschrift2010;122(Suppl 2):91‐5. [DOI: 10.1007/s00508‐010‐1340‐2] ">Vogrin 2010</a>). </p> <section id="CD010071-sec-0088"> <h5 class="title">Function</h5> <p>Data on short‐term function were available from three tendinopathy trials and one augmentation trial.The test for subgroup differences was not significant (P value 0.26; I² = 20.7%) (see <a href="./references#CD010071-fig-0010" title="">Analysis 2.1</a>). Moderately heterogenous data pooled from the tendinopathy trials showed no difference between PRT and control in short‐term function (SMD 0.14, 95% CI ‐0.38 to 0.67; P value 0.13; I² = 50%; 182 participants, three trials). </p> <p>Data on medium‐term function were available from three tendinopathy trials and two augmentation trials. The test for subgroup differences was not significant (P value 0.69; I² = 0%) (see <a href="./references#CD010071-fig-0011" title="">Analysis 2.2</a>). Significantly heterogeneous data pooled for the three tendinopathy trials showed little evidence (P value 0.95) of a difference between in PRT and control in medium‐term function (SMD ‐0.02, 95% CI ‐0.83 to 0.78; I² = 70%; 98 participants, three trials). A similar finding of little difference (P value 0.42) applied to pooled function data for the two augmentation trials (SMD ‐0.22, 95% CI ‐0.77 to 0.32; I² = 0%; 53 participants, two trials). </p> <p>Data on long‐term function were available from one tendinopathy trial and nine augmentation trials. The test for subgroup differences was not significant (P value 0.44; I² = 0%) (see <a href="./references#CD010071-fig-0012" title="">Analysis 2.3</a>). Significantly heterogeneous data (I² = 69%) pooled for the nine augmentation trials showed no statistically significant difference between PRT and control in long‐term function (SMD 0.28, 95% CI ‐0.08 to 0.64; P value 0.13; 430 participants, nine trials). </p> </section> <section id="CD010071-sec-0089"> <h5 class="title">Pain</h5> <p>Data on short‐term pain were available from one tendinopathy trial and three augmentation trials. The test for subgroup differences was not significant (P value 0.91; I² = 0%) (see <a href="./references#CD010071-fig-0013" title="">Analysis 2.4</a>). Slightly heterogeneous pooled data (I² = 30%) for augmentation procedures showed some clinically small benefit of PRT in short‐term pain (MD ‐1.04, 95% CI ‐1.71 to ‐0.37; 147 participants, three trials). Medium‐term pain data were only available from two tendinopathy trials; and long‐term pain data from two augmentation trials. As above, we did not pool these data given their clearly significant heterogeneity (see <a href="./references#CD010071-fig-0014" title="">Analysis 2.5</a> and <a href="./references#CD010071-fig-0015" title="">Analysis 2.6</a>). </p> </section> <section id="CD010071-sec-0090"> <h5 class="title">Adverse effects</h5> <p>Adverse effects were reported in one tendinopathy trial and in three augmentation trials (see <a href="./references#CD010071-fig-0016" title="">Analysis 2.7</a>). </p> </section> </section> <section id="CD010071-sec-0091"> <h4 class="title">Analysis of individual conditions</h4> <section id="CD010071-sec-0092"> <h5 class="title">Rotator cuff tears (surgical repair)</h5> <p>Six studies compared standard arthroscopic rotator cuff repair with or without PRP application at the repair site (<a href="./references#CD010071-bbs2-0002" title="AntunaS , BarcoR , MartinezJM , SanchezJM . Effect of platelet‐rich fibrin on rotator cuff repair (PRP‐Fibrin). http://clinicaltrials.gov/show/NCT01612845 (accessed 04 December 2013). AntunaSA , Barco LaaksoR , Martinez DiezJM , Sanchez MarquezJMM . PRP‐fibrin for arthroscopically repaired massive rotator cuff tears: a prospective randomized clinical trial. In: American Academy of Orthopaedic Surgeons Annual Meeting; 2012 Mar 7‐11; San Francisco (Ca)2012. AntuñaS , BarcoJ , Martínez DíesJM , Sánchez MárquezJM . Platelet‐rich fibrin in arthroscopic repair of massive rotator cuff tears: A prospective randomized pilot clinical trial. Acta Orthopaedica Belgica2013;79:25‐30. MoraesV . Personal communication. Email to: S Antuna 18 April 2013. ">Antuna 2013</a>; <a href="./references#CD010071-bbs2-0003" title="CastriciniR , LongoUG , BenedettoM , PanfoliN , PiraniN , ZiniR , et al. Platelet‐rich plasma augmentation for arthroscopic rotator cuff repair: a randomized controlled trial. American Journal of Sports Medicine2011;39(2):258‐65. [DOI: 10.1177/0363546510390780] ">Castricini 2011</a>; <a href="./references#CD010071-bbs2-0008" title="GuminaS , CampagnaV , FerrazzaG , GiannicolaG , FratalocchiF , MilaniA , et al. Use of platelet‐leukocyte membrane in arthroscopic repair of large rotator cuff tears. Journal of Bone and Joint Surgery ‐ American Volume2012;94(15):1345‐52. [DOI: 10.2106/JBJS.K.00394] ">Gumina 2012</a>; <a href="./references#CD010071-bbs2-0010" title="MalavoltaE , Ferreira NetoAA . Platelet rich plasma on arthroscopic repair of the complete rotator cuff lesions: a prospective and randomized study. http://clinicaltrials.gov/ct2/show/NCT01029574 (accessed 26 August 2013). MoraesV . Personal communication. Email to: E Malavolta. ">NCT01029574</a>; <a href="./references#CD010071-bbs2-0012" title="RandelliP , ArrigoniP , RagoneV , AliprandiA , CabitzaP . Platelet rich plasma in arthroscopic rotator cuff repair: a prospective RCT study, 2‐year follow‐up. Journal of Shoulder and Elbow Surgery2011;20(4):518‐28. [DOI: 10.1016/j.jse.2011.02.008] ">Randelli 2011</a>; <a href="./references#CD010071-bbs2-0013" title="RodeoSA , DelosD , WilliamsRJ , AdlerRS , PearleA , WarrenRF . The effect of platelet‐rich fibrin matrix on rotator cuff tendon healing: a prospective, randomized clinical study. American Journal of Sports Medicine2012;40(6):1234‐41. [DOI: 10.1177/0363546512442924] ">Rodeo 2012</a>). Twelve participants were lost to follow‐up. Data were available for 291 participants. </p> <section id="CD010071-sec-0093"> <h6 class="title">Function</h6> <p>Functional status at one‐year follow‐up was documented in all six studies; the Constant score was reported in five studies (<a href="./references#CD010071-bbs2-0002" title="AntunaS , BarcoR , MartinezJM , SanchezJM . Effect of platelet‐rich fibrin on rotator cuff repair (PRP‐Fibrin). http://clinicaltrials.gov/show/NCT01612845 (accessed 04 December 2013). AntunaSA , Barco LaaksoR , Martinez DiezJM , Sanchez MarquezJMM . PRP‐fibrin for arthroscopically repaired massive rotator cuff tears: a prospective randomized clinical trial. In: American Academy of Orthopaedic Surgeons Annual Meeting; 2012 Mar 7‐11; San Francisco (Ca)2012. AntuñaS , BarcoJ , Martínez DíesJM , Sánchez MárquezJM . Platelet‐rich fibrin in arthroscopic repair of massive rotator cuff tears: A prospective randomized pilot clinical trial. Acta Orthopaedica Belgica2013;79:25‐30. MoraesV . Personal communication. Email to: S Antuna 18 April 2013. ">Antuna 2013</a>; <a href="./references#CD010071-bbs2-0003" title="CastriciniR , LongoUG , BenedettoM , PanfoliN , PiraniN , ZiniR , et al. Platelet‐rich plasma augmentation for arthroscopic rotator cuff repair: a randomized controlled trial. American Journal of Sports Medicine2011;39(2):258‐65. [DOI: 10.1177/0363546510390780] ">Castricini 2011</a>; <a href="./references#CD010071-bbs2-0008" title="GuminaS , CampagnaV , FerrazzaG , GiannicolaG , FratalocchiF , MilaniA , et al. Use of platelet‐leukocyte membrane in arthroscopic repair of large rotator cuff tears. Journal of Bone and Joint Surgery ‐ American Volume2012;94(15):1345‐52. [DOI: 10.2106/JBJS.K.00394] ">Gumina 2012</a>; <a href="./references#CD010071-bbs2-0010" title="MalavoltaE , Ferreira NetoAA . Platelet rich plasma on arthroscopic repair of the complete rotator cuff lesions: a prospective and randomized study. http://clinicaltrials.gov/ct2/show/NCT01029574 (accessed 26 August 2013). MoraesV . Personal communication. Email to: E Malavolta. ">NCT01029574</a>; <a href="./references#CD010071-bbs2-0012" title="RandelliP , ArrigoniP , RagoneV , AliprandiA , CabitzaP . Platelet rich plasma in arthroscopic rotator cuff repair: a prospective RCT study, 2‐year follow‐up. Journal of Shoulder and Elbow Surgery2011;20(4):518‐28. [DOI: 10.1016/j.jse.2011.02.008] ">Randelli 2011</a>). A minimal clinically important difference of 10.4 for this commonly used score has been estimated in a study of rotator cuff surgery patients (<a href="./references#CD010071-bbs2-0057" title="KukkonenJ , KaukoT , VahlbergT , JoukainenA , AärimaaV . Investigating minimal clinically important difference for Constant score in patients undergoing rotator cuff surgery. Journal of Shoulder and Elbow Surgery2013;22(12):1650‐5. ">Kukkonen 2013</a>). Pooled Constant scores at one‐year follow‐up showed a clinically non‐significant difference in favour of PRT (MD 2.47, CI 95% 0.68 to 4.26; I² = 50%; 290 participants, five trials; see <a href="./references#CD010071-fig-0017" title="">Analysis 3.1</a>). The Constant scores at two years after the intervention from two trials were not pooled because these were significantly heterogeneous (I² = 85%; see <a href="./references#CD010071-fig-0018" title="">Analysis 3.2</a>) (<a href="./references#CD010071-bbs2-0002" title="AntunaS , BarcoR , MartinezJM , SanchezJM . Effect of platelet‐rich fibrin on rotator cuff repair (PRP‐Fibrin). http://clinicaltrials.gov/show/NCT01612845 (accessed 04 December 2013). AntunaSA , Barco LaaksoR , Martinez DiezJM , Sanchez MarquezJMM . PRP‐fibrin for arthroscopically repaired massive rotator cuff tears: a prospective randomized clinical trial. In: American Academy of Orthopaedic Surgeons Annual Meeting; 2012 Mar 7‐11; San Francisco (Ca)2012. AntuñaS , BarcoJ , Martínez DíesJM , Sánchez MárquezJM . Platelet‐rich fibrin in arthroscopic repair of massive rotator cuff tears: A prospective randomized pilot clinical trial. Acta Orthopaedica Belgica2013;79:25‐30. MoraesV . Personal communication. Email to: S Antuna 18 April 2013. ">Antuna 2013</a>; <a href="./references#CD010071-bbs2-0012" title="RandelliP , ArrigoniP , RagoneV , AliprandiA , CabitzaP . Platelet rich plasma in arthroscopic rotator cuff repair: a prospective RCT study, 2‐year follow‐up. Journal of Shoulder and Elbow Surgery2011;20(4):518‐28. [DOI: 10.1016/j.jse.2011.02.008] ">Randelli 2011</a>). Results based on other scores at one‐ or two‐year follow‐ups are shown in <a href="./references#CD010071-fig-0019" title="">Analysis 3.3</a>: UCLA (University of California Los Angeles) scores, two trials (<a href="./references#CD010071-bbs2-0010" title="MalavoltaE , Ferreira NetoAA . Platelet rich plasma on arthroscopic repair of the complete rotator cuff lesions: a prospective and randomized study. http://clinicaltrials.gov/ct2/show/NCT01029574 (accessed 26 August 2013). MoraesV . Personal communication. Email to: E Malavolta. ">NCT01029574</a>; <a href="./references#CD010071-bbs2-0012" title="RandelliP , ArrigoniP , RagoneV , AliprandiA , CabitzaP . Platelet rich plasma in arthroscopic rotator cuff repair: a prospective RCT study, 2‐year follow‐up. Journal of Shoulder and Elbow Surgery2011;20(4):518‐28. [DOI: 10.1016/j.jse.2011.02.008] ">Randelli 2011</a>); <a href="./references#CD010071-fig-0020" title="">Analysis 3.4</a>: SST (Simple Shoulder Test), two trials (<a href="./references#CD010071-bbs2-0008" title="GuminaS , CampagnaV , FerrazzaG , GiannicolaG , FratalocchiF , MilaniA , et al. Use of platelet‐leukocyte membrane in arthroscopic repair of large rotator cuff tears. Journal of Bone and Joint Surgery ‐ American Volume2012;94(15):1345‐52. [DOI: 10.2106/JBJS.K.00394] ">Gumina 2012</a>; <a href="./references#CD010071-bbs2-0012" title="RandelliP , ArrigoniP , RagoneV , AliprandiA , CabitzaP . Platelet rich plasma in arthroscopic rotator cuff repair: a prospective RCT study, 2‐year follow‐up. Journal of Shoulder and Elbow Surgery2011;20(4):518‐28. [DOI: 10.1016/j.jse.2011.02.008] ">Randelli 2011</a>); <a href="./references#CD010071-fig-0021" title="">Analysis 3.5</a> and <a href="./references#CD010071-fig-0022" title="">Analysis 3.6</a>: DASH (Disabilities of the Arm, Shoulder and Hand), one trial (<a href="./references#CD010071-bbs2-0002" title="AntunaS , BarcoR , MartinezJM , SanchezJM . Effect of platelet‐rich fibrin on rotator cuff repair (PRP‐Fibrin). http://clinicaltrials.gov/show/NCT01612845 (accessed 04 December 2013). AntunaSA , Barco LaaksoR , Martinez DiezJM , Sanchez MarquezJMM . PRP‐fibrin for arthroscopically repaired massive rotator cuff tears: a prospective randomized clinical trial. In: American Academy of Orthopaedic Surgeons Annual Meeting; 2012 Mar 7‐11; San Francisco (Ca)2012. AntuñaS , BarcoJ , Martínez DíesJM , Sánchez MárquezJM . Platelet‐rich fibrin in arthroscopic repair of massive rotator cuff tears: A prospective randomized pilot clinical trial. Acta Orthopaedica Belgica2013;79:25‐30. MoraesV . Personal communication. Email to: S Antuna 18 April 2013. ">Antuna 2013</a>); <a href="./references#CD010071-fig-0023" title="">Analysis 3.7</a> L'Insalata, one trial (<a href="./references#CD010071-bbs2-0013" title="RodeoSA , DelosD , WilliamsRJ , AdlerRS , PearleA , WarrenRF . The effect of platelet‐rich fibrin matrix on rotator cuff tendon healing: a prospective, randomized clinical study. American Journal of Sports Medicine2012;40(6):1234‐41. [DOI: 10.1177/0363546512442924] ">Rodeo 2012</a>); and <a href="./references#CD010071-fig-0024" title="">Analysis 3.8</a>: ASES (American Shoulder and Elbow Surgeons), one trial (<a href="./references#CD010071-bbs2-0013" title="RodeoSA , DelosD , WilliamsRJ , AdlerRS , PearleA , WarrenRF . The effect of platelet‐rich fibrin matrix on rotator cuff tendon healing: a prospective, randomized clinical study. American Journal of Sports Medicine2012;40(6):1234‐41. [DOI: 10.1177/0363546512442924] ">Rodeo 2012</a>). These show some variation in the direction and size of effect among different trials. When Constant data from five studies were pooled with the L'Insalata scores for <a href="./references#CD010071-bbs2-0013" title="RodeoSA , DelosD , WilliamsRJ , AdlerRS , PearleA , WarrenRF . The effect of platelet‐rich fibrin matrix on rotator cuff tendon healing: a prospective, randomized clinical study. American Journal of Sports Medicine2012;40(6):1234‐41. [DOI: 10.1177/0363546512442924] ">Rodeo 2012</a> they showed little difference between the two groups (SMD 0.13, 95% CI ‐0.24 to 0.51; I² = 63%; 323 participants, six trials; see <a href="./references#CD010071-fig-0025" title="">Analysis 3.9</a>. However, the results of these six trials were significantly heterogenous. </p> </section> <section id="CD010071-sec-0094"> <h6 class="title">Pain</h6> <p><a href="./references#CD010071-fig-0026" title="">Analysis 3.10</a> presents pain score data from two studies (105 participants) in the immediate post‐operative period (seven days). Pooled data showed some benefit of PRP (MD ‐1.40, 95% CI ‐2.44 to ‐0.36). The results at 30 days were heterogeneous, with those in <a href="./references#CD010071-bbs2-0012" title="RandelliP , ArrigoniP , RagoneV , AliprandiA , CabitzaP . Platelet rich plasma in arthroscopic rotator cuff repair: a prospective RCT study, 2‐year follow‐up. Journal of Shoulder and Elbow Surgery2011;20(4):518‐28. [DOI: 10.1016/j.jse.2011.02.008] ">Randelli 2011</a> still favouring PRT but those in <a href="./references#CD010071-bbs2-0010" title="MalavoltaE , Ferreira NetoAA . Platelet rich plasma on arthroscopic repair of the complete rotator cuff lesions: a prospective and randomized study. http://clinicaltrials.gov/ct2/show/NCT01029574 (accessed 26 August 2013). MoraesV . Personal communication. Email to: E Malavolta. ">NCT01029574</a> showing no difference between the two groups (MD ‐0.69, 95% CI ‐1.64 to 0.25; I² = 44%; 105 participants, two trials; see <a href="./references#CD010071-fig-0029" title="">Analysis 3.13</a>). Results at one‐year and two‐year follow‐ups were again from two trials with heterogenous results. Pooled results at one year showed little difference between the two groups (‐0.30, 95% CI ‐1.20 to 0.61; I² = 33%; 82 participants, two trials; see <a href="./references#CD010071-fig-0028" title="">Analysis 3.12</a>). The clearly heterogeneous results at two years (I² = 67%) meant that we did not pool these results (see <a href="./references#CD010071-fig-0027" title="">Analysis 3.11</a>). </p> </section> <section id="CD010071-sec-0095"> <h6 class="title">Retear rates</h6> <p>The three studies that assessed retear rates found fewer retears in the PRP group after one year (10/101 versus 19/98; RR 0.55, 95% CI 0.30 to 1.01; I² = 25%; see <a href="./references#CD010071-fig-0030" title="">Analysis 3.14</a>) (<a href="./references#CD010071-bbs2-0003" title="CastriciniR , LongoUG , BenedettoM , PanfoliN , PiraniN , ZiniR , et al. Platelet‐rich plasma augmentation for arthroscopic rotator cuff repair: a randomized controlled trial. American Journal of Sports Medicine2011;39(2):258‐65. [DOI: 10.1177/0363546510390780] ">Castricini 2011</a>; <a href="./references#CD010071-bbs2-0008" title="GuminaS , CampagnaV , FerrazzaG , GiannicolaG , FratalocchiF , MilaniA , et al. Use of platelet‐leukocyte membrane in arthroscopic repair of large rotator cuff tears. Journal of Bone and Joint Surgery ‐ American Volume2012;94(15):1345‐52. [DOI: 10.2106/JBJS.K.00394] ">Gumina 2012</a>; <a href="./references#CD010071-bbs2-0012" title="RandelliP , ArrigoniP , RagoneV , AliprandiA , CabitzaP . Platelet rich plasma in arthroscopic rotator cuff repair: a prospective RCT study, 2‐year follow‐up. Journal of Shoulder and Elbow Surgery2011;20(4):518‐28. [DOI: 10.1016/j.jse.2011.02.008] ">Randelli 2011</a>). However, after two years, pooled results from two studies demonstrated more comparable rates of retear in the two groups (19/36 versus 22/37; RR 0.88, 95% CI 0.59 to 1.32; I² = 14%; see <a href="./references#CD010071-fig-0031" title="">Analysis 3.15</a>) (<a href="./references#CD010071-bbs2-0002" title="AntunaS , BarcoR , MartinezJM , SanchezJM . Effect of platelet‐rich fibrin on rotator cuff repair (PRP‐Fibrin). http://clinicaltrials.gov/show/NCT01612845 (accessed 04 December 2013). AntunaSA , Barco LaaksoR , Martinez DiezJM , Sanchez MarquezJMM . PRP‐fibrin for arthroscopically repaired massive rotator cuff tears: a prospective randomized clinical trial. In: American Academy of Orthopaedic Surgeons Annual Meeting; 2012 Mar 7‐11; San Francisco (Ca)2012. AntuñaS , BarcoJ , Martínez DíesJM , Sánchez MárquezJM . Platelet‐rich fibrin in arthroscopic repair of massive rotator cuff tears: A prospective randomized pilot clinical trial. Acta Orthopaedica Belgica2013;79:25‐30. MoraesV . Personal communication. Email to: S Antuna 18 April 2013. ">Antuna 2013</a>; <a href="./references#CD010071-bbs2-0012" title="RandelliP , ArrigoniP , RagoneV , AliprandiA , CabitzaP . Platelet rich plasma in arthroscopic rotator cuff repair: a prospective RCT study, 2‐year follow‐up. Journal of Shoulder and Elbow Surgery2011;20(4):518‐28. [DOI: 10.1016/j.jse.2011.02.008] ">Randelli 2011</a>). </p> </section> <section id="CD010071-sec-0096"> <h6 class="title">Participant satisfaction</h6> <p>One study assessed participant satisfaction after two years and found that two participants, one from the PRP group and one from the control group, were dissatisfied with the procedure (satisfied participants: RR 1.00, 95% CI 0.81 to 1.23; see <a href="./references#CD010071-fig-0032" title="">Analysis 3.16</a>) (<a href="./references#CD010071-bbs2-0002" title="AntunaS , BarcoR , MartinezJM , SanchezJM . Effect of platelet‐rich fibrin on rotator cuff repair (PRP‐Fibrin). http://clinicaltrials.gov/show/NCT01612845 (accessed 04 December 2013). AntunaSA , Barco LaaksoR , Martinez DiezJM , Sanchez MarquezJMM . PRP‐fibrin for arthroscopically repaired massive rotator cuff tears: a prospective randomized clinical trial. In: American Academy of Orthopaedic Surgeons Annual Meeting; 2012 Mar 7‐11; San Francisco (Ca)2012. AntuñaS , BarcoJ , Martínez DíesJM , Sánchez MárquezJM . Platelet‐rich fibrin in arthroscopic repair of massive rotator cuff tears: A prospective randomized pilot clinical trial. Acta Orthopaedica Belgica2013;79:25‐30. MoraesV . Personal communication. Email to: S Antuna 18 April 2013. ">Antuna 2013</a>). </p> </section> </section> <section id="CD010071-sec-0097"> <h5 class="title">Shoulder impingement syndrome (surgery)</h5> <p>One study compared PRP versus no PRP application augmenting open subacromial decompression for shoulder impingement syndrome in 40 participants (<a href="./references#CD010071-bbs2-0007" title="EvertsPA , DevileeRJ , MahoneyCB , vanErpA , OosterbosCJ , StellenboomM , et al. Exogenous application of platelet‐leukocyte gel during open subacromial decompression contributes to improved patient outcome. European Surgical Research2008;40(2):203‐10. [DOI: 10.1159/000110862] ">Everts 2008</a>); because of the limited availability of data at three‐month follow‐up, we present the data for six weeks here. (Data for pain were extracted from a graph.) </p> <p>At six weeks, the PRP group had less pain (MD ‐1.40, 95% CI ‐2.36 to ‐0.44; see <a href="./references#CD010071-fig-0035" title="">Analysis 4.3</a>) and better function as assessed using the Shoulder Index Score (SIS), which measures pain and activities of daily living (MD ‐0.90, 95% CI ‐1.79 to ‐0.01; see <a href="./references#CD010071-fig-0033" title="">Analysis 4.1</a>). One participant in the PRP group and two participants in the control group had instability at six weeks (<i>see</i><a href="./references#CD010071-fig-0034" title="">Analysis 4.2</a>). No adverse effects were reported. </p> </section> <section id="CD010071-sec-0098"> <h5 class="title">Elbow epicondylitis</h5> <p>Three studies compared ultrasound‐guided PRP injections versus controls (<a href="./references#CD010071-bbs2-0005" title="CreaneyL , WallaceA , CurtisM , ConnellD . Growth factor‐based therapies provide additional benefit beyond physical therapy in resistant elbow tendinopathy: a prospective, single‐blind, randomised trial of autologous blood injections versus platelet‐rich plasma injections. British Journal of Sports Medicine2011;45(12):966‐71. [DOI: 10.1136/bjsm.2010.082503] ">Creaney 2011</a>; <a href="./references#CD010071-bbs2-0009" title="KroghTP , FredbergU , Stengaard‐PedersenK , ChristensenR , JensenP , EllingsenT . Treatment of lateral epicondylitis with platelet‐rich plasma, glucocorticoid, or saline: a randomized, double‐blind, placebo‐controlled trial. American Journal of Sports Medicine2013;41(3):625‐35. [DOI: 10.1177/0363546512472975] ">Krogh 2013</a>; <a href="./references#CD010071-bbs2-0015" title="ThanasasC , PapadimitriouG , CharalambidisC , ParaskevopoulosI , PapanikolaouA . Platelet‐rich plasma versus autologous whole blood for the treatment of chronic lateral elbow epicondylitis: a randomized controlled clinical trial. American Journal of Sports Medicine2011;39(10):2130‐4. [DOI: 10.1177/0363546511417113] ">Thanasas 2011</a>). Two studies used autologous whole blood controls (<a href="./references#CD010071-bbs2-0005" title="CreaneyL , WallaceA , CurtisM , ConnellD . Growth factor‐based therapies provide additional benefit beyond physical therapy in resistant elbow tendinopathy: a prospective, single‐blind, randomised trial of autologous blood injections versus platelet‐rich plasma injections. British Journal of Sports Medicine2011;45(12):966‐71. [DOI: 10.1136/bjsm.2010.082503] ">Creaney 2011</a>; <a href="./references#CD010071-bbs2-0015" title="ThanasasC , PapadimitriouG , CharalambidisC , ParaskevopoulosI , PapanikolaouA . Platelet‐rich plasma versus autologous whole blood for the treatment of chronic lateral elbow epicondylitis: a randomized controlled clinical trial. American Journal of Sports Medicine2011;39(10):2130‐4. [DOI: 10.1177/0363546511417113] ">Thanasas 2011</a>), and <a href="./references#CD010071-bbs2-0009" title="KroghTP , FredbergU , Stengaard‐PedersenK , ChristensenR , JensenP , EllingsenT . Treatment of lateral epicondylitis with platelet‐rich plasma, glucocorticoid, or saline: a randomized, double‐blind, placebo‐controlled trial. American Journal of Sports Medicine2013;41(3):625‐35. [DOI: 10.1177/0363546512472975] ">Krogh 2013</a> used saline injections. (<a href="./references#CD010071-bbs2-0009" title="KroghTP , FredbergU , Stengaard‐PedersenK , ChristensenR , JensenP , EllingsenT . Treatment of lateral epicondylitis with platelet‐rich plasma, glucocorticoid, or saline: a randomized, double‐blind, placebo‐controlled trial. American Journal of Sports Medicine2013;41(3):625‐35. [DOI: 10.1177/0363546512472975] ">Krogh 2013</a> also assessed glucocorticoid injections in a third arm, but this intervention was not considered in this review.) <a href="./references#CD010071-bbs2-0005" title="CreaneyL , WallaceA , CurtisM , ConnellD . Growth factor‐based therapies provide additional benefit beyond physical therapy in resistant elbow tendinopathy: a prospective, single‐blind, randomised trial of autologous blood injections versus platelet‐rich plasma injections. British Journal of Sports Medicine2011;45(12):966‐71. [DOI: 10.1136/bjsm.2010.082503] ">Creaney 2011</a> applied two injections during a one‐month term, while the others applied a single injection (<a href="./references#CD010071-bbs2-0009" title="KroghTP , FredbergU , Stengaard‐PedersenK , ChristensenR , JensenP , EllingsenT . Treatment of lateral epicondylitis with platelet‐rich plasma, glucocorticoid, or saline: a randomized, double‐blind, placebo‐controlled trial. American Journal of Sports Medicine2013;41(3):625‐35. [DOI: 10.1177/0363546512472975] ">Krogh 2013</a>; <a href="./references#CD010071-bbs2-0015" title="ThanasasC , PapadimitriouG , CharalambidisC , ParaskevopoulosI , PapanikolaouA . Platelet‐rich plasma versus autologous whole blood for the treatment of chronic lateral elbow epicondylitis: a randomized controlled clinical trial. American Journal of Sports Medicine2011;39(10):2130‐4. [DOI: 10.1177/0363546511417113] ">Thanasas 2011</a>). <a href="./references#CD010071-bbs2-0005" title="CreaneyL , WallaceA , CurtisM , ConnellD . Growth factor‐based therapies provide additional benefit beyond physical therapy in resistant elbow tendinopathy: a prospective, single‐blind, randomised trial of autologous blood injections versus platelet‐rich plasma injections. British Journal of Sports Medicine2011;45(12):966‐71. [DOI: 10.1136/bjsm.2010.082503] ">Creaney 2011</a> included participants with 'resistant elbow tendinopathy' while <a href="./references#CD010071-bbs2-0009" title="KroghTP , FredbergU , Stengaard‐PedersenK , ChristensenR , JensenP , EllingsenT . Treatment of lateral epicondylitis with platelet‐rich plasma, glucocorticoid, or saline: a randomized, double‐blind, placebo‐controlled trial. American Journal of Sports Medicine2013;41(3):625‐35. [DOI: 10.1177/0363546512472975] ">Krogh 2013</a> and <a href="./references#CD010071-bbs2-0015" title="ThanasasC , PapadimitriouG , CharalambidisC , ParaskevopoulosI , PapanikolaouA . Platelet‐rich plasma versus autologous whole blood for the treatment of chronic lateral elbow epicondylitis: a randomized controlled clinical trial. American Journal of Sports Medicine2011;39(10):2130‐4. [DOI: 10.1177/0363546511417113] ">Thanasas 2011</a> included participants with lateral epicondylitis. Together, the three studies assessed 219 participants, with data available for pooling for 151 participants. <a href="./references#CD010071-bbs2-0009" title="KroghTP , FredbergU , Stengaard‐PedersenK , ChristensenR , JensenP , EllingsenT . Treatment of lateral epicondylitis with platelet‐rich plasma, glucocorticoid, or saline: a randomized, double‐blind, placebo‐controlled trial. American Journal of Sports Medicine2013;41(3):625‐35. [DOI: 10.1177/0363546512472975] ">Krogh 2013</a> reported a high rate of loss to follow‐up after three months, but no losses until three months. As the trial authors suggested in their report, we have only included the three‐month results here. </p> <section id="CD010071-sec-0099"> <h6 class="title">Function</h6> <p>Function was assessed using the PRTEE (Patient‐Rated Tennis Elbow Evaluation) in <a href="./references#CD010071-bbs2-0005" title="CreaneyL , WallaceA , CurtisM , ConnellD . Growth factor‐based therapies provide additional benefit beyond physical therapy in resistant elbow tendinopathy: a prospective, single‐blind, randomised trial of autologous blood injections versus platelet‐rich plasma injections. British Journal of Sports Medicine2011;45(12):966‐71. [DOI: 10.1136/bjsm.2010.082503] ">Creaney 2011</a> and <a href="./references#CD010071-bbs2-0009" title="KroghTP , FredbergU , Stengaard‐PedersenK , ChristensenR , JensenP , EllingsenT . Treatment of lateral epicondylitis with platelet‐rich plasma, glucocorticoid, or saline: a randomized, double‐blind, placebo‐controlled trial. American Journal of Sports Medicine2013;41(3):625‐35. [DOI: 10.1177/0363546512472975] ">Krogh 2013</a>, while the Liverpool Elbow score was used in <a href="./references#CD010071-bbs2-0015" title="ThanasasC , PapadimitriouG , CharalambidisC , ParaskevopoulosI , PapanikolaouA . Platelet‐rich plasma versus autologous whole blood for the treatment of chronic lateral elbow epicondylitis: a randomized controlled clinical trial. American Journal of Sports Medicine2011;39(10):2130‐4. [DOI: 10.1177/0363546511417113] ">Thanasas 2011</a>. The results of the individual scores at short‐ and medium‐term follow‐ups are shown in <a href="./references#CD010071-fig-0036" title="">Analysis 5.1</a>, <a href="./references#CD010071-fig-0037" title="">Analysis 5.2</a>, <a href="./references#CD010071-fig-0038" title="">Analysis 5.3</a> and <a href="./references#CD010071-fig-0039" title="">Analysis 5.4</a>. The results were heterogenous with those in <a href="./references#CD010071-bbs2-0009" title="KroghTP , FredbergU , Stengaard‐PedersenK , ChristensenR , JensenP , EllingsenT . Treatment of lateral epicondylitis with platelet‐rich plasma, glucocorticoid, or saline: a randomized, double‐blind, placebo‐controlled trial. American Journal of Sports Medicine2013;41(3):625‐35. [DOI: 10.1177/0363546512472975] ">Krogh 2013</a> and <a href="./references#CD010071-bbs2-0015" title="ThanasasC , PapadimitriouG , CharalambidisC , ParaskevopoulosI , PapanikolaouA . Platelet‐rich plasma versus autologous whole blood for the treatment of chronic lateral elbow epicondylitis: a randomized controlled clinical trial. American Journal of Sports Medicine2011;39(10):2130‐4. [DOI: 10.1177/0363546511417113] ">Thanasas 2011</a> tending to favour PRT whilst the converse applied in <a href="./references#CD010071-bbs2-0005" title="CreaneyL , WallaceA , CurtisM , ConnellD . Growth factor‐based therapies provide additional benefit beyond physical therapy in resistant elbow tendinopathy: a prospective, single‐blind, randomised trial of autologous blood injections versus platelet‐rich plasma injections. British Journal of Sports Medicine2011;45(12):966‐71. [DOI: 10.1136/bjsm.2010.082503] ">Creaney 2011</a>. <a href="./references#CD010071-bbs2-0005" title="CreaneyL , WallaceA , CurtisM , ConnellD . Growth factor‐based therapies provide additional benefit beyond physical therapy in resistant elbow tendinopathy: a prospective, single‐blind, randomised trial of autologous blood injections versus platelet‐rich plasma injections. British Journal of Sports Medicine2011;45(12):966‐71. [DOI: 10.1136/bjsm.2010.082503] ">Creaney 2011</a> noted that the favourable PRTEE change scores at six months in the control group (autologous blood) (MD ‐11.00, 95% CI ‐18.07 to ‐3.93) should be viewed cautiously because of the exclusion of some participants submitted for surgery because of treatment failure: "caution is advised against concluding that there is a true difference". Pooled results from two trials using different scores (final scores were not available for <a href="./references#CD010071-bbs2-0005" title="CreaneyL , WallaceA , CurtisM , ConnellD . Growth factor‐based therapies provide additional benefit beyond physical therapy in resistant elbow tendinopathy: a prospective, single‐blind, randomised trial of autologous blood injections versus platelet‐rich plasma injections. British Journal of Sports Medicine2011;45(12):966‐71. [DOI: 10.1136/bjsm.2010.082503] ">Creaney 2011</a>) for function at short‐term follow‐up favoured PRT (SMD 0.40, 95% CI ‐0.08 to 0.89; 68 participants, two trials; <i>see</i><a href="./references#CD010071-fig-0040" title="">Analysis 5.5</a>). </p> </section> <section id="CD010071-sec-0100"> <h6 class="title">Pain</h6> <p>Data from <a href="./references#CD010071-bbs2-0015" title="ThanasasC , PapadimitriouG , CharalambidisC , ParaskevopoulosI , PapanikolaouA . Platelet‐rich plasma versus autologous whole blood for the treatment of chronic lateral elbow epicondylitis: a randomized controlled clinical trial. American Journal of Sports Medicine2011;39(10):2130‐4. [DOI: 10.1177/0363546511417113] ">Thanasas 2011</a> showed lower pain scores in the PRP group at six weeks (MD ‐0.86, 95% CI ‐1.51 to ‐0.21; see <a href="./references#CD010071-fig-0041" title="">Analysis 5.6</a>) and six months (MD ‐0.75, 95% CI ‐1.57 to 0.07; see <a href="./references#CD010071-fig-0042" title="">Analysis 5.7</a>). <a href="./references#CD010071-bbs2-0009" title="KroghTP , FredbergU , Stengaard‐PedersenK , ChristensenR , JensenP , EllingsenT . Treatment of lateral epicondylitis with platelet‐rich plasma, glucocorticoid, or saline: a randomized, double‐blind, placebo‐controlled trial. American Journal of Sports Medicine2013;41(3):625‐35. [DOI: 10.1177/0363546512472975] ">Krogh 2013</a> also assessed pain related to the injection itself, querying by mail whether "injection therapy had caused any additional pain on a numeric rating scale from 0 to 10" and reported that PRP injections were more painful than saline injections. </p> </section> <section id="CD010071-sec-0101"> <h6 class="title">Complications</h6> <p><a href="./references#CD010071-bbs2-0009" title="KroghTP , FredbergU , Stengaard‐PedersenK , ChristensenR , JensenP , EllingsenT . Treatment of lateral epicondylitis with platelet‐rich plasma, glucocorticoid, or saline: a randomized, double‐blind, placebo‐controlled trial. American Journal of Sports Medicine2013;41(3):625‐35. [DOI: 10.1177/0363546512472975] ">Krogh 2013</a> reported that four participants in the PRP group and three in the saline group contacted the institution due to concerns about persisting pain. </p> </section> </section> <section id="CD010071-sec-0102"> <h5 class="title">Anterior cruciate ligament (ACL) reconstruction</h5> <section id="CD010071-sec-0103"> <h6 class="title">Graft donor site</h6> <p>Two studies assessed the effects of PRP application at the patellar tendon donor site (<a href="./references#CD010071-bbs2-0001" title="AlmeidaAM . Platelet‐rich plasma in the regeneration of the patellar ligament after harvesting its central third: a prospective randomised study [Efeito do plasma rico em plaquetas na regeneração do terço central do ligamento da patela: estudo prospectivo randomizado] (Thesis). São Paulo: Universidade de São Paulo, Faculdade de Medicina, 2013. AlmeidaAM , DemangeMK , SobradoMF , RodriguesMB , PedrinelliA , HernandezAJ . Patellar tendon healing with platelet‐rich plasma. American Journal of Sports Medicine2012;40(6):1283‐8. ">Almeida 2012</a>; <a href="./references#CD010071-bbs2-0004" title="CervellinM , GirolamoL , BaitC , DentiM , VoltiP . Autologous platelet‐rich plasma gel to reduce donor‐site morbidity after patellar tendon graft harvesting for anterior cruciate ligamente reconstruction: a randomized, controlled clinical study. Knee Surgery, Sports Traumatology, Arthroscopy2012;20(1):114‐20. [DOI: 10.1007/s00167‐011‐1570‐5] ">Cervellin 2012</a>). Both studies added PRP to the site of patellar tendon defect after harvesting. The studies were very similar in their design and outcomes. In all, there were 67 participants, of whom 65 were assessed at follow‐up. These studies analysed function and pain scores and also had a specific analysis of MRI parameters, such as patellar tendon graft area measurements. <a href="./references#CD010071-bbs2-0001" title="AlmeidaAM . Platelet‐rich plasma in the regeneration of the patellar ligament after harvesting its central third: a prospective randomised study [Efeito do plasma rico em plaquetas na regeneração do terço central do ligamento da patela: estudo prospectivo randomizado] (Thesis). São Paulo: Universidade de São Paulo, Faculdade de Medicina, 2013. AlmeidaAM , DemangeMK , SobradoMF , RodriguesMB , PedrinelliA , HernandezAJ . Patellar tendon healing with platelet‐rich plasma. American Journal of Sports Medicine2012;40(6):1283‐8. ">Almeida 2012</a> found no difference in function at six‐month follow‐up, when based on Tegner scores (MD 0.30, 95% CI ‐0.72 to 1.32; see <a href="./references#CD010071-fig-0043" title="">Analysis 6.1</a>) or Lysholm scores (MD 0.40, 95% CI ‐7.32 to 8.12; see <a href="./references#CD010071-fig-0044" title="">Analysis 6.2</a>). In contrast, <a href="./references#CD010071-bbs2-0004" title="CervellinM , GirolamoL , BaitC , DentiM , VoltiP . Autologous platelet‐rich plasma gel to reduce donor‐site morbidity after patellar tendon graft harvesting for anterior cruciate ligamente reconstruction: a randomized, controlled clinical study. Knee Surgery, Sports Traumatology, Arthroscopy2012;20(1):114‐20. [DOI: 10.1007/s00167‐011‐1570‐5] ">Cervellin 2012</a> reported differences favouring the PRP group at one‐year follow‐up (MD 13.30, 95% CI 8.01 to 18.59; see <a href="./references#CD010071-fig-0045" title="">Analysis 6.3</a>). One study highlighted that the findings might demonstrate that PRP application may be of little relevance from the clinical perspective (<a href="./references#CD010071-bbs2-0001" title="AlmeidaAM . Platelet‐rich plasma in the regeneration of the patellar ligament after harvesting its central third: a prospective randomised study [Efeito do plasma rico em plaquetas na regeneração do terço central do ligamento da patela: estudo prospectivo randomizado] (Thesis). São Paulo: Universidade de São Paulo, Faculdade de Medicina, 2013. AlmeidaAM , DemangeMK , SobradoMF , RodriguesMB , PedrinelliA , HernandezAJ . Patellar tendon healing with platelet‐rich plasma. American Journal of Sports Medicine2012;40(6):1283‐8. ">Almeida 2012</a>). <a href="./references#CD010071-bbs2-0001" title="AlmeidaAM . Platelet‐rich plasma in the regeneration of the patellar ligament after harvesting its central third: a prospective randomised study [Efeito do plasma rico em plaquetas na regeneração do terço central do ligamento da patela: estudo prospectivo randomizado] (Thesis). São Paulo: Universidade de São Paulo, Faculdade de Medicina, 2013. AlmeidaAM , DemangeMK , SobradoMF , RodriguesMB , PedrinelliA , HernandezAJ . Patellar tendon healing with platelet‐rich plasma. American Journal of Sports Medicine2012;40(6):1283‐8. ">Almeida 2012</a> found lower pain scores in the PRP group in the first day after surgery (MD ‐1.30, 95% CI ‐2.23 to ‐0.37; see <a href="./references#CD010071-fig-0046" title="">Analysis 6.4</a>). The studies reported that there were no adverse effects or complications. </p> </section> <section id="CD010071-sec-0104"> <h6 class="title">Anterior cruciate ligament (ACL) reconstruction ‐ augmentation procedure</h6> <p>Four studies analysed the effects of PRP application during the ACL reconstruction procedure (<a href="./references#CD010071-bbs2-0011" title="OrregoM , LarrainC , RosalesJ , ValenzuelaL , MatasJ , DurrutyJ , et al. Effects of platelet concentrate and a bone plug on the healing of hamstring tendons in a bone tunnel. Arthroscopy2008;24(12):1373‐80. [DOI: 10.1016/j.arthro.2008.07.016] ">Orrego 2008</a>; <a href="./references#CD010071-bbs2-0016" title="VadalàA , IorioR , DeCarliA , FerrettiM , ParavaniD , CapernaL , et al. Platelet‐rich plasma: does it help reduce tunnel widening after ACL reconstruction?. Knee Surgery Sports Traumatology Arthroscopy2013;21(4):824‐9. [DOI: 10.1007/s00167‐012‐1980‐z] ">Vadalà 2013</a>; <a href="./references#CD010071-bbs2-0017" title="Valentí NínJR , GasqueGM , AzcárateAV , BeolaJD , GonzalezMH . Has platelet‐rich plasma any role in anterior cruciate ligament allograft healing?. Arthroscopy2009;25(11):1206‐13. [DOI: 10.1016/j.arthro.2009.06.002] ">Valenti Nín 2009</a>; <a href="./references#CD010071-bbs2-0018" title="VogrinM , RuprehtM , CrnjacA , DinevskiD , KrajncZ , RecnikG . The effect of platelet‐derived growth factors on knee stability after anterior cruciate ligament reconstruction: a prospective randomized clinical study. Wiener Klinische Wochenschrift2010;122(Suppl 2):91‐5. [DOI: 10.1007/s00508‐010‐1340‐2] ">Vogrin 2010</a>). There were 203 participants, but the data for five were lost. All studies reported the application of PRP to the knee bone tunnels or in the inner area of the graft, or both. No difference between groups was found for the IKDC (International Knee Documentation Committee) result at one year, either in the scores (MD ‐1.40, 95% CI ‐6.01 to 3.21; one trial; <i>see</i><a href="./references#CD010071-fig-0047" title="">Analysis 7.1</a>) or in the numbers of people with good or better results (94/96 versus 94/97; RR 1.01, 95% CI 0.96 to 1.07; see <a href="./references#CD010071-fig-0048" title="">Analysis 7.2</a>). <a href="./references#CD010071-bbs2-0016" title="VadalàA , IorioR , DeCarliA , FerrettiM , ParavaniD , CapernaL , et al. Platelet‐rich plasma: does it help reduce tunnel widening after ACL reconstruction?. Knee Surgery Sports Traumatology Arthroscopy2013;21(4):824‐9. [DOI: 10.1007/s00167‐012‐1980‐z] ">Vadalà 2013</a> also found no difference in the Lysholm scores (see <a href="./references#CD010071-fig-0049" title="">Analysis 7.3</a>). This trial specifically reported that there were no adverse effects associated with the procedure. </p> </section> </section> <section id="CD010071-sec-0105"> <h5 class="title">Patellar tendinopathy</h5> <p><a href="./references#CD010071-bbs2-0019" title="WasterlainA , DragooJ . Platelet‐rich plasma as a treatment for patellar tendinopathy: a double‐blind randomized controlled trial. Individual patient data (as supplied June 2013). Data on file. ">Wasterlain 2013</a> compared ultrasound‐guided application of PRP with dry needling control in 23 people with patellar tendinopathy. Three participants were lost to final follow‐up at six months. The protocol permitted participants to switch treatments if not satisfied, and analyses were performed on an intention‐to‐treat basis. Assessment at six months demonstrated that the dry needling participants tended towards higher VISA scores (MD ‐16.01, 95% CI ‐32.28 to 0.26; see <a href="./references#CD010071-fig-0050" title="">Analysis 8.1</a>), and Tegner scores (MD 0.60, 95% CI ‐2.44 to 1.24; <i>see</i><a href="./references#CD010071-fig-0051" title="">Analysis 8.2</a>). In contrast, Lysholm scores favoured PRP (MD 15.50, 95% CI 0.55 to 30.45; see <a href="./references#CD010071-fig-0052" title="">Analysis 8.3</a>). PRP group participants had less pain at six‐month follow‐up (MD 1.40, 95% CI 0.32 to 2.48; <i>see</i><a href="./references#CD010071-fig-0053" title="">Analysis 8.4</a>). No complications or adverse effects were found. No difference between groups was found for quality of life assessed using the SF‐12 (MD ‐1.60, 95% CI ‐5.66 to 2.46; see <a href="./references#CD010071-fig-0054" title="">Analysis 8.5</a>). As sample sizes were small, results from this study should be considered with caution. </p> </section> <section id="CD010071-sec-0106"> <h5 class="title">Chronic Achilles tendinopathy</h5> <p>One study compared PRP versus placebo (saline) injection in 54 participants with chronic Achilles tendinopathy (<a href="./references#CD010071-bbs2-0006" title="DeJongeS , DeVosRJ , WeirA , VanSchieHT , Bierma‐ZeinstraSM , VerhaarJA , et al. One‐year follow‐up of platelet‐rich plasma treatment in chronic Achilles tendinopathy. American Journal of Sports Medicine2011;39(8):1623‐9. deVosRJ , WeirA , TolJL , VerhaarJA , WeinansH , vanSchieHT . No effects of PRP on ultrasonographic tendon structure and neovascularization in chronic midportion Achilles tendinopathy. British Journal of Sports Medicine2011;45(5):387‐92. [DOI: 10.1136/bjsm.2010.076398] deVosRJ , WeirA , vanSchieHT , Bierma‐ZeinstraSM , VerhaarJA , WeinansH , et al. Platelet‐rich plasma injection for chronic Achilles tendinopathy. JAMA2010;303(2):144‐9. ">De Vos 2010</a>); both groups received eccentric exercises. No participants were lost during the follow‐up period. The authors stated a priori that a 12‐point difference in VISA‐A scores was the relevant difference to be detected. </p> <p><a href="./references#CD010071-bbs2-0006" title="DeJongeS , DeVosRJ , WeirA , VanSchieHT , Bierma‐ZeinstraSM , VerhaarJA , et al. One‐year follow‐up of platelet‐rich plasma treatment in chronic Achilles tendinopathy. American Journal of Sports Medicine2011;39(8):1623‐9. deVosRJ , WeirA , TolJL , VerhaarJA , WeinansH , vanSchieHT . No effects of PRP on ultrasonographic tendon structure and neovascularization in chronic midportion Achilles tendinopathy. British Journal of Sports Medicine2011;45(5):387‐92. [DOI: 10.1136/bjsm.2010.076398] deVosRJ , WeirA , vanSchieHT , Bierma‐ZeinstraSM , VerhaarJA , WeinansH , et al. Platelet‐rich plasma injection for chronic Achilles tendinopathy. JAMA2010;303(2):144‐9. ">De Vos 2010</a> found no difference between the two groups in function assessed using VISA‐A score in the short term (six weeks: see <a href="./references#CD010071-fig-0055" title="">Analysis 9.1</a>), medium term (six months: see <a href="./references#CD010071-fig-0056" title="">Analysis 9.2</a>) and long term (one year: see <a href="./references#CD010071-fig-0057" title="">Analysis 9.3</a>). Similar numbers of participants in the two groups indicated they were satisfied with their outcome in the medium‐term (<i>see</i><a href="./references#CD010071-fig-0058" title="">Analysis 9.4</a>) and long‐term (<i>see</i><a href="./references#CD010071-fig-0059" title="">Analysis 9.5</a>). Return to sports was also similar in the two groups at medium‐term (see <a href="./references#CD010071-fig-0060" title="">Analysis 9.6</a>) and long‐term follow‐up (<i>see</i><a href="./references#CD010071-fig-0061" title="">Analysis 9.7</a>). </p> </section> <section id="CD010071-sec-0107"> <h5 class="title">Acute Achilles tendon rupture (surgical repair)</h5> <p>One study compared PRP application in acute surgical repair of acute Achilles tendon ruptures in 30 participants (<a href="./references#CD010071-bbs2-0014" title="SchepullT , KvistJ , NorrmanH , TrinksM , BerlinG , AspenbergP . Autologous platelet have no effect on the healing of human achilles tendon ruptures: a randomized single‐blind study. American Journal of Sports Medicine2011;39(1):38‐47. [DOI: 10.1177/0363546510383515] ">Schepull 2010</a>), four of whom were lost to follow‐up at one‐year follow‐up. Assessment of function was based on the heel‐raise index, a validated test used to evaluate calf muscle function. There was no difference between the PRP and no PRP groups in the heel‐raise index results at 19‐week follow‐up (MD ‐9.00, 95% CI ‐23.10 to 5.10; <i>see</i><a href="./references#CD010071-fig-0062" title="">Analysis 10.1</a>), or at one year (MD 2.00, 95% CI ‐17.22 to 21.22; <i>see</i><a href="./references#CD010071-fig-0063" title="">Analysis 10.2</a>). The authors reported two complications in the PRP group, one re‐rupture and one deep infection, and no complications with the controls (RR 4.41, 95% CI 0.23 to 84.79; see <a href="./references#CD010071-fig-0064" title="">Analysis 10.3</a>). This study also looked at the influence of PRP on the mechanical properties of the tendon using tantalum beads as landmarks for three‐dimensional radiographic studies; these results are not reported here. </p> </section> </section> <section id="CD010071-sec-0108"> <h4 class="title">Sensitivity analyses</h4> <p>Three trials were considered to be at high risk of selection bias from failure to conceal allocation. Two were quasi‐randomised (<a href="./references#CD010071-bbs2-0011" title="OrregoM , LarrainC , RosalesJ , ValenzuelaL , MatasJ , DurrutyJ , et al. Effects of platelet concentrate and a bone plug on the healing of hamstring tendons in a bone tunnel. Arthroscopy2008;24(12):1373‐80. [DOI: 10.1016/j.arthro.2008.07.016] ">Orrego 2008</a>; <a href="./references#CD010071-bbs2-0018" title="VogrinM , RuprehtM , CrnjacA , DinevskiD , KrajncZ , RecnikG . The effect of platelet‐derived growth factors on knee stability after anterior cruciate ligament reconstruction: a prospective randomized clinical study. Wiener Klinische Wochenschrift2010;122(Suppl 2):91‐5. [DOI: 10.1007/s00508‐010‐1340‐2] ">Vogrin 2010</a>), and envelopes were opened three days before surgery in the third trial (<a href="./references#CD010071-bbs2-0008" title="GuminaS , CampagnaV , FerrazzaG , GiannicolaG , FratalocchiF , MilaniA , et al. Use of platelet‐leukocyte membrane in arthroscopic repair of large rotator cuff tears. Journal of Bone and Joint Surgery ‐ American Volume2012;94(15):1345‐52. [DOI: 10.2106/JBJS.K.00394] ">Gumina 2012</a>). Both quasi‐RCTs assessed ACL reconstruction, but data were available from <a href="./references#CD010071-bbs2-0011" title="OrregoM , LarrainC , RosalesJ , ValenzuelaL , MatasJ , DurrutyJ , et al. Effects of platelet concentrate and a bone plug on the healing of hamstring tendons in a bone tunnel. Arthroscopy2008;24(12):1373‐80. [DOI: 10.1016/j.arthro.2008.07.016] ">Orrego 2008</a> only. Removing this trial from <a href="./references#CD010071-fig-0048" title="">Analysis 7.2</a> did not affect the result: the RR changed from 1.01 (95% CI 0.96 to 1.07) to 1.03 (95% CI 0.97 to 1.09). <a href="./references#CD010071-bbs2-0008" title="GuminaS , CampagnaV , FerrazzaG , GiannicolaG , FratalocchiF , MilaniA , et al. Use of platelet‐leukocyte membrane in arthroscopic repair of large rotator cuff tears. Journal of Bone and Joint Surgery ‐ American Volume2012;94(15):1345‐52. [DOI: 10.2106/JBJS.K.00394] ">Gumina 2012</a>, one of the rotator cuff repair trials, was more influential. Removing this trial from <a href="./references#CD010071-fig-0005" title="">Analysis 1.3</a> changed the pooled result from SMD 0.25 (95% CI ‐0.07 to 0.57) to SMD 0.20 (95% CI ‐0.15 to 0.56); removing it from the augmentation procedures in <a href="./references#CD010071-fig-0012" title="">Analysis 2.3</a> changed the result from SMD 0.28 (95% CI ‐0.08 to 0.64) to SMD 0.23 (95% CI ‐0.18 to 0.63); and removing it from <a href="./references#CD010071-fig-0025" title="">Analysis 3.9</a> changed the result from SMD 0.29 (95% CI ‐0.01 to 0.60) to SMD 0.21 (95% CI ‐0.13 to 0.55). </p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD010071-sec-0109" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD010071-sec-0109"></div> <p>This comprehensive systematic review aimed to assess the use of PRT as a treatment option for musculoskeletal soft tissue injuries. From the clinical perspective, there are questions regarding its clinical effectiveness and the possibility of adverse effects. Hence, this review and its focus on these key clinical endpoints. </p> <section id="CD010071-sec-0110"> <h3 class="title" id="CD010071-sec-0110">Summary of main results</h3> <p>We included data on 1088 participants from 19 small single‐centre trials (17 randomised and two quasi‐randomised) that compared platelet‐rich therapy (PRT) with placebo, autologous whole blood, dry needling or no platelet‐rich therapy. These 19 trials covered eight clinical conditions: rotator cuff tears (arthroscopic repair) (six trials); shoulder impingement syndrome surgery (one trial); elbow epicondylitis (three trials); anterior cruciate ligament (ACL) reconstruction (four trials): hamstrings autologous graft (three trials), patellar tendon autologous graft (one trial)), ACL reconstruction (donor graft site application ‐ patellar tendon autologous graft) (two trials), patellar tendinopathy (one trial), Achilles tendinopathy (one trial) and acute Achilles rupture surgical repair (one trial). There were no trials available that evaluated PRT for sprains or muscle injuries; however, trial results will be available soon (see <a href="./references#CD010071-bbs1-0003" title="">Ongoing studies</a>). In our overall analyses, which compared PRT versus control (no PRT, autologous whole blood, dry needling or placebo), we presented the results subgrouped by these eight conditions. For function and pain, we presented separate results for short‐term (up to three months); medium‐term (usually six months) and long‐term (usually one year). </p> <p>The results for function were available for a maximum of 45% of the participants included in the review and usually far less. These showed no statistically significant differences between the PRT and no PRT (control) in short‐term function (P value 0.26; 162 participants, four trials), in medium‐term function (P value 0.72; 151 participants, five trials) and in long‐term function (P value 0.12; 484 participants, 10 trials). In each case, the 95% confidence intervals indicated the possibility of a poorer outcome in the PRT group up to a moderate difference in favour of PRT at both short‐ and long‐term follow‐up. In all three analyses, the results of the individual trials were statistically heterogeneous, and significantly so at long‐term follow‐up. Sensitivity analyses where single outlier trials were removed showed the lack of robustness of these findings (with the effect moving closer to the null), as did the removal of the results for one trial at a high risk of selection bias. The interpretation of the SMD results is hampered by the variety of condition‐ or limb‐specific functional scores. However, based on the finding of clinically insignificant findings from the pooled results of five rotator cuff repair trials reporting Constant scores at long‐term follow‐up as a guide (MD 2.47, CI 95% 0.68 to 4.26; see <a href="./references#CD010071-fig-0017" title="">Analysis 3.1</a>), it is unlikely that the upper limit of the 95% confidence interval for long‐term function (0.57) and, by corollary, that of short‐term function (0.71), translates to a clinically important difference. This impression is reinforced when the SMD results (random‐effects) of these five trials are viewed using the same data as in <a href="./references#CD010071-fig-0017" title="">Analysis 3.1</a> (SMD 0.25, 95% CI ‐0.10 to 0.61; not shown). </p> <p>Homogenous data pooled from four trials, and three conditions, showed a small reduction in short‐term pain in favour of PRT; however, the clinical significance of a mean 0.95 difference in a 10‐point visual analogue scale (VAS) is marginal. Four of the 11 trials reporting on adverse outcomes reported a total of 12 adverse effects, with no significant difference between groups in the pooled result. Seven of these adverse effects were concerns about persisting pain that led to clinical contact in one trial. </p> <p>Subgrouping by PRT therapy for tendinopathies (five trials) and surgical augmentation procedures (14 trials) was more revealing in the distribution of results in the analyses (with tendinopathies dominating short‐term and medium‐term function analyses, and augmentation dominating the long‐term analysis) and the substantial heterogeneity in the results of the trials within each subgroup. Where pooled, the results of trials in each category did not differ markedly from the overall findings. </p> <p>Overall, the available evidence is insufficient to indicate whether the effects of PRT will differ importantly in individual clinical conditions. Primary outcome data could be pooled for just two individual conditions: rotator cuff tears (arthroscopic repair) (six trials) and elbow epicondylitis (three trials). The results for the former were heterogenous; the pooled results for long‐term function for all six trials showed no statistically or clinically significant differences between the two groups (324 participants). The results of the elbow epicondylitis trials were also heterogeneous. Pooled results from two trials showed no statistically or clinically significant differences between the two groups (151 participants) in short‐term function. (Change score data only were available for the largest trial; this precluded pooling with final score short‐term and medium‐term function data from the other trials on this condition.) </p> </section> <section id="CD010071-sec-0111"> <h3 class="title" id="CD010071-sec-0111">Overall completeness and applicability of evidence</h3> <p>The current evidence base on which to decide whether to use PRT for treating musculoskeletal injuries is weak, as it consists of 19 small single‐centre studies reporting a variety of outcome measures, several of which were not directly relevant to clinical outcomes. In particular, several trials reported on the effects of PRT on tissue healing by the use of imaging methods, such as magnetic resonance imaging (MRI) or ultrasound. However, as the relationship between these outcomes and symptoms or function is unclear, we have not reported these findings in this review. We focused on outcomes of direct relevance to patients required to assess whether PRT actually works in practice. </p> <p>Overall, data from less than half of the 1088 trial participants were included in any analysis. </p> <p>These trials covered a variety of conditions, which could be subgrouped according to whether PRT was used as the main treatment for tendinopathies or as a surgical augmentation procedure. These groups could be subgrouped also into eight clinical conditions. In general, the demographic characteristics, such as gender, age and sports activity level of the trial participants in these eight categories were representative. However, caution is still required as the available evidence for each category may not be applicable overall, given the clinical variation within them, for example complete versus partial rotator cuff tears and acute versus chronic tendinopathies. </p> <p>As well as clinical heterogeneity in the review population, there was heterogeneity in the application of PRT. It is possible that the effectiveness of the intervention may vary depending on how the platelet‐rich plasma (PRP) is prepared, but currently there is no consensus regarding standardisation for research or clinical use. There are several preparation methods for platelet products, which are likely to be a source of heterogeneity for the assessment and comparison of the effectiveness of PRT. Additionally, some of the proposed protocols lacked documented a priori validation (<a href="./references#CD010071-bbs2-0047" title="Dohan EhrenfestDM , RasmussonL , AlbrektssonT . Classification of platelet concentrates: from pure platelet‐rich plasma (P‐PRP) to leucocyte‐ and platelet‐rich fibrin (L‐PRF). Trends in Biotechnology2009;27(3):158‐67. ">Dohan 2009</a>; <a href="./references#CD010071-bbs2-0043" title="DeLongJM , RusselRP , MazzoccaAD . Platelet‐rich plasma: the PAW classification system. Arthroscopy2012;28(7):998‐1009. ">De Long 2012</a>). A specific explanation of these difficulties and differences can be found in the literature (<a href="./references#CD010071-bbs2-0043" title="DeLongJM , RusselRP , MazzoccaAD . Platelet‐rich plasma: the PAW classification system. Arthroscopy2012;28(7):998‐1009. ">De Long 2012</a>; <a href="./references#CD010071-bbs2-0047" title="Dohan EhrenfestDM , RasmussonL , AlbrektssonT . Classification of platelet concentrates: from pure platelet‐rich plasma (P‐PRP) to leucocyte‐ and platelet‐rich fibrin (L‐PRF). Trends in Biotechnology2009;27(3):158‐67. ">Dohan 2009</a>; <a href="./references#CD010071-bbs2-0048" title="Council of Europe. Guide to the preparation, use and quality assurance of blood components. 13th Edition. Strasbourg, France: Council of Europe, 2007. ">Europe 2007</a>); however, this is based mostly on empirical evidence and basic science studies. While conceptually, PRT is supposed to enhance healing, it is possible that various platelet‐rich products, including those applied in the included trials, have different biological mechanisms. This again undermines a more general application. </p> <p>While doing this review, we decided to extend our acceptable controls to include autologous whole blood and dry needling, as used in two elbow tendinopathy studies. Both these interventions are aimed at increasing the blood available at the injured site and thus do not meet the characteristics of a placebo fully. However, they can still be considered to be a control, given that PRT is an 'improved' fraction of whole blood in terms of the concentration of growth factors. We did not include pharmacological controls such as steroids (<a href="./references#CD010071-bbs2-0063" title="PeerboomsJC , SluimerJ , BruijnDJ , GosensT . Positive effect of an autologous platelet concentrate in lateral epicondylitis in a double‐blind randomized controlled trial: platelet‐rich plasma versus corticosteroid injection with a 1‐year follow‐up. American Journal of Sports Medicine2010;38(2):255‐62. ">Peerbooms 2010</a>), which would change the question to a comparison between two 'active' interventions. We have now made this exclusion explicit in <a href="#CD010071-sec-0032">Types of interventions</a>. </p> <p>The timing and duration of expected benefit of PRT should also be considered when considering the plausibility of the results. For instance: would any early improvement be expected to persist? At any rate, the potential for a small, but clinically marginal effect, in favour of PRT for short‐term pain is of questionable value in the context of the lack of evidence in favour of PRT for short‐term or long‐term function. </p> </section> <section id="CD010071-sec-0112"> <h3 class="title" id="CD010071-sec-0112">Quality of the evidence</h3> <p>This is discussed for the overall population only. The quality of the evidence available for all primary outcomes for which data were pooled (short‐term function, long‐term function, short‐term pain and adverse effects) was downgraded three levels in each case: one for limitations in design and implementation that related to potential risk of bias, often selective reporting bias (discussed below); one for inconsistency of results in terms of the variety in conditions under test but also the lack of standardisation in the PRT intervention (discussed further below); and one because most studies included in the review did not contribute to the outcome. Thus overall we judged the evidence to be of very low quality, which indicates that we are very uncertain about the estimates for all outcomes. </p> <p>Randomisation methodologies and allocation concealment were adequate in most of the trials, but there were some key methodological concerns regarding this clinically heterogeneous group of trials that assessed a wide variety of conditions. Despite the fact we were assessing recent research (participants recruited after 2005), many studies had not made public an a priori research protocol or trial registration document. The latter are important for research transparency and, on particular, help identify and probably reduce selective reporting. It is possible, that selective reporting may result in researchers not reporting adverse effects, or reporting imaging analysis or other surrogate outcomes that tend not to have a clear relation to functional status. </p> <p>A major concern particular to PRP research is the methodology for its preparation. There are a wide variety of PRP preparation protocols. Studies used different preparation methodologies with mostly minor, and occasionally major, modifications from preparation instructions derived from specific commercial kits. In addition, classification proposals of platelet‐rich products are available (<a href="./references#CD010071-bbs2-0043" title="DeLongJM , RusselRP , MazzoccaAD . Platelet‐rich plasma: the PAW classification system. Arthroscopy2012;28(7):998‐1009. ">De Long 2012</a>; <a href="./references#CD010071-bbs2-0047" title="Dohan EhrenfestDM , RasmussonL , AlbrektssonT . Classification of platelet concentrates: from pure platelet‐rich plasma (P‐PRP) to leucocyte‐ and platelet‐rich fibrin (L‐PRF). Trends in Biotechnology2009;27(3):158‐67. ">Dohan 2009</a>; <a href="./references#CD010071-bbs2-0048" title="Council of Europe. Guide to the preparation, use and quality assurance of blood components. 13th Edition. Strasbourg, France: Council of Europe, 2007. ">Europe 2007</a>) and have demonstrated from the clinical science perspective that the effectiveness of these products may be strongly linked to three key items: 1) the absolute number of platelets, 2) the manner in which platelet activation occurs, and 3) the presence or absence of white cells. We have described the PRP preparation protocols in each of the studies in the <a href="#CD010071-sec-0053">Description of studies</a> section. Other variations that were also recognised include the time span between the PRP preparation and delivery (studies varied from the night before the procedure to intraoperative preparation); the method of PRP delivery, such as image‐guided, arthroscope‐guided, direct vision‐guided or no guidance; the number of PRP applications; and post‐operative interventions (casting, anti‐inflammatory drugs). The variation in these methodologies among the trials reduces the quality of the evidence. </p> </section> <section id="CD010071-sec-0113"> <h3 class="title" id="CD010071-sec-0113">Potential biases in the review process</h3> <p>A comprehensive search strategy with no language restriction was conducted. Handsearching from retrieved studies and other available systematic reviews confirmed our trial findings. Nevertheless, we have some concerns that some studies may have been missed during the review process. Since PRP is a novel therapy with ongoing studies, it is possible that we might have missed some new relevant research. As a safeguard, we have contacted well known researchers in the area twice (authors of narrative reviews, researchers who conducted non randomised trials and contacts from trial registry database). We have received some feedback declaring that no new research is being conducted by them and also from authors declaring that they have been conducting clinical trials, however, no data are, as yet, available. We also made contact with authors who did not provide data after declaring that research assessments were finished. Some authors were contacted to provide some additional data (<a href="./references#CD010071-bbs2-0001" title="AlmeidaAM . Platelet‐rich plasma in the regeneration of the patellar ligament after harvesting its central third: a prospective randomised study [Efeito do plasma rico em plaquetas na regeneração do terço central do ligamento da patela: estudo prospectivo randomizado] (Thesis). São Paulo: Universidade de São Paulo, Faculdade de Medicina, 2013. AlmeidaAM , DemangeMK , SobradoMF , RodriguesMB , PedrinelliA , HernandezAJ . Patellar tendon healing with platelet‐rich plasma. American Journal of Sports Medicine2012;40(6):1283‐8. ">Almeida 2012</a>; <a href="./references#CD010071-bbs2-0009" title="KroghTP , FredbergU , Stengaard‐PedersenK , ChristensenR , JensenP , EllingsenT . Treatment of lateral epicondylitis with platelet‐rich plasma, glucocorticoid, or saline: a randomized, double‐blind, placebo‐controlled trial. American Journal of Sports Medicine2013;41(3):625‐35. [DOI: 10.1177/0363546512472975] ">Krogh 2013</a>; <a href="./references#CD010071-bbs2-0010" title="MalavoltaE , Ferreira NetoAA . Platelet rich plasma on arthroscopic repair of the complete rotator cuff lesions: a prospective and randomized study. http://clinicaltrials.gov/ct2/show/NCT01029574 (accessed 26 August 2013). MoraesV . Personal communication. Email to: E Malavolta. ">NCT01029574</a>), but <a href="./references#CD010071-bbs2-0009" title="KroghTP , FredbergU , Stengaard‐PedersenK , ChristensenR , JensenP , EllingsenT . Treatment of lateral epicondylitis with platelet‐rich plasma, glucocorticoid, or saline: a randomized, double‐blind, placebo‐controlled trial. American Journal of Sports Medicine2013;41(3):625‐35. [DOI: 10.1177/0363546512472975] ">Krogh 2013</a> did not provide this, as the trialists considered that raw data should not be circulated. <a href="./references#CD010071-bbs2-0001" title="AlmeidaAM . Platelet‐rich plasma in the regeneration of the patellar ligament after harvesting its central third: a prospective randomised study [Efeito do plasma rico em plaquetas na regeneração do terço central do ligamento da patela: estudo prospectivo randomizado] (Thesis). São Paulo: Universidade de São Paulo, Faculdade de Medicina, 2013. AlmeidaAM , DemangeMK , SobradoMF , RodriguesMB , PedrinelliA , HernandezAJ . Patellar tendon healing with platelet‐rich plasma. American Journal of Sports Medicine2012;40(6):1283‐8. ">Almeida 2012</a> and <a href="./references#CD010071-bbs2-0010" title="MalavoltaE , Ferreira NetoAA . Platelet rich plasma on arthroscopic repair of the complete rotator cuff lesions: a prospective and randomized study. http://clinicaltrials.gov/ct2/show/NCT01029574 (accessed 26 August 2013). MoraesV . Personal communication. Email to: E Malavolta. ">NCT01029574</a> provided their doctoral theses as the source of data and the author of <a href="./references#CD010071-bbs2-0010" title="MalavoltaE , Ferreira NetoAA . Platelet rich plasma on arthroscopic repair of the complete rotator cuff lesions: a prospective and randomized study. http://clinicaltrials.gov/ct2/show/NCT01029574 (accessed 26 August 2013). MoraesV . Personal communication. Email to: E Malavolta. ">NCT01029574</a> is currently preparing his research for publication. <a href="./references#CD010071-bbs2-0019" title="WasterlainA , DragooJ . Platelet‐rich plasma as a treatment for patellar tendinopathy: a double‐blind randomized controlled trial. Individual patient data (as supplied June 2013). Data on file. ">Wasterlain 2013</a> has also provided data prior to publication elsewhere. </p> <p>Where possible, we followed the methods in our protocol. All key changes are listed in <a href="#CD010071-sec-0137">Differences between protocol and review</a>. As stated above, these changes included extending our acceptable controls to include autologous whole blood and dry needling, but also clarifying that other active agents (such as steroid injections) were not acceptable controls. </p> </section> <section id="CD010071-sec-0114"> <h3 class="title" id="CD010071-sec-0114">Agreements and disagreements with other studies or reviews</h3> <p>We found some narrative reviews and three systematic reviews that partially (<a href="./references#CD010071-bbs2-0041" title="ChahalJ , VanThielGS , MallN , HeardW , BachBR , ColeBJ , et al. The role of platelet‐rich plasma in arthroscopic rotator cuff repair: a systematic review with quantitative synthesis. Arthroscopy2012;28(11):1718‐27. ">Chahal 2012</a>; <a href="./references#CD010071-bbs2-0070" title="TaylorDW , PetreraM , HendryM , TheodoropoulosJS . A systematic review of the use of platelet‐rich plasma in sports medicine as a new treatment for tendon and ligament injuries. Clinical Journal of Sport Medicine2011;21(4):344‐52. ">Taylor 2011</a>), or considerably (<a href="./references#CD010071-bbs2-0068" title="ShethU , SimunovicN , KleinG , FuF , EinhornTA , SchemitschE , et al. Efficacy of autologous platelet‐rich plasma use for orthopaedic indications: a meta‐analysis. Journal of Bone and Joint Surgery ‐American Volume2012;94(4):298‐07. ">Sheth 2012</a>), overlapped with our analysis. All of these reviews focused on functional outcomes, such as pain and functional scores, but included studies other than randomised trials. </p> <p><a href="./references#CD010071-bbs2-0041" title="ChahalJ , VanThielGS , MallN , HeardW , BachBR , ColeBJ , et al. The role of platelet‐rich plasma in arthroscopic rotator cuff repair: a systematic review with quantitative synthesis. Arthroscopy2012;28(11):1718‐27. ">Chahal 2012</a> conducted a systematic review that assessed PRP as an augmentation procedure after full‐thickness rotator cuff repair. The authors included randomised controlled trials and cohort studies with a minimum one‐year follow‐up assessment. The authors stated that their a priori hypothesis was that PRP has no effect on the rate of retears or improvement in functional status. The authors included five studies in their analysis, two of which were RCTs included in our review. Using the Detsky scale for quality assessment, the authors described the included studies as high quality. No differences between groups were found for functional assessments or overall rates of retear. Subgroup analysis suggested that there were lower rates of retear for small to medium tears in the PRP group. As in our assessment, the authors highlighted the clinical heterogeneity of the included studies, such as the tear patterns (size, number of involved tendons), surgical technique implemented (single versus double row fixation) and PRP preparation methodology. </p> <p><a href="./references#CD010071-bbs2-0068" title="ShethU , SimunovicN , KleinG , FuF , EinhornTA , SchemitschE , et al. Efficacy of autologous platelet‐rich plasma use for orthopaedic indications: a meta‐analysis. Journal of Bone and Joint Surgery ‐American Volume2012;94(4):298‐07. ">Sheth 2012</a> conducted a systematic review that assessed PRP for 'orthopaedic indications' and therefore included a broader range of conditions than our review. The authors opted to include studies other than randomised trials, such as cohort studies, and also included trials with corticosteroid control groups. They searched for pain, function and healing endpoints and included 33 studies, 23 of which were randomised controlled studies. Quality assessment used the GRADE approach that resulted in assessments of 'very low' quality for all but one of the studies. Pooled analysis for pain scores demonstrated no benefit of PRP in all time frames or in dedicated analysis for RCTs and non RCTs. The authors have highlighted the same difficulties that we found in summarising the results due to the heterogeneity of conditions and autologous blood products. They also advised that trials of larger sample sizes would be required to detect minimally important differences in pain and function. </p> <p><a href="./references#CD010071-bbs2-0070" title="TaylorDW , PetreraM , HendryM , TheodoropoulosJS . A systematic review of the use of platelet‐rich plasma in sports medicine as a new treatment for tendon and ligament injuries. Clinical Journal of Sport Medicine2011;21(4):344‐52. ">Taylor 2011</a> performed a systematic review that included tendon and ligament injuries. The authors included both randomised and non randomised studies. No quality assessment was performed. The authors highlighted the difference in PRP terminology as well as demonstrating concerns about the preparation methodology. They also assessed platelet quantification. The authors did not perform quantitative synthesis and stated in their results that PRP generally has no effect compared with other treatments. Despite this, the authors concluded that PRP has "several potential advantages" such as "faster recovery"  and '"possibly, a reduction in recurrence". </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD010071-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/urn:x-wiley:14651858:media:CD010071:CD010071-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_t/tCD010071-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram" data-id="CD010071-fig-0001" src="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/full#CD010071-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010071-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/urn:x-wiley:14651858:media:CD010071:CD010071-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_t/tCD010071-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study" data-id="CD010071-fig-0002" src="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/full#CD010071-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010071-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/urn:x-wiley:14651858:media:CD010071:CD010071-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_t/tCD010071-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 PRT versus control: all conditions, Outcome 1 Function (all scores/instruments): short term (up to 3 months follow‐up)." data-id="CD010071-fig-0003" src="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 PRT versus control: all conditions, Outcome 1 Function (all scores/instruments): short term (up to 3 months follow‐up). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/references#CD010071-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010071-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/urn:x-wiley:14651858:media:CD010071:CD010071-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_t/tCD010071-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 PRT versus control: all conditions, Outcome 2 Function (all scores/instruments): medium term (over 3 months, under 1 year follow‐up)." data-id="CD010071-fig-0004" src="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 PRT versus control: all conditions, Outcome 2 Function (all scores/instruments): medium term (over 3 months, under 1 year follow‐up). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/references#CD010071-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010071-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/urn:x-wiley:14651858:media:CD010071:CD010071-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_t/tCD010071-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 PRT versus control: all conditions, Outcome 3 Functional (all scores/instruments): long term (1 year or more follow‐up)." data-id="CD010071-fig-0005" src="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 PRT versus control: all conditions, Outcome 3 Functional (all scores/instruments): long term (1 year or more follow‐up). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/references#CD010071-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010071-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/urn:x-wiley:14651858:media:CD010071:CD010071-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_t/tCD010071-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 PRT versus control: all conditions, Outcome 4 Pain (VAS: 0 to 10: worst pain): short term (up to 3 months follow‐up)." data-id="CD010071-fig-0006" src="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 PRT versus control: all conditions, Outcome 4 Pain (VAS: 0 to 10: worst pain): short term (up to 3 months follow‐up). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/references#CD010071-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010071-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/urn:x-wiley:14651858:media:CD010071:CD010071-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_t/tCD010071-CMP-001-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 PRT versus control: all conditions, Outcome 5 Pain (VAS: 0 to 10: worst pain): medium term (over 3 months, under 1 year follow‐up)." data-id="CD010071-fig-0007" src="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 PRT versus control: all conditions, Outcome 5 Pain (VAS: 0 to 10: worst pain): medium term (over 3 months, under 1 year follow‐up). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/references#CD010071-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010071-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/urn:x-wiley:14651858:media:CD010071:CD010071-CMP-001-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_t/tCD010071-CMP-001-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 PRT versus control: all conditions, Outcome 6 Pain (VAS: 0 to 10: worst pain): long term (1 year or more follow‐up)." data-id="CD010071-fig-0008" src="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-CMP-001-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 PRT versus control: all conditions, Outcome 6 Pain (VAS: 0 to 10: worst pain): long term (1 year or more follow‐up). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/references#CD010071-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-CMP-001-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010071-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/urn:x-wiley:14651858:media:CD010071:CD010071-CMP-001-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_t/tCD010071-CMP-001-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 PRT versus control: all conditions, Outcome 7 Adverse effects (any of PRT or placebo application)." data-id="CD010071-fig-0009" src="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-CMP-001-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1 PRT versus control: all conditions, Outcome 7 Adverse effects (any of PRT or placebo application). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/references#CD010071-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-CMP-001-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010071-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/urn:x-wiley:14651858:media:CD010071:CD010071-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_t/tCD010071-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 PRT versus control: subgrouped by tendinopathies and augmentation procedures, Outcome 1 Function (all scores/instruments): short term (up to 3 months follow‐up)." data-id="CD010071-fig-0010" src="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 PRT versus control: subgrouped by tendinopathies and augmentation procedures, Outcome 1 Function (all scores/instruments): short term (up to 3 months follow‐up). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/references#CD010071-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010071-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/urn:x-wiley:14651858:media:CD010071:CD010071-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_t/tCD010071-CMP-002-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 PRT versus control: subgrouped by tendinopathies and augmentation procedures, Outcome 2 Function (all scores/instruments): medium term (over 3 months, under 1 year follow‐up)." data-id="CD010071-fig-0011" src="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 PRT versus control: subgrouped by tendinopathies and augmentation procedures, Outcome 2 Function (all scores/instruments): medium term (over 3 months, under 1 year follow‐up). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/references#CD010071-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010071-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/urn:x-wiley:14651858:media:CD010071:CD010071-CMP-002-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_t/tCD010071-CMP-002-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 PRT versus control: subgrouped by tendinopathies and augmentation procedures, Outcome 3 Functional (all scores/instruments): long term (1 year or more follow‐up)." data-id="CD010071-fig-0012" src="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-CMP-002-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2 PRT versus control: subgrouped by tendinopathies and augmentation procedures, Outcome 3 Functional (all scores/instruments): long term (1 year or more follow‐up). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/references#CD010071-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-CMP-002-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010071-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/urn:x-wiley:14651858:media:CD010071:CD010071-CMP-002-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_t/tCD010071-CMP-002-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 PRT versus control: subgrouped by tendinopathies and augmentation procedures, Outcome 4 Pain (VAS: 0 to 10: worst pain): short term (up to 3 months follow‐up)." data-id="CD010071-fig-0013" src="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-CMP-002-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2 PRT versus control: subgrouped by tendinopathies and augmentation procedures, Outcome 4 Pain (VAS: 0 to 10: worst pain): short term (up to 3 months follow‐up). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/references#CD010071-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-CMP-002-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010071-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/urn:x-wiley:14651858:media:CD010071:CD010071-CMP-002-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_t/tCD010071-CMP-002-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 PRT versus control: subgrouped by tendinopathies and augmentation procedures, Outcome 5 Pain (VAS: 0 to 10: worst pain): medium term (over 3 months, under 1 year follow‐up." data-id="CD010071-fig-0014" src="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-CMP-002-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.5</div> <div class="figure-caption"> <p>Comparison 2 PRT versus control: subgrouped by tendinopathies and augmentation procedures, Outcome 5 Pain (VAS: 0 to 10: worst pain): medium term (over 3 months, under 1 year follow‐up. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/references#CD010071-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-CMP-002-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010071-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/urn:x-wiley:14651858:media:CD010071:CD010071-CMP-002-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_t/tCD010071-CMP-002-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 PRT versus control: subgrouped by tendinopathies and augmentation procedures, Outcome 6 Pain (VAS: 0 to 10: worst pain): long term (1 year or more follow‐up)." data-id="CD010071-fig-0015" src="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-CMP-002-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.6</div> <div class="figure-caption"> <p>Comparison 2 PRT versus control: subgrouped by tendinopathies and augmentation procedures, Outcome 6 Pain (VAS: 0 to 10: worst pain): long term (1 year or more follow‐up). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/references#CD010071-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-CMP-002-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010071-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/urn:x-wiley:14651858:media:CD010071:CD010071-CMP-002-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_t/tCD010071-CMP-002-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 PRT versus control: subgrouped by tendinopathies and augmentation procedures, Outcome 7 Adverse effects (any of PRT pr placebo application." data-id="CD010071-fig-0016" src="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-CMP-002-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.7</div> <div class="figure-caption"> <p>Comparison 2 PRT versus control: subgrouped by tendinopathies and augmentation procedures, Outcome 7 Adverse effects (any of PRT pr placebo application. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/references#CD010071-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-CMP-002-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010071-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/urn:x-wiley:14651858:media:CD010071:CD010071-CMP-003-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_t/tCD010071-CMP-003-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 PRT versus control: Rotator cuff tears (surgical repair), Outcome 1 Function (Constant score): long term (1 year follow‐up)." data-id="CD010071-fig-0017" src="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-CMP-003-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3 PRT versus control: Rotator cuff tears (surgical repair), Outcome 1 Function (Constant score): long term (1 year follow‐up). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/references#CD010071-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-CMP-003-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010071-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/urn:x-wiley:14651858:media:CD010071:CD010071-CMP-003-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_t/tCD010071-CMP-003-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 PRT versus control: Rotator cuff tears (surgical repair), Outcome 2 Function (Constant score): long term (2 year follow‐up)." data-id="CD010071-fig-0018" src="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-CMP-003-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3 PRT versus control: Rotator cuff tears (surgical repair), Outcome 2 Function (Constant score): long term (2 year follow‐up). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/references#CD010071-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-CMP-003-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010071-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/urn:x-wiley:14651858:media:CD010071:CD010071-CMP-003-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_t/tCD010071-CMP-003-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 PRT versus control: Rotator cuff tears (surgical repair), Outcome 3 Function (UCLA score): long term (1 year follow‐up)." data-id="CD010071-fig-0019" src="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-CMP-003-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.3</div> <div class="figure-caption"> <p>Comparison 3 PRT versus control: Rotator cuff tears (surgical repair), Outcome 3 Function (UCLA score): long term (1 year follow‐up). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/references#CD010071-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-CMP-003-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010071-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/urn:x-wiley:14651858:media:CD010071:CD010071-CMP-003-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_t/tCD010071-CMP-003-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 PRT versus control: Rotator cuff tears (surgical repair), Outcome 4 Function (Simple Shoulder Test (SST)): long term (1 year follow‐up)." data-id="CD010071-fig-0020" src="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-CMP-003-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.4</div> <div class="figure-caption"> <p>Comparison 3 PRT versus control: Rotator cuff tears (surgical repair), Outcome 4 Function (Simple Shoulder Test (SST)): long term (1 year follow‐up). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/references#CD010071-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-CMP-003-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010071-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/urn:x-wiley:14651858:media:CD010071:CD010071-CMP-003-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_t/tCD010071-CMP-003-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 PRT versus control: Rotator cuff tears (surgical repair), Outcome 5 Function (DASH score): long term (1 year follow‐up)." data-id="CD010071-fig-0021" src="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-CMP-003-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.5</div> <div class="figure-caption"> <p>Comparison 3 PRT versus control: Rotator cuff tears (surgical repair), Outcome 5 Function (DASH score): long term (1 year follow‐up). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/references#CD010071-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-CMP-003-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010071-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/urn:x-wiley:14651858:media:CD010071:CD010071-CMP-003-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_t/tCD010071-CMP-003-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 PRT versus control: Rotator cuff tears (surgical repair), Outcome 6 Function (DASH score): long term (2 year follow‐up)." data-id="CD010071-fig-0022" src="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-CMP-003-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.6</div> <div class="figure-caption"> <p>Comparison 3 PRT versus control: Rotator cuff tears (surgical repair), Outcome 6 Function (DASH score): long term (2 year follow‐up). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/references#CD010071-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-CMP-003-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010071-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/urn:x-wiley:14651858:media:CD010071:CD010071-CMP-003-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_t/tCD010071-CMP-003-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 PRT versus control: Rotator cuff tears (surgical repair), Outcome 7 Function (L'Insalata score): long term (1 year follow‐up)." data-id="CD010071-fig-0023" src="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-CMP-003-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.7</div> <div class="figure-caption"> <p>Comparison 3 PRT versus control: Rotator cuff tears (surgical repair), Outcome 7 Function (L'Insalata score): long term (1 year follow‐up). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/references#CD010071-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-CMP-003-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010071-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/urn:x-wiley:14651858:media:CD010071:CD010071-CMP-003-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_t/tCD010071-CMP-003-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 PRT versus control: Rotator cuff tears (surgical repair), Outcome 8 Function (ASES score): long term (1 year follow‐up)." data-id="CD010071-fig-0024" src="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-CMP-003-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.8</div> <div class="figure-caption"> <p>Comparison 3 PRT versus control: Rotator cuff tears (surgical repair), Outcome 8 Function (ASES score): long term (1 year follow‐up). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/references#CD010071-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-CMP-003-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010071-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/urn:x-wiley:14651858:media:CD010071:CD010071-CMP-003-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_t/tCD010071-CMP-003-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 PRT versus control: Rotator cuff tears (surgical repair), Outcome 9 Function (all scores/instruments): long term (1 year follow‐up)." data-id="CD010071-fig-0025" src="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-CMP-003-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.9</div> <div class="figure-caption"> <p>Comparison 3 PRT versus control: Rotator cuff tears (surgical repair), Outcome 9 Function (all scores/instruments): long term (1 year follow‐up). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/references#CD010071-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-CMP-003-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010071-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/urn:x-wiley:14651858:media:CD010071:CD010071-CMP-003-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_t/tCD010071-CMP-003-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 PRT versus control: Rotator cuff tears (surgical repair), Outcome 10 Pain (Analogue Scale): short term (7 day follow‐up)." data-id="CD010071-fig-0026" src="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-CMP-003-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.10</div> <div class="figure-caption"> <p>Comparison 3 PRT versus control: Rotator cuff tears (surgical repair), Outcome 10 Pain (Analogue Scale): short term (7 day follow‐up). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/references#CD010071-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-CMP-003-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010071-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/urn:x-wiley:14651858:media:CD010071:CD010071-CMP-003-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_t/tCD010071-CMP-003-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 PRT versus control: Rotator cuff tears (surgical repair), Outcome 11 Pain (Analogue Scale): long term (2 year follow‐up)." data-id="CD010071-fig-0027" src="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-CMP-003-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.11</div> <div class="figure-caption"> <p>Comparison 3 PRT versus control: Rotator cuff tears (surgical repair), Outcome 11 Pain (Analogue Scale): long term (2 year follow‐up). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/references#CD010071-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-CMP-003-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010071-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/urn:x-wiley:14651858:media:CD010071:CD010071-CMP-003-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_t/tCD010071-CMP-003-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 PRT versus control: Rotator cuff tears (surgical repair), Outcome 12 Pain (Analogue Scale): long term (1 year follow‐up)." data-id="CD010071-fig-0028" src="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-CMP-003-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.12</div> <div class="figure-caption"> <p>Comparison 3 PRT versus control: Rotator cuff tears (surgical repair), Outcome 12 Pain (Analogue Scale): long term (1 year follow‐up). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/references#CD010071-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-CMP-003-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010071-fig-0029"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/urn:x-wiley:14651858:media:CD010071:CD010071-CMP-003-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_t/tCD010071-CMP-003-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 PRT versus control: Rotator cuff tears (surgical repair), Outcome 13 Pain (Analogue Scale): short term (30 day follow‐up)." data-id="CD010071-fig-0029" src="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-CMP-003-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.13</div> <div class="figure-caption"> <p>Comparison 3 PRT versus control: Rotator cuff tears (surgical repair), Outcome 13 Pain (Analogue Scale): short term (30 day follow‐up). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/references#CD010071-fig-0029">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-CMP-003-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010071-fig-0030"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/urn:x-wiley:14651858:media:CD010071:CD010071-CMP-003-14" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_t/tCD010071-CMP-003-14.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 PRT versus control: Rotator cuff tears (surgical repair), Outcome 14 Rate of retear: long term (1 year follow‐up)." data-id="CD010071-fig-0030" src="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-CMP-003-14.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.14</div> <div class="figure-caption"> <p>Comparison 3 PRT versus control: Rotator cuff tears (surgical repair), Outcome 14 Rate of retear: long term (1 year follow‐up). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/references#CD010071-fig-0030">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-CMP-003-14.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010071-fig-0031"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/urn:x-wiley:14651858:media:CD010071:CD010071-CMP-003-15" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_t/tCD010071-CMP-003-15.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 PRT versus control: Rotator cuff tears (surgical repair), Outcome 15 Rate of retear: long term (2 year follow‐up)." data-id="CD010071-fig-0031" src="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-CMP-003-15.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.15</div> <div class="figure-caption"> <p>Comparison 3 PRT versus control: Rotator cuff tears (surgical repair), Outcome 15 Rate of retear: long term (2 year follow‐up). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/references#CD010071-fig-0031">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-CMP-003-15.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010071-fig-0032"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/urn:x-wiley:14651858:media:CD010071:CD010071-CMP-003-16" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_t/tCD010071-CMP-003-16.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 PRT versus control: Rotator cuff tears (surgical repair), Outcome 16 Patient satisfaction." data-id="CD010071-fig-0032" src="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-CMP-003-16.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.16</div> <div class="figure-caption"> <p>Comparison 3 PRT versus control: Rotator cuff tears (surgical repair), Outcome 16 Patient satisfaction. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/references#CD010071-fig-0032">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-CMP-003-16.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010071-fig-0033"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/urn:x-wiley:14651858:media:CD010071:CD010071-CMP-004-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_t/tCD010071-CMP-004-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 PRT versus control: Shoulder impingement syndrome (surgery), Outcome 1 Functional (self‐evaluation instability score: short term (6 week follow‐up)." data-id="CD010071-fig-0033" src="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-CMP-004-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4 PRT versus control: Shoulder impingement syndrome (surgery), Outcome 1 Functional (self‐evaluation instability score: short term (6 week follow‐up). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/references#CD010071-fig-0033">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-CMP-004-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010071-fig-0034"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/urn:x-wiley:14651858:media:CD010071:CD010071-CMP-004-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_t/tCD010071-CMP-004-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 PRT versus control: Shoulder impingement syndrome (surgery), Outcome 2 Functional instability after surgery: 6 week follow‐up." data-id="CD010071-fig-0034" src="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-CMP-004-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.2</div> <div class="figure-caption"> <p>Comparison 4 PRT versus control: Shoulder impingement syndrome (surgery), Outcome 2 Functional instability after surgery: 6 week follow‐up. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/references#CD010071-fig-0034">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-CMP-004-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010071-fig-0035"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/urn:x-wiley:14651858:media:CD010071:CD010071-CMP-004-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_t/tCD010071-CMP-004-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 PRT versus control: Shoulder impingement syndrome (surgery), Outcome 3 Pain (VAS): short term (6 week follow‐up)." data-id="CD010071-fig-0035" src="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-CMP-004-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.3</div> <div class="figure-caption"> <p>Comparison 4 PRT versus control: Shoulder impingement syndrome (surgery), Outcome 3 Pain (VAS): short term (6 week follow‐up). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/references#CD010071-fig-0035">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-CMP-004-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010071-fig-0036"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/urn:x-wiley:14651858:media:CD010071:CD010071-CMP-005-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_t/tCD010071-CMP-005-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 PRT versus control: Elbow epicondylitis, Outcome 1 Function (PRTEE score): short term (3 month follow‐up)." data-id="CD010071-fig-0036" src="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-CMP-005-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.1</div> <div class="figure-caption"> <p>Comparison 5 PRT versus control: Elbow epicondylitis, Outcome 1 Function (PRTEE score): short term (3 month follow‐up). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/references#CD010071-fig-0036">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-CMP-005-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010071-fig-0037"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/urn:x-wiley:14651858:media:CD010071:CD010071-CMP-005-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_t/tCD010071-CMP-005-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 PRT versus control: Elbow epicondylitis, Outcome 2 Function (PRTEE scores): medium term (6 month follow‐up)." data-id="CD010071-fig-0037" src="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-CMP-005-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.2</div> <div class="figure-caption"> <p>Comparison 5 PRT versus control: Elbow epicondylitis, Outcome 2 Function (PRTEE scores): medium term (6 month follow‐up). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/references#CD010071-fig-0037">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-CMP-005-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010071-fig-0038"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/urn:x-wiley:14651858:media:CD010071:CD010071-CMP-005-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_t/tCD010071-CMP-005-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 PRT versus control: Elbow epicondylitis, Outcome 3 Function (Liverpool elbow score): short term (3 month follow‐up)." data-id="CD010071-fig-0038" src="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-CMP-005-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.3</div> <div class="figure-caption"> <p>Comparison 5 PRT versus control: Elbow epicondylitis, Outcome 3 Function (Liverpool elbow score): short term (3 month follow‐up). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/references#CD010071-fig-0038">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-CMP-005-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010071-fig-0039"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/urn:x-wiley:14651858:media:CD010071:CD010071-CMP-005-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_t/tCD010071-CMP-005-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 PRT versus control: Elbow epicondylitis, Outcome 4 Function (Liverpool elbow score): medium term (6 month follow‐up)." data-id="CD010071-fig-0039" src="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-CMP-005-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.4</div> <div class="figure-caption"> <p>Comparison 5 PRT versus control: Elbow epicondylitis, Outcome 4 Function (Liverpool elbow score): medium term (6 month follow‐up). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/references#CD010071-fig-0039">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-CMP-005-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010071-fig-0040"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/urn:x-wiley:14651858:media:CD010071:CD010071-CMP-005-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_t/tCD010071-CMP-005-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 PRT versus control: Elbow epicondylitis, Outcome 5 Function (all scores/instruments): short term (3 months or less follow‐up)." data-id="CD010071-fig-0040" src="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-CMP-005-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.5</div> <div class="figure-caption"> <p>Comparison 5 PRT versus control: Elbow epicondylitis, Outcome 5 Function (all scores/instruments): short term (3 months or less follow‐up). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/references#CD010071-fig-0040">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-CMP-005-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010071-fig-0041"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/urn:x-wiley:14651858:media:CD010071:CD010071-CMP-005-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_t/tCD010071-CMP-005-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 PRT versus control: Elbow epicondylitis, Outcome 6 Pain (VAS): short term (6 week follow‐up)." data-id="CD010071-fig-0041" src="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-CMP-005-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.6</div> <div class="figure-caption"> <p>Comparison 5 PRT versus control: Elbow epicondylitis, Outcome 6 Pain (VAS): short term (6 week follow‐up). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/references#CD010071-fig-0041">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-CMP-005-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010071-fig-0042"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/urn:x-wiley:14651858:media:CD010071:CD010071-CMP-005-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_t/tCD010071-CMP-005-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 PRT versus control: Elbow epicondylitis, Outcome 7 Pain (VAS): medium term (6 month follow‐up)." data-id="CD010071-fig-0042" src="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-CMP-005-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.7</div> <div class="figure-caption"> <p>Comparison 5 PRT versus control: Elbow epicondylitis, Outcome 7 Pain (VAS): medium term (6 month follow‐up). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/references#CD010071-fig-0042">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-CMP-005-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010071-fig-0043"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/urn:x-wiley:14651858:media:CD010071:CD010071-CMP-006-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_t/tCD010071-CMP-006-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 PRT versus control: ACL reconstruction (patellar tendon graft donor site), Outcome 1 Function (Tegner scores): medium term (6 month follow‐up)." data-id="CD010071-fig-0043" src="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-CMP-006-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.1</div> <div class="figure-caption"> <p>Comparison 6 PRT versus control: ACL reconstruction (patellar tendon graft donor site), Outcome 1 Function (Tegner scores): medium term (6 month follow‐up). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/references#CD010071-fig-0043">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-CMP-006-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010071-fig-0044"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/urn:x-wiley:14651858:media:CD010071:CD010071-CMP-006-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_t/tCD010071-CMP-006-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 PRT versus control: ACL reconstruction (patellar tendon graft donor site), Outcome 2 Function (Lysholm score): medium term (6 month follow‐up)." data-id="CD010071-fig-0044" src="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-CMP-006-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.2</div> <div class="figure-caption"> <p>Comparison 6 PRT versus control: ACL reconstruction (patellar tendon graft donor site), Outcome 2 Function (Lysholm score): medium term (6 month follow‐up). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/references#CD010071-fig-0044">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-CMP-006-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010071-fig-0045"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/urn:x-wiley:14651858:media:CD010071:CD010071-CMP-006-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_t/tCD010071-CMP-006-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 PRT versus control: ACL reconstruction (patellar tendon graft donor site), Outcome 3 Function (VISA score): long term (1 year follow‐up)." data-id="CD010071-fig-0045" src="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-CMP-006-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.3</div> <div class="figure-caption"> <p>Comparison 6 PRT versus control: ACL reconstruction (patellar tendon graft donor site), Outcome 3 Function (VISA score): long term (1 year follow‐up). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/references#CD010071-fig-0045">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-CMP-006-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010071-fig-0046"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/urn:x-wiley:14651858:media:CD010071:CD010071-CMP-006-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_t/tCD010071-CMP-006-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 PRT versus control: ACL reconstruction (patellar tendon graft donor site), Outcome 4 Pain (VAS): first post‐op day." data-id="CD010071-fig-0046" src="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-CMP-006-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.4</div> <div class="figure-caption"> <p>Comparison 6 PRT versus control: ACL reconstruction (patellar tendon graft donor site), Outcome 4 Pain (VAS): first post‐op day. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/references#CD010071-fig-0046">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-CMP-006-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010071-fig-0047"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/urn:x-wiley:14651858:media:CD010071:CD010071-CMP-007-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_t/tCD010071-CMP-007-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 PRT versus control: ACL reconstruction, Outcome 1 Function (IKDC scores): long term (1 year follow‐up)." data-id="CD010071-fig-0047" src="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-CMP-007-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.1</div> <div class="figure-caption"> <p>Comparison 7 PRT versus control: ACL reconstruction, Outcome 1 Function (IKDC scores): long term (1 year follow‐up). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/references#CD010071-fig-0047">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-CMP-007-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010071-fig-0048"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/urn:x-wiley:14651858:media:CD010071:CD010071-CMP-007-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_t/tCD010071-CMP-007-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 PRT versus control: ACL reconstruction, Outcome 2 Function (IKDC categories A &amp; B: normal/nearly normal): medium and long term follow‐up." data-id="CD010071-fig-0048" src="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-CMP-007-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.2</div> <div class="figure-caption"> <p>Comparison 7 PRT versus control: ACL reconstruction, Outcome 2 Function (IKDC categories A &amp; B: normal/nearly normal): medium and long term follow‐up. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/references#CD010071-fig-0048">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-CMP-007-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010071-fig-0049"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/urn:x-wiley:14651858:media:CD010071:CD010071-CMP-007-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_t/tCD010071-CMP-007-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 PRT versus control: ACL reconstruction, Outcome 3 Function (Lysholm score): long term (1 year follow‐up)." data-id="CD010071-fig-0049" src="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-CMP-007-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.3</div> <div class="figure-caption"> <p>Comparison 7 PRT versus control: ACL reconstruction, Outcome 3 Function (Lysholm score): long term (1 year follow‐up). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/references#CD010071-fig-0049">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-CMP-007-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010071-fig-0050"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/urn:x-wiley:14651858:media:CD010071:CD010071-CMP-008-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_t/tCD010071-CMP-008-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 PRT versus control: Patellar tendinopathy, Outcome 1 Function (VISA scores): medium term (6 month follow‐up)." data-id="CD010071-fig-0050" src="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-CMP-008-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.1</div> <div class="figure-caption"> <p>Comparison 8 PRT versus control: Patellar tendinopathy, Outcome 1 Function (VISA scores): medium term (6 month follow‐up). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/references#CD010071-fig-0050">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-CMP-008-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010071-fig-0051"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/urn:x-wiley:14651858:media:CD010071:CD010071-CMP-008-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_t/tCD010071-CMP-008-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 PRT versus control: Patellar tendinopathy, Outcome 2 Function (Tegner scores): medium term (6 month follow‐up)." data-id="CD010071-fig-0051" src="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-CMP-008-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.2</div> <div class="figure-caption"> <p>Comparison 8 PRT versus control: Patellar tendinopathy, Outcome 2 Function (Tegner scores): medium term (6 month follow‐up). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/references#CD010071-fig-0051">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-CMP-008-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010071-fig-0052"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/urn:x-wiley:14651858:media:CD010071:CD010071-CMP-008-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_t/tCD010071-CMP-008-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 PRT versus control: Patellar tendinopathy, Outcome 3 Function (Lysholm score): medium term (6 month follow‐up)." data-id="CD010071-fig-0052" src="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-CMP-008-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.3</div> <div class="figure-caption"> <p>Comparison 8 PRT versus control: Patellar tendinopathy, Outcome 3 Function (Lysholm score): medium term (6 month follow‐up). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/references#CD010071-fig-0052">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-CMP-008-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010071-fig-0053"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/urn:x-wiley:14651858:media:CD010071:CD010071-CMP-008-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_t/tCD010071-CMP-008-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 PRT versus control: Patellar tendinopathy, Outcome 4 Pain (VAS): medium term (6 month follow‐up)." data-id="CD010071-fig-0053" src="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-CMP-008-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.4</div> <div class="figure-caption"> <p>Comparison 8 PRT versus control: Patellar tendinopathy, Outcome 4 Pain (VAS): medium term (6 month follow‐up). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/references#CD010071-fig-0053">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-CMP-008-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010071-fig-0054"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/urn:x-wiley:14651858:media:CD010071:CD010071-CMP-008-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_t/tCD010071-CMP-008-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 PRT versus control: Patellar tendinopathy, Outcome 5 Quality of Life (SF‐12 score): medium term (6 month follow‐up)." data-id="CD010071-fig-0054" src="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-CMP-008-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.5</div> <div class="figure-caption"> <p>Comparison 8 PRT versus control: Patellar tendinopathy, Outcome 5 Quality of Life (SF‐12 score): medium term (6 month follow‐up). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/references#CD010071-fig-0054">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-CMP-008-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010071-fig-0055"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/urn:x-wiley:14651858:media:CD010071:CD010071-CMP-009-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_t/tCD010071-CMP-009-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 PRT versus control: Achilles tendinopathy, Outcome 1 Function (VISA‐A scores): short term (6 week follow‐up)." data-id="CD010071-fig-0055" src="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-CMP-009-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.1</div> <div class="figure-caption"> <p>Comparison 9 PRT versus control: Achilles tendinopathy, Outcome 1 Function (VISA‐A scores): short term (6 week follow‐up). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/references#CD010071-fig-0055">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-CMP-009-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010071-fig-0056"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/urn:x-wiley:14651858:media:CD010071:CD010071-CMP-009-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_t/tCD010071-CMP-009-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 PRT versus control: Achilles tendinopathy, Outcome 2 Function (VISA‐A score): medium term (6 month follow‐up)." data-id="CD010071-fig-0056" src="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-CMP-009-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.2</div> <div class="figure-caption"> <p>Comparison 9 PRT versus control: Achilles tendinopathy, Outcome 2 Function (VISA‐A score): medium term (6 month follow‐up). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/references#CD010071-fig-0056">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-CMP-009-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010071-fig-0057"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/urn:x-wiley:14651858:media:CD010071:CD010071-CMP-009-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_t/tCD010071-CMP-009-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 PRT versus control: Achilles tendinopathy, Outcome 3 Function (VISA‐A scores): long term (1 year follow‐up)." data-id="CD010071-fig-0057" src="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-CMP-009-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.3</div> <div class="figure-caption"> <p>Comparison 9 PRT versus control: Achilles tendinopathy, Outcome 3 Function (VISA‐A scores): long term (1 year follow‐up). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/references#CD010071-fig-0057">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-CMP-009-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010071-fig-0058"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/urn:x-wiley:14651858:media:CD010071:CD010071-CMP-009-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_t/tCD010071-CMP-009-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 PRT versus control: Achilles tendinopathy, Outcome 4 Satisfied patients: medium term (6 month follow‐up)." data-id="CD010071-fig-0058" src="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-CMP-009-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.4</div> <div class="figure-caption"> <p>Comparison 9 PRT versus control: Achilles tendinopathy, Outcome 4 Satisfied patients: medium term (6 month follow‐up). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/references#CD010071-fig-0058">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-CMP-009-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010071-fig-0059"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/urn:x-wiley:14651858:media:CD010071:CD010071-CMP-009-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_t/tCD010071-CMP-009-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 PRT versus control: Achilles tendinopathy, Outcome 5 Satisfied patients: long term (1 year follow‐up)." data-id="CD010071-fig-0059" src="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-CMP-009-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.5</div> <div class="figure-caption"> <p>Comparison 9 PRT versus control: Achilles tendinopathy, Outcome 5 Satisfied patients: long term (1 year follow‐up). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/references#CD010071-fig-0059">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-CMP-009-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010071-fig-0060"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/urn:x-wiley:14651858:media:CD010071:CD010071-CMP-009-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_t/tCD010071-CMP-009-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 PRT versus control: Achilles tendinopathy, Outcome 6 Return to desired sports: medium term (6 month follow‐up)." data-id="CD010071-fig-0060" src="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-CMP-009-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.6</div> <div class="figure-caption"> <p>Comparison 9 PRT versus control: Achilles tendinopathy, Outcome 6 Return to desired sports: medium term (6 month follow‐up). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/references#CD010071-fig-0060">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-CMP-009-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010071-fig-0061"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/urn:x-wiley:14651858:media:CD010071:CD010071-CMP-009-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_t/tCD010071-CMP-009-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 PRT versus control: Achilles tendinopathy, Outcome 7 Return to desired sports: long term (1 year follow‐up)." data-id="CD010071-fig-0061" src="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-CMP-009-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.7</div> <div class="figure-caption"> <p>Comparison 9 PRT versus control: Achilles tendinopathy, Outcome 7 Return to desired sports: long term (1 year follow‐up). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/references#CD010071-fig-0061">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-CMP-009-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010071-fig-0062"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/urn:x-wiley:14651858:media:CD010071:CD010071-CMP-010-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_t/tCD010071-CMP-010-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 10 PRT versus control: Acute Achilles tendon ruptures (surgical repair), Outcome 1 Function (heel‐raise index): medium term (6 month follow‐up)." data-id="CD010071-fig-0062" src="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-CMP-010-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.1</div> <div class="figure-caption"> <p>Comparison 10 PRT versus control: Acute Achilles tendon ruptures (surgical repair), Outcome 1 Function (heel‐raise index): medium term (6 month follow‐up). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/references#CD010071-fig-0062">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-CMP-010-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010071-fig-0063"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/urn:x-wiley:14651858:media:CD010071:CD010071-CMP-010-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_t/tCD010071-CMP-010-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 10 PRT versus control: Acute Achilles tendon ruptures (surgical repair), Outcome 2 Function (heel‐raise index): long term (1 year follow‐up)." data-id="CD010071-fig-0063" src="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-CMP-010-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.2</div> <div class="figure-caption"> <p>Comparison 10 PRT versus control: Acute Achilles tendon ruptures (surgical repair), Outcome 2 Function (heel‐raise index): long term (1 year follow‐up). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/references#CD010071-fig-0063">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-CMP-010-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010071-fig-0064"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/urn:x-wiley:14651858:media:CD010071:CD010071-CMP-010-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_t/tCD010071-CMP-010-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 10 PRT versus control: Acute Achilles tendon ruptures (surgical repair), Outcome 3 Complications." data-id="CD010071-fig-0064" src="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-CMP-010-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.3</div> <div class="figure-caption"> <p>Comparison 10 PRT versus control: Acute Achilles tendon ruptures (surgical repair), Outcome 3 Complications. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/references#CD010071-fig-0064">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/media/CDSR/CD010071/image_n/nCD010071-CMP-010-03.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="comparison" data-id="CD010071-tbl-0001"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">PRT versus control: all conditions</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Function (all scores/instruments): short term (up to 3 months follow‐up) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>162</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.26 [‐0.19, 0.71]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Rotator cuff tear (surgical repair)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Shoulder impingement syndrome (surgery)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.62 [‐0.02, 1.25]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 Elbow epicondylitis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>68</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.41 [‐0.08, 0.89]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4 ACL reconstruction (patellar tendon graft donor site)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.5 ACL reconstruction</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.6 Patellar tendinopathy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.7 Achilles tendinopathy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>54</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.30 [‐0.84, 0.24]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.8 Achilles tendon rupture (surgical repair)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Function (all scores/instruments): medium term (over 3 months, under 1 year follow‐up) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>151</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.09 [‐0.56, 0.39]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Rotator cuff tear (surgical repair)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Shoulder impingement syndrome (surgery)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3 Elbow epicondylitis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>27</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.74 [‐0.05, 1.52]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.4 ACL reconstruction (patellar tendon graft donor site)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>25</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.04 [‐0.76, 0.84]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.5 ACL reconstruction</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.6 Patellar tendinopathy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.93 [‐1.95, 0.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.7 Achilles tendinopathy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>54</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.04 [‐0.57, 0.49]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.8 Achilles tendon rupture (surgical repair)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.46 [‐1.21, 0.29]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Functional (all scores/instruments): long term (1 year or more follow‐up) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>484</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.25 [‐0.07, 0.57]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Rotator cuff tear (surgical repair)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>324</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.13 [‐0.24, 0.51]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Shoulder impingement syndrome (surgery)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3 Elbow epicondylitis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.4 ACL reconstruction (patellar tendon graft donor site)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.53 [0.82, 2.24]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.5 ACL reconstruction</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.31 [‐0.31, 0.94]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.6 Patellar tendinopathy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.7 Achilles tendinopathy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>54</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.03 [‐0.51, 0.56]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.8 Achilles tendon rupture (surgical repair)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>26</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.08 [‐0.69, 0.85]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Pain (VAS: 0 to 10: worst pain): short term (up to 3 months follow‐up) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>175</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.95 [‐1.41, ‐0.48]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Rotator cuff tears (surgical repair)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>107</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.69 [‐1.64, 0.25]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Shoulder impingement syndrome (surgery)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.4 [‐2.36, ‐0.44]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.3 Elbow epicondylitis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.86 [‐1.51, ‐0.21]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.4 ACL reconstruction (patellar tendon graft donor site)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.5 ACL reconstruction</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.6 Patellar tendinopathy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.7 Achilles tendinopathy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.8 Achilles tendon rupture (surgical repair)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Pain (VAS: 0 to 10: worst pain): medium term (over 3 months, under 1 year follow‐up) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Rotator cuff tear (surgical repair)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 Shoulder impingement syndrome (surgery)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.3 Elbow epicondylitis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>27</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.75 [‐1.57, 0.07]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.4 ACL reconstruction (patellar tendon graft donor site)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.5 ACL reconstruction</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.6 Patellar tendinopathy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.4 [0.32, 2.48]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.7 Achilles tendinopathy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.8 Achilles tendon rupture (surgical repair)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Pain (VAS: 0 to 10: worst pain): long term (1 year or more follow‐up) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 Rotator cuff tear (surgical repair)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>81</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.29 [‐1.02, 0.44]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 Shoulder impingement syndrome (surgery)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.3 Elbow epicondylitis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.4 ACL reconstruction (patellar tendon graft donor site)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.5 ACL reconstruction</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.6 Patellar tendinopathy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.7 Achilles tendinopathy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.8 Achilles tendon rupture (surgical repair)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Adverse effects (any of PRT or placebo application) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>486</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.31 [0.48, 3.59]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">PRT versus control: all conditions</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/references#CD010071-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010071-tbl-0002"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">PRT versus control: subgrouped by tendinopathies and augmentation procedures</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Function (all scores/instruments): short term (up to 3 months follow‐up) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Tendinopathies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>122</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.14 [‐0.38, 0.67]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Augmentation procedures</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.62 [‐0.02, 1.25]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Function (all scores/instruments): medium term (over 3 months, under 1 year follow‐up) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Tendinopathies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>98</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.02 [‐0.83, 0.78]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Augmentation procedures</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.22 [‐0.77, 0.32]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Functional (all scores/instruments): long term (1 year or more follow‐up) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Tendinopathies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>54</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.03 [‐0.51, 0.56]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Augmentation procedures</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>430</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.28 [‐0.08, 0.64]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Pain (VAS: 0 to 10: worst pain): short term (up to 3 months follow‐up) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>175</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.95 [‐1.41, ‐0.48]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Tendinopathies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.86 [‐1.51, ‐0.21]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Augmentation procedures</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>147</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.04 [‐1.71, ‐0.37]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Pain (VAS: 0 to 10: worst pain): medium term (over 3 months, under 1 year follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Tendinopathies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 Augmentation procedures</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Pain (VAS: 0 to 10: worst pain): long term (1 year or more follow‐up) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 Tendinopathies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 Augmentation procedures</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Adverse effects (any of PRT pr placebo application <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 Tendinopathies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>94</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.33 [0.34, 5.21]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.2 Augmentation procedures</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>392</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.29 [0.29, 5.71]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">PRT versus control: subgrouped by tendinopathies and augmentation procedures</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/references#CD010071-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010071-tbl-0003"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">PRT versus control: Rotator cuff tears (surgical repair)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Function (Constant score): long term (1 year follow‐up) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>290</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.47 [0.68, 4.26]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Function (Constant score): long term (2 year follow‐up) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Function (UCLA score): long term (1 year follow‐up) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>98</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.56 [‐0.19, 3.31]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Function (Simple Shoulder Test (SST)): long term (1 year follow‐up) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>120</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.42 [0.07, 0.78]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Function (DASH score): long term (1 year follow‐up) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Function (DASH score): long term (2 year follow‐up) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Function (L'Insalata score): long term (1 year follow‐up) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Function (ASES score): long term (1 year follow‐up) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Function (all scores/instruments): long term (1 year follow‐up) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>324</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.13 [‐0.24, 0.51]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Pain (Analogue Scale): short term (7 day follow‐up) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>105</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.40 [‐2.44, ‐0.36]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Pain (Analogue Scale): long term (2 year follow‐up) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Pain (Analogue Scale): long term (1 year follow‐up) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>82</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.30 [‐1.20, 0.61]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 Pain (Analogue Scale): short term (30 day follow‐up) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>107</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.69 [‐1.64, 0.25]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">14 Rate of retear: long term (1 year follow‐up) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>199</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.55 [0.30, 1.01]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">15 Rate of retear: long term (2 year follow‐up) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>73</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.88 [0.59, 1.32]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">16 Patient satisfaction <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">PRT versus control: Rotator cuff tears (surgical repair)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/references#CD010071-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010071-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">PRT versus control: Shoulder impingement syndrome (surgery)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Functional (self‐evaluation instability score: short term (6 week follow‐up) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Functional instability after surgery: 6 week follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Pain (VAS): short term (6 week follow‐up) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">PRT versus control: Shoulder impingement syndrome (surgery)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/references#CD010071-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010071-tbl-0005"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">PRT versus control: Elbow epicondylitis</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Function (PRTEE score): short term (3 month follow‐up) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>151</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.81 [‐7.73, 4.11]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Function (PRTEE scores): medium term (6 month follow‐up) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Function (Liverpool elbow score): short term (3 month follow‐up) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Function (Liverpool elbow score): medium term (6 month follow‐up) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Function (all scores/instruments): short term (3 months or less follow‐up) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>68</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.40 [‐0.08, 0.89]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Pain (VAS): short term (6 week follow‐up) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Pain (VAS): medium term (6 month follow‐up) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">PRT versus control: Elbow epicondylitis</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/references#CD010071-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010071-tbl-0006"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">PRT versus control: ACL reconstruction (patellar tendon graft donor site)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Function (Tegner scores): medium term (6 month follow‐up) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Function (Lysholm score): medium term (6 month follow‐up) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Function (VISA score): long term (1 year follow‐up) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Pain (VAS): first post‐op day <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">PRT versus control: ACL reconstruction (patellar tendon graft donor site)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/references#CD010071-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010071-tbl-0007"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">PRT versus control: ACL reconstruction</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Function (IKDC scores): long term (1 year follow‐up) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Function (IKDC categories A &amp; B: normal/nearly normal): medium and long term follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>193</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.96, 1.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Function (Lysholm score): long term (1 year follow‐up) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">PRT versus control: ACL reconstruction</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/references#CD010071-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010071-tbl-0008"> <div class="table-heading"><span class="table-label">Comparison 8.</span> <span class="table-title">PRT versus control: Patellar tendinopathy</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Function (VISA scores): medium term (6 month follow‐up) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Function (Tegner scores): medium term (6 month follow‐up) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Function (Lysholm score): medium term (6 month follow‐up) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Pain (VAS): medium term (6 month follow‐up) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Quality of Life (SF‐12 score): medium term (6 month follow‐up) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 8.</span> <span class="table-title">PRT versus control: Patellar tendinopathy</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/references#CD010071-tbl-0008">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010071-tbl-0009"> <div class="table-heading"><span class="table-label">Comparison 9.</span> <span class="table-title">PRT versus control: Achilles tendinopathy</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Function (VISA‐A scores): short term (6 week follow‐up) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Function (VISA‐A score): medium term (6 month follow‐up) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Function (VISA‐A scores): long term (1 year follow‐up) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Satisfied patients: medium term (6 month follow‐up) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Satisfied patients: long term (1 year follow‐up) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Return to desired sports: medium term (6 month follow‐up) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Return to desired sports: long term (1 year follow‐up) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 9.</span> <span class="table-title">PRT versus control: Achilles tendinopathy</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/references#CD010071-tbl-0009">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010071-tbl-0010"> <div class="table-heading"><span class="table-label">Comparison 10.</span> <span class="table-title">PRT versus control: Acute Achilles tendon ruptures (surgical repair)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Function (heel‐raise index): medium term (6 month follow‐up) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Function (heel‐raise index): long term (1 year follow‐up) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Complications <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 10.</span> <span class="table-title">PRT versus control: Acute Achilles tendon ruptures (surgical repair)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010071.pub3/references#CD010071-tbl-0010">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD010071.pub3&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD010071-note-0001">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD010071-note-0004">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD010071-note-0007">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD010071-note-0003">Français</a> </li> <li class="section-language"> <a class="" href="hr#CD010071-note-0002">Hrvatski</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br/> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734739000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734739000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773542000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773471000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010071\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010071\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010071\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010071\x2epub3"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010071\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010071\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010071\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010071\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010071\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010071\x2epub3"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010071\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010071\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010071\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010071\x2epub3"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010071\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010071\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010071\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010071\x2epub3"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=IYhCEbRn&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010071.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD010071.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD010071.pub3/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD010071.pub3/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010071.pub3%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740715126952"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD010071.pub3/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740715126960"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD010071.pub3/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918d7f807adf1bde',t:'MTc0MDcxNTEyNy4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 